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 Versatile 1,4-substituted 1,2,3-triazole based ligands and their transition metal 
complexes have attracted rising attention during last decade and have been 
widely used in catalysis, luminescence and magnetism. Moreover, abundant 
literatures have demonstrated the importance and advantages of integrated 
1,2,3-triazole based molecules as the ligands for transition metal complexes. 
Compare with other kinds of ligands, such as imidazoles, pyrazoles and the 
like, 1,4-substituted 1,2,3-triazole based ligands are still lacking and need 
further study. Meanwhile, with the feature of easy-modification, 1,2,3-triazole 
based ligands could provide the transition metal complexes with optimal 
properties. However, this point has been ignored for long time. Therefore, for 
filling this gap and extending the scope of 1,2,3-triazole based complexes, the 
aim of this study was to present the study of novel functionalized 1,2,3-
triazole ligands and their corresponding transition metal (namely copper, zinc, 
cadmium, nickel, cobalt, iron, manganese and platinum) complexes. In 
addition, structural, luminescent and magnetic analysis, and catalytic activities 
of these complexes towards CuAAC reaction and hydrosilylation reaction 
were also performed. 
Chapter 1 is a general introduction on the development and importance of 
molecular materials, meanwhile, the irreplaceable position of integrated 1,2,3-
triazole ligands via CuAAC click reaction and corresponding transition metal 
complexes in molecular materials is also presented. Literature review of 
CuAAC reaction and closely related 1,2,3-triazole ligand systems and 
corresponding transition metal complexes are provided, and the applications of 
these complexes in photoluminescence and catalysis are also discussed.  
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The following Chapter 2 focuses on the design and synthesis procedures of a 
range of novel hybridized 1,2,3-triazole ligands, containing flexible mono-
triazole, bis-triazole and conjugated bis-triazole ligands. Modified CuAAC 
reaction was chosen for ligands synthesis using CuSO4 as catalyst and sodium 
ascorbate as reducing agent under different reaction conditions (solvents and 
temperatures). 
Subsequently, Chapter 3 describes the synthesis, isolation and 
characterisation of novel hybridized 1,2,3-triazoles supported novel Cu(I) 
complexes. Interesting photoluminescent and crystallographic characteristics 
of these complexes are highlighted. The excellent catalytic activities towards 
one-pot azide-alkyne cycloaddition reaction of three Cu(I) complexes bearing 
different functionalized triazole ligands are also compared under different 
substrates.  
Chapter 4 concerns a range of novel photoluminesecnt d10 metal complexes 
(Zn(II) and Cd(II)) synthesized by hybridized 1,2,3-triazole ligands with three 
functional units, viz. triazole, picolyl and thiopyridyl/ hydroxy and 
corresponding metal precursors. Versatile assemblies including mononuclear, 
metallocyclic and polymeric assemblies as well as a combination of these are 
achieved which demonstrate coordinative and skeletal flexibilities of 
hybridized spacers to determine the assembly outcome. 
Chapter 5 provides an array of isostructural coordination assemblies (M = 
Mn(II), Fe(II), Co(II), Ni(II)) directed by two positional isomers of pyridyl 
and thioether hybridised 1,2,3-triazole spacers. Use of the 4-picolyl as a 
coordinative pendant enables the spacer to function as an open-bridge that 
promotes polymeric propagation, whereas its 2-picolyl isomer favours the 
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chelating mode that support discrete mono-/di-nuclear entities. It is also 
evident that geometric and steric features of the metals, and intra-/inter-
molecular H-bonding interactions could also influence these coordination 
modes. 
Chapter 6 reports a comprehensive study of novel multi-functionalized 1,2,3-
triazole based Cu(II), Ni(II), Co(II), Fe(II) and Mn(II) complexes. The 
synthesis procedure and a series of characterization have been discussed. 
Moreover, the absorbing crystal structures (mononuclear, and dinuclear 
assemblies) and magnetic properties of Cu(II), Ni(II) and Co(II) dinuclear 
complexes are also emphasized. The magnetic results suggest the hybridized 
triazole ligands could support magnetically active complexes. 
Lastly, Chapter 7 presents our attempts to synthesize novel pincer Pt(II) 
complexes using conjugated bis-triazole based ligands which are novel 
bipyridine analogues. And with the help of several kinds of bridged ligands, 
Pt(II) dinuclear complexes are also synthesized. The preliminary solid and 
solution photoluminescent properties of ligands and complexes are analyzed. 
These Pt(II) complexes in hydrosilylation reaction of terminal and internal 
alkynes also gives promising results.  
In conclusion, the scope of hybridized 1,2,3-triazole based ligands and 
corresponding transition metal complexes has been extended. A series of 
novel transition metal complexes with attractive structures and properties 
(catalytic, photoluminescent or magnetic property) have been investigated and 
some of them have been applied as catalysts to kinds of practically valuable 
catalytic reactions, which has pointed another new direction for functionalized 




Materials and physical measurements 
All chemicals and solvents were used as received without further 
purification unless particular instruction. The catalytic reactions were 
conducted by MultiMAX reactors at 800 rpm. 1H and 13C NMR were 
measured at r.t. with Bruker ACF300 300 MHz, Bruker 400 MHz and 
AMX500 500 MHz FT NMR spectrometers. Electrospray ionisation mass 
spectrometric (ESI-MS) analysis was performed on a Finnigan LCQ 
quadrapole ion trap and Brucker amaZon X ion trap mass spectrometers in 
the positive ion mode. Elemental analyses for C, H, N and S were 
performed on the Perkin-Elmer PE 2400 CHNS elemental analyzer and 
Elementar Vario Micro Cube. Infrared spectra were obtained on the Varian 
3100 FT-IR spectrometer using samples in KBr discs. UV-Vis absorption 
spectra were recorded on a UVIKON Spectrometer. Photoluminescence 
were measured using a Perkin Elmer LS 55 Luminescence Spectrometer 
(open mode and 1 % transmittance attenuator mode were used in 
measurements for ligands and metal complexes). Thermogravimetric 
analysis (TGA) was carried out in a nitrogen or air stream using 
simultaneous DTA-TGA equipment of TA Instruments SDT 2960 or Perkin 
Elmer instrument with a heating rate of 10 °C/min. Powder X-ray 
diffraction data were collected on a SIEMENS D5005 or a Bruker AXS 
GADDS X-ray diffractometer with Cu-Kα radiation (λ = 1.5406 Å). EPR 
spectrum was measured using a Bruker ER 200-D-SRC spectrometer for 
solid sample at 298 K. Magnetic measurements were carried out using 
vibrating sample magnetometer integrated with Quantum design PPMS 
xiii 
 
(Physical Property Measurement System) or a Quantum Design SQUID 
MPMS XL-5 magnetometer. 
Caution! Sodium azide is potentially explosive and hence must be handled 
with great caution.  
Caution! ClO4 salts are highly explosive materials and hence must be handled 
with great caution and small scale. 
X-ray crystallography 
All measurements were conducted on a Bruker AXS SMART APEX 
diffractometer, equipped with a CCD area-detector using Mo-Kα radiation (λ 
= 0.71073 Å). The collecting frames of date, indexing reflection and 
determination of lattice parameters and polarization effects were performed 
with the SMART suite programs.1 The integration of intensity of reflections 
and scaling was carried out by SAINT.1 The empirical absorption correction 
was performed by SADABS.2 The space group determination, structure 
solution and least-squares refinements on |F|2 were carried out with the 
SHELXS-97 and SHELXL-97.3 The structures were solved by direct methods 
to locate the heavy atoms, followed by difference maps for the light non-
hydrogen atoms. Anisotropic thermal parameters were refined for the rest of 
the non-hydrogen atoms. Hydrogen atoms were placed geometrically and 
refined isotropically. CCDC reference numbers: 938526 (L19), 922885 (1), 
922886 (2), 938527(4), 938528(5), 938529(6), 938530(7), 938531(8), 
938532(9), 991496 (11), 991497 (12), 991493 (14), 991491 (15), 991498 (16), 
991495 (17), 991494 (18), 991492 (19) and 886407 (20). 
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Chapter 1 Introduction 
Functional molecular complexes and materials with unique architectures are of 
considerable interest because of their extensive structural diversity and 
potential applications in molecular recognition, catalysis, electrical 
conductivity, photoluminescence, gas storage, molecular magnet technologies 
and biochemistry.1-13 These complexes and materials are usually produced by 
simple self-assembly process with both strong and weak interactions, 
including coordinative bonds, hydrogen bonds and π-π stacking interaction. 
Meanwhile, such an assembly process is governed by the subtle interplay of 
metal ions, ligands, solvents, temperature and counter-ions.14 Among these 
factors, the coordination capability of ligand is obviously the most important 
and crucial. On account of its essential position, various ligands have been 
prepared and used in the syntheses of functional molecular complexes and 
materials, such as N-heterocyclic, schiff base, phosphorus, NHC-carbene and 
carboxylic acid ligands. Nowadays, functionalized N-heterocyclic azole 
ligands are gaining in popularity, and are increasingly used in the assembly of 
coordinative metal oligomers and polymers.14 These kinds of ligands have 
several advantages – easy to prepare and modify, bind readily to 3d-matals 
and are soluble in common organic solvents. It is also known that the 
coordination complexes and materials based on the N-based ligands are more 
robust and intricate. Currently, typical examples of N-heterocyclic azole 
ligands include imidazole, benzoimidazole, pyrazole, triazole, benzotriazole 
and tetrazole ligands.14-18 Of these azole ligands, triazole is the most versatile 
azole ligand and functionalized groups can easily be added during post 
modification or in the pre-synthesis. The suffix 'triazole', applies to five-
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membered aromatic ring with three nitrogen atoms at positions 1, 2 and 3 
(1,2,3-triazole) or at positions 1, 2 and 4 (1,2,4-triazole). However, when 
compared to the 1,2,4-triazole, 1,2,3-triazole is more attractive, as it could be 
readily and modularly synthesized via the copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) click reaction. Hence, in this work, we focused on 
functionalized 1,2,3-triazole ligands. 
1.1 CuAAC click reaction 
According to the literature, the study of 1,2,3-triazoles has accelerated 
exponentially starting with an early review of 1,3-dipolar cycloadditions by 
Huisgen in the 1960s.19,20 This Huisgen cyclization reaction would generate 
the mixture of 1,4- and 1,5-substituted 1,2,3-triazole isomers under heating. 
Later, along with the exploration of novel synthesis methodology, 1,4- and 
1,5-substituted 1,2,3-triazole isomers can be obtained separately under 
different reaction conditions. 1,5-disubstituted 1,2,3-triazoles can be 
selectively synthesized by ruthenium-catalyzed azide-alkyne cycloaddition 
(RuAAC) reaction,21 while 1,4-disubstituted 1,2,3-triazoles can be synthesized 
by CuAAC click reaction,22,23 which was independently reported by Sharpless 
and Meldal in 2002. (Scheme 1.1) Although both 1,2,3-triazole isomers have 
the same integrated triazole part and molecular diversity, and various 
coordination modes, the cost of 1,5-substituted 1,2,3-triazole are much higher 
because of the use of ruthenium catalysts.24-27 Moreover, RuAAC reaction is 
more sensitive to solvent and the steric demands of the azide substituents. 
Therefore, 1,4-substituted 1,2,3-triazoles prepared from the CuAAC reaction 
are more widely used as ligands in coordination chemistry.  
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As the premier and representative example of the click reaction, CuAAC 
reaction is remarkable for its efficiency, modularity, atom economy, mild 
reaction conditions, straightforward purification of products and high 
tolerance of functional groups. Along with the developments of multifarious 
catalysts, and methodologies of one-pot reaction, the mechanism of this 
transformation is even more difficult to understand. Despite the mechanism 
being well studied, various aspects remain uncertain. Nevertheless, the 
CuAAC reaction has found applications from organic synthesis to medicinal 
chemistry and from materials design to bio-conjugation enhancement. 
Meanwhile, using CuAAC reactions, the rapid and facile creation of various 
1,4-substituted 1,2,3-triazole ligands through the use of modular building 
blocks becomes possible and in return, accelerates the process of discovery 
and optimization of new metal chelating systems and metal complexes with 
novel structures, properties or applications.28  
  





1.1.1 Mechanistic aspects of CuAAC click reaction  
Based on the initial computational treatment of CuAAC click reaction 
involving mononuclear copper(I) acetylides and organic azides (propyne and 
methyl azide were chosen for simplicity), the possible stepwise catalytic cycle 
is proposed which is depicted in Scheme 1.2.29 In a first stage (step A), the 
starting alkyne would react with the copper(I) species to form the copper(I) 
acetylide exothermically, which probably occurs through a π-alkyne copper(I) 
complex intermediate. This π-coordination of alkyne to copper(I) centre could 
significantly acidify terminal hydrogen of the alkyne, bringing it into the 
proper range to be deprotonated in an aqueous medium and resulting in the 
formation of a σ-acetylide. The azide would then coordinate to copper centre 
in formed copper(I) acetylide by nitrogen adjacent to R2 group (step B) and 
the coordination event is synergistic for both reactive partners which reveals 
β-nucleophilic, vinylidene-like properties of the acetylide, whereas the azide’s 
terminus becomes even more electrophilic. This process could be considered 
as ligand exchange step which is nearly thermoneutral computationally. In the 
next step (step C), the activated azide electrophilically attack the acetylide 
carbon by the 'external-end' nitrogen atom to form the first C-N bond to 
generate a strained copper metallacycle. This step is endothermic, however, 
the energy barrier is considerably lower than the barrier for the uncatalyzed 
reaction, and accounts for the observed rate acceleration accomplished by Cu(I) 
catalysts. Copper triazolide could be generated by subsequent ring contraction 
(step D), which is quite facile and energetically favorable. If protected by 
steric bulky group, copper triazolide complexes could be isolated from the 
CuAAC reaction mixture.30 This direct precursor could give final triazole 
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product by protonation and release the copper(I) catalyst to complete the 
catalyst cycle synchronously (step E). Moreover, in rare cases of low catalyst 
loading and high catalytic rate, step E can be turnover-limiting.31  
 
Scheme 1.2 The initial mechanism for CuAAC reaction between organic 
azides and teminal alkynes29  
 
Further kinetics studies of the copper-mediated reaction32 with low catalyst 
loading, saturating alkyne concentration and in the presence of the triazole 
products showed that the reaction is second order in copper. Second order 
dependence on catalyst concentration was illustrated by several other 
experimental results.30,31 After a series of DFT calculations, dinuclear copper(I) 
acetylides are found to be favored over mononuclear or polynuclear 
intermediates in catalytic cycle which revealed the lowest activation 
barrier.33,34 The improved catalytic cycle taking into account the possibility of 
dinuclear copper(I) acetylides involvement is suggested as in Scheme 1.3, 
which was put forward in a review paper by Medal and coworkers.35 
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Meanwhile, they also proposed another possible reaction pathway: the 
coordination of the azide to copper(I) via the terminal nitrogen, however, this 
proposal have been examined and found to be energetically unfavorable and 
no feasible intermediates could be identified. There is no experimental 
evidence to support this proposal either. 
 
Scheme 1.3 Outline of plausible mechanism for CuAAC reaction between 
organic azides and teminal alkynes35  
 
Additional experimental studies further extended our mechanistic 
understanding of CuAAC reaction and helped us formulate experimental 
guidelines. For example, preparation of the reactive copper(I) acetylides in situ 
in the presence of an organic azide are critical for the success of the reaction.36 
Moreover, the nature of the copper counter ions also have dramatic effects on 
the rate and efficiency of the reactions. On account of these mechanistic 
insights, Fokin and coworkers combined the previously proposed mechanism 
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containing the key bond-making and bond-breaking steps with quantitative 
measure of catalyst activation and deactivation pathways and their effect on 
the overall process to provide a new catalytic cycle in Scheme 1.4.29 This new 
mechanism underscores the importance of every step affecting the fate of the 
catalytic cycle intermediates including multiple equilibrium, competing 
pathways and catalytic cycle dead ends even if some of them are potentially 
reversible. 
 
Scheme 1.4 Several key equilibria and irreversible off-cycle pathways affect 
the productive CuAAC catalytic cycle29 
 
Although the mechanism of CuAAC click reaction has not been well 
understood yet, several observations and hypotheses are presented based on 
the current investigation. For instance, because the formation of the higher 
order polynuclear copper acetylides have been observed to be detrimental on 
the rate and outcome of the reaction, solvents that could promote ligands 
exchange are preferred in the CuAAC reaction such as water and alcohols. In 
addition, dinuclear copper(I) complexes may exhibit enhanced reactivity 
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according to the discovery of second order in copper in CuAAC reaction. 
Besides, the existence of competing pathways in catalytic cycle indicates the 
necessity of the use of ligands, which could not only balance the competing 
requirements of binding copper(I) strongly enough to prevent the formation of 
unreactive polymeric complexes, but also provide enough electron density to 
the copper centre to promote the catalysis while not destabilizing the copper(I) 
oxidation state. 
1.1.2 Development of CuAAC catalysts 
Due to the great value and wide usage of the CuAAC click reaction, various 
types of copper(I) and copper(II) catalysts have been explored in the last 
decade, including simple Cu(I) salts (CuI or CuBr), Cu(II) salts coupled with 
reducing agents (the most common one is CuSO4/sodium ascorbate in the 
aqueous conditions), Cu(0) (wire, tunings, powder or nanoparticles) with or 
without CuSO4 and nano-structured copper catalysts.
35 There are also a range 




42 for improved solubility in organic 
solvents, and Cu(OAc)2 for increased rate of reaction compared to 
CuSO4/NaAsc.
43-46 
As introduced in mechanistic aspects above, the addition of ligands are 
necessary, which can not only protect the Cu(I) centres from oxidation and to 
enhance the rate of reaction, but also greatly improve activities of copper 
catalysts, allowing for smoother reaction conditions and broaden applicability. 
Currently, diverse ligands have been investigated, including phosphorous47-49, 
NHC-carbene50-54, sulfur25,55-57 and nitrogen (amine and heterocycle, even 
triazole molecules) based molecules. In the following paragraphs, the recent 
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developments of most popular nitrogen ligated copper species in CuAAC click 
reaction will be discussed and compared in detail.58,59  
1.1.2.1 Nitrogen based ligands 
Nitrogen based ligands have been the first and most widely employed ligands 
in CuAAC click reaction. Initially, nitrogen containing additives are only 
considered as the base or a straightforward way to increase the solubility of 
copper(I) species in the reaction media. Along with involvement of more sorts 
of nitrogen containing ligands, the values of them have also been evaluated 
again. 
1.1.2.1.1 Amine ligands 
Initially, a range of simple tertiary amines, such as most commonly used 
triethylamine (I-1)60-65, tripropylamine (I-2), tributylamine (I-3), and 
diisopropylethylamine (DIPEA, I-4) 22,37,66-73, were used as base/ligand in the 
CuAAC click reactions combined with other more strongly coordinating 
ligands. Later, they were found to be efficient without other additives. 
Afterwards, diamine ligands including tetra/tri-methylethylenediamine (I-5/I-
6)74,75 and phenylenediamine (I-7)76 have also been involved. They have been 
used to maximize the product ratio (1,4,5-trisubstituted vs 1,4-disubstituted 
triazoles)39, functionalization of polypeptides75 and cycloaddition of different 
alkynes and glucosyl azides in water.76 Subsequently, other readily available 
multi-amines have also been employed, including HMTETA (I-8)77, famous 
PMDETA (I-9)69,77-86 and Me6TREN (I-10)
77,87. Among them, PMDETA is 
one of typical examples, which have well established efficiency together with 
CuBr in polymerization process. Besides, several well defined copper-tren 
complexes bearing crowded tripodal ligands ((I-11)67,88, (I-12)89 and (I-13/I-
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14)90) have also been developed to achieve better catalytic results. These 
ligands could effectively protect the copper centers against oxidation while 
keep them highly active. (Scheme 1.5)  
 
Scheme 1.5 Amines or amine ligated copper catalyst used in CuAAC click 
reaction58,59 
 
1.1.2.1.2 Mixed N,O ligands 
There are also some N,O mixed ligands have been employed in CuAAC 
reaction, such as amino acids L-proline (I-15)91-93 and histidine derivatives (I-
18)94. In particular, a recyclable proline-containing ionic liquid (I-16)95 was 
successfully used in the cycloaddition of in situ generated organic azides. 
Meanwhile, a O,N,O-containing macrocycle (I-17) was found to be active in 
the synthesis of interlocked rotaxanes.38,96 Recently, a novel mixed N,O ligand 
supported Cu(II) complex (I-19)97 have also been demonstrated to be active in 











































Absolutely, N(sp2)-type ligands are the most significant and widely used 
additives and various N(sp2)-type ligands have been involved in CuAAC 
reaction, which can be generally classified into four categories‒imine ligands, 
pyridine derivatives, benzimidazole/ benzothiazole/ pyrazole ligands, and 
triazole ligands and triazole-copper complexes. (Scheme 1.7) Finn and co-
workers have systematically investigated and compared the effect of a array of 
N(sp2)-type ligands in CuAAC reaction, including fluorescence quenching 
study98, kinetic and mechanistic report of ligand accelerated CuAAC 
reation99,100.  
The first applied imine ligands were simple pyridylimines (I-20)101,102, then it 
was followed by a series of more complicated modified imines ((I-22)‒(I-
26)103, (I-27)‒(I-31)104 and (I-33/I-34)26). A range of chiral pybox derivatives 
(I-35/I-36)105 were also applied to the kinetic resolution of racemic azides 
through their cycloaddition with a terminal alkyne by Fokin and Finn. Besides, 
cyclic imines have also been chosen as ligands, such as commercially 
available cyclic imine 1,8-diazabicycloundec-7-ene (DBU, I-21)106,107 and a 
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related triazabicyclodecene scaffold, which has been reported for the polymer-
supported CuAAC reaction.108   
Pyridine derivatives have also been investigated in CuAAC reaction. Beside 
simple pyridine I-3772,109, which could ensure clean CuAAC reaction from 
propargyl carbamates, kinds of pyridine derivatives are listed in Scheme 1.7b, 
including widely used bipyridyl derivatives ((I-40)77,110,111 and (I-41)77,110), 
1,10-phenanthroline (I-42)98,112 and its derivatives (I-44 and I-45113) and 
tripyridylamine (I-43)39,77. Among them, lutidine (I-39)73,111,114 is popular and 
it has notably been used as additive in the synthesis of cyclic peptides, 
functionalization of DNA115, human growth hormone116,117, and stabilization 
of organogels118. Sulfonated bathophenanthroline (I-44)42,119-121 has also 
mainly been applied to the functionalization of biomolecules and synthesis of 
bioconjugation due to its excellent solubility in aqueous solution. 
Moreover, diverse structures related to benzimidazole and benzothiazole ((I-
46)‒(I-48))31,99,100 have also been examined in CuAAC reaction. The results 
revealed that the most optimal ligands depends on the reaction conditions. 
Pyrazole related ligands supported Cu(I) complexes have been screened as 
catalysts for the synthesis of N-sulfony-1,2,3-triazoles from N-sulfonylazides 
and alkynes,122 and I-49 supported complexes [TpmBrCu(NCMe)]BF4 was the 
















































Scheme 1.7 (a) Imine ligands, (b) Pyridine derivatives and (c) Benzimidazole/ 
benzothiazole/ pyrazole ligands. 58,59 
 
Triazole ligands and triazole based copper complexes 
Undoubtedly, among all kinds of N(sp2)-type ligands, polytriazoles are the 
most commonly used ones in CuAAC reaction, which were discovered by the 
observation of accelerating reaction rates in their preparation in 2003.123-125 
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Since the first example of polytriazoles as additives in CuAAC reaction, a 
comparative study of different architectures was reported (Scheme 1.8), and 
different mono- (I-63), bis- (I-65) and tris-triazoles (I-50 and I-59) were 
screened.126 Still, tris-triazoles, especially TBTA (I-50)37,126-136, have virtually 
become the only triazole ligands used in CuAAC reaction. Meanwhile, several 
functionalized triazole ligands, such as water soluble ligands (I-51, I-52, I-64 
and I-66)137,138, acetated ligand (I-55)139 and sulfated ligands ((I-56)‒(I-
58))140,141 have also been developed. A well-defined Cu(I) complexes (I-67)127 
with TBTA have been prepared and this complex displayed unusual dinuclear 
structure bridged by two triazole units, but no Cu(I) centre coordination with 
tertiary amine moiety. Compared to the air sensitive complex I-67, better 
catalytic perfomance was observed using air stable tri(triazolyl)methane 
complex (I-68)142. 
Due to the high efficiency and substrate tolerance of polytriazole ligands and 
their supported copper complexes, the study of novel well defined triazole-









1.2 Hybridised 1,2,3-triazoles as ligands or building blocks in transition 
metal complexes 
Transition metal complexes have attracted considerable interest in many areas 
of functional materials, catalysis, nanotechnology and life sciences, and will 
undoubtedly continue to do so in the future. The design of ligand systems to 
provide transition metal complexes with optimal properties is fundamental in 
this respect.28 The challenge is to find ideal synthetic strategies, which allow 
for the rapid creation of diverse functionalized ligand scaffolds using modular 
building blocks. In return, this would accelerate the process of discovery and 
optimization of new ligand systems and metal complexes with novel 
properties or applications, and further enhance modern coordination chemistry. 
The 'click' concept was first introduced by Sharpless and co-worker in 
2001,143,144 and its criteria potentially fulfills the requirements of ideal 
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synthetic protocols. As the classic example of click reaction, copper catalyzed 
1,3-cycloaddtion of alkynes and azides (CuAAC) reaction not only possesses 
its essential advantages, like efficiency, selectivity, wide substrate scope, mild 
reaction conditions, easy performance, insensitivity and simple work-up 
procedure, but also enables the modular tuning of steric and electronic 
properties of ligands facilely. 
With the help of CuAAC click reaction, the model ligand system, 1,4-
substituted 1,2,3-triazole ligands, have been prepared in large numbers. 
However, compared with imidazole, pyrazole and 1,2,4-triazole etc. ligand 
systems, substituted triazole supported transition metal complexes remain 
relatively unexplored. In fact, the 1,2,3-triazole itself is astonishingly stable 
and essentially inert to oxidation, reduction and hydrolysis; that's why it has 
been employed as linker in various polymers, materials and biological 
molecules. Meanwhile, 1,4-substituted 1,2,3-triazole has versatile coordination 
modes including monodentate binding through the N3 nitrogen atom (A), 
monodentate coordination through the N2 nitrogen atom (B), bidentate 
bridging coordination of two metal centres through both the N2 and N3 
nitrogen atoms (C), and monodentate binding through the C5 carbon atom (D). 
(Scheme 1.9) From the reported examples, the binding modes of A, C and D 
have all been observed, and the details will be discussed in the next 










1.2.1 Monodentate and bridging coordination modes of 1,2,3-triazole 
ligands 
First, the literature reviews about monodentate 1,2,3-triazole as N-donor 
ligands will be presented. Van Koten et al. are the first to report structurally 
characterized metal complexes (I-69) bearing simple 1,2,3-triazole ligands.73 
The complexes I-69a‒d were prepared by the addition of 1,2,3-triazole ligands 
to a mixture of the either Pd or Pt NCN pincer complex and AgBF4 in 
dichloromethane. The 1,2,3-triazole units were confirmed to coordinate to the 
Pd or Pt centers by more electron rich N3 nitrogen atoms by crystal structures. 
(Scheme 1.10) The following 1H NMR competition experiments also showed 
that 1,2,3-triazoles are excellent ligands and the their binding strength could 
be further fine-tuned by changing substituent groups. 
Later, both Astruc and Crowley have synthesized novel Pd(II) complexes (I-
70) using 1,2,3-triazole ligands, which coordinated to Pd(II) ions in the same 
monodentate mode through N3 atom.146,147 With the different metal precursors, 
trans-[Pd(A)2Cl2] complexes (I-70a and I-70b) and unexpected salt 
[Pd(A)4](BF4)2 (I-70c) have been obtained in high yields. (Scheme 1.10) 
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Scheme 1.10 Synthetic routes of Pd(II) complexes containing monodentate 
1,2,3-triazole ligands; (i) for I-70a, Pd(CH3CN)2Cl2, toluene, r.t., 2.5 h; for I-
70b, Pd(CH3CN)2Cl2, acetone, r.t., 1 h; for I-70c, [Pd(CH3CN)4](BF4)2, 
acetone, r.t., 1 h.145 
 
1,2,3-triazole ligands have also been applied to coordinated with Re(I) centre 
by N3 atom in monodentate fashion, and a series of cationic Re(I) complexes 
[Re(bpy)(CO)3(A)](PF6) (I-71a–d) have been formed.
148 According to the 
positioning of the CO bands in the IR spectra, 1,2,3-triazole in Re(I) 
complexes are slightly stronger donors than pyridine. These complexes are 
luminescence active in dichloromethane at r.t. in atmosphere, and the emission 
maxima are blue-shifted relative to the parent chloride complexes. 
Additionally, relatively long luminescent lifetimes are also observed.  
On the basis of previously discussed examples and theoretical studies 
(DFT)149,150, N3 nitrogen is confirmed to be the most electron rich atom of 
1,2,3-triazole unit. Hence, 1,2,3-triazole unit is expected to coordinate through 
the N3 not the N2 nitrogen in a monodentate mode.  
 





Second, the only example of simple 1,2,3-triazole units acting as bridging 
ligands will be reported, although this coordination mode is relatively 
common in more complicated triazole ligands. Crowley and co-workers 
synthesized two dimeric Ag(I) complexes (I-72a and I-72b) in dark with same 
dinuclear core [(L)2Ag2]
2+, in which the two Ag(I) centres were bridged by 
two 1,2,3-triazole units through N2 and N3 nitrogen atoms.151 (Scheme 1.12) 
In I-72a, the Ag(I) ions are also interacted with the benzyl substituent through 
an unusual η1 benzyl-Ag(I) interaction, giving the Ag(I) centres trigonal planar 
coordination spheres. Meanwhile, in I-72b, the η1 benzyl-Ag(I) interaction is 
replaced by the Ag-N(1,2,3-triazole) interaction between Ag(I) centre and 
additional monodentate 1,2,3-triazole ligand molecules, and the Ag(I) centres 
are coordinated to three N atoms in a distorted trigonal planar coordination 
geometry. This phenomenon is presumably due to the donor ability of the 
benzyl ring has been weakened by the strong electron withdrawing fluorine 
substituents. 
 
Scheme 1.12 Synthetic routes of Ag(I) complexes containing bridging 1,2,3-
triazole ligands145 
 
Third, due to the acidic nature of hydrogen on the C5 atom of 1,2,3-triazole, 
the C5 atom can be readily deprotonated to provide anionic triazole ligands 
and a series of related study have been operated. When Straub and coworkers 
practised CuAAC reaction between the bulky NHC stabilized Cu(I) acetylide 
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and azidodi-4-tolylmethane, a stable Cu(I) 1,4-substituted-1,2,3-triazole 
intermediate were isolated, in which triazole was coordinated to Cu(I) centre 
by C5 atom.30 The confirmation of the 1,2,3-triazolide intermediate provided 
strong evidence and deeper insight of proposed catalytic mechanism. Building 
on this work, Cray et al. have synthesized an array of stable and luminescent 
Au(I)-1,2,3-triazolide complexes coordinated by C5 atom in high yields.152 
Beside 1,2,3-triazolides which display the C5 coordination mode, 1,2,3-
triazoles are readily and regioselectively alkyl/benzylated at the N3 position to 
provide the related 1,3,4-trisubstutited-1,2,3-triazolium salts.153-156 (Scheme 
1.13) Albrecht has demonstrated the triazolium salts can be converted into 
abnormal or mesoionic N-heterocyclic 'click' carbene complexes.157 For 
example, stable Ag(I) 1,2,3-triazolylidenes (I-73) could be generated by 
deprotonation of 1,2,3-triazolium salts with Ag2O, which can be further used 
to synthesize a wide variety of transition metal (Pd(II)157-159, Ru(II)160, 
Rh(I)157,158, Ir(I)157, Cu(I)50,161 and Au(I)162) 1,2,3-triazolylidene complexes163 
via transmetallation. These complexes have been exploited as catalysts for a 
range of reactions including CuAAC, cross coupling, oxidation and oxidative 





Scheme 1.13 Synthetic routes of 1,3,4-trisubstituted-1,2,3-triazolium salts and 
1,3,4-trisubstituted-1,2,3-triazole-5-ylidenes complexes; (i) either MeI, 
CH3CN, 70°C, 12h or Me3OBF4, CH2Cl2, r.t., 3 d; (ii) for X = I, Ag2O, 
CH2Cl2, r.t., 15 h; for X = BF4, Ag2O, NMe4Cl, CH2Cl2/MeCN(1:1), r.t., 18 h; 
(iii) [M(cod)Cl]2 (M = Rh, Ir), CH2Cl2, r.t., 24 h; (v) [Ru(arene)Cl2]2, CH2Cl2, 
r.t., 24 h; (vi) CuCl, CH2Cl2/MeCN(1:1), r.t., 6 h; (vii) Au(SMe2)Cl, 




1.2.2 Bidentate ligands containing 1,2,3-triazole units 
Since Mindt and Schibli proposed the 'click-to-chelate' concept,164 enormous 
chelating 'click' ligands have been developed and can be divided into two 
types, most common 'regular' ligands and 'inverse' ligands. When the chelate 
pocket involves coordination through the N3 atom of 1,2,3-triazole, they are 
called 'regular' ligands, while 'inverse' ligands refer to 1,2,3-triazole unit 
coordinating through the less electron rich N2 atom. Currently, bidentate 
ligands containing 1,2,3-triazole units are the most studied class of 'click' 
chelate, in which 'regular' 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine ligands and 
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'inverse' [2-(4-R-1H-1,2,3-triazol-1-yl)methyl]pyridine ligands have received 
the most attention and will be discussed in details. 
A series of 'regular' 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine ligands have been 
broadly investigated as readily tunable bipyridyl analogues, which also act as 
N-N five membered chelates through N3 nitrogen atoms of 1,2,3-triazole unit 
and pyridyl N donors. A wide range of transition metal complexes bearing 
these ligands have been synthesized and examined. (I-80‒I-90, Scheme 1. 14) 
For instance, Obata, Yano and Benoist have synthesized several fac isomers of 
octahedral Re(I) complexes using [Re(CO)5Cl] and corresponding 
pyridyltriazole ligands (I-80a‒f), which are luminescence active in solutions at 
r.t. and exhibit larger quantum yields and longer luminescent lifetimes 
compared with [Re(bpy)(CO)3Cl] analogue.
165-167 Benoist and Machura have 
also synthesized the radiolabeled 99Tc complexes (I-80f),
166 which is 
potentially the selective central nervous system imaging agent. Fletcher and 
Schubert have independently prepared the non-emissive [Ru(bpy)3]
2+ 
analogues I-82a–b by RuCl3⋅H2O and pyridyltriazole ligands under heating 
condition.168,169 A range of heteroleptic Ru(II) complexes of the formulation 
[Ru(bpy)3-n(L)n]
2+ have also been synthesized, and their photophysical and 
electrochemical properties revealed that as more pyridyl-triazole ligands are 
incorporated into the complexes, both the UV/vis and luminescence spectra 
are blue-shifted.169-171 Bauerle et al. have synthesized the heteroleptic Ru(II) 
complexes I-85 and used it as a sensitizer in DSSC.172 De Cola et al. have 
produced a family of heteroleptic cationic Ir(III) complexes containing ppy or 
F2ppy and pyridyl-triazole ligands.
173-176 Based on the investigation of 
photophysical and electrochemical properties, these Ir(III) complexes 
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displayed excellent emission quantum yields, long excited state lifetimes, and 
reversible electrochemical behaviors. Beside precious metals, octahedral 
Fe(II)177 (I-83a‒b) and Ni(II)178 (I-84a‒d) complexes with pyridyl-triazole 
ligands have also been synthesized and their applications in biological area 
and catalytic ethylene oligomerisation reaction have been studied, respectively.  
Meanwhile, a variety of tetrahedral Ag(I) and Cu(I) complexes179,180 (I-81a‒c), 
and square planar Pd(II) and Pt(II) complexes181-185 (I-89a–g and I-90a–g) 
with pyridyl-triazole ligands have been synthesized and crystallographically 
characterized. Milani have shown that Pd(II) complex I-89g is catalytic active 
for styrene carbonylation reaction to produce low molecular weight 
oligoketones.183 
Albrecht et al. have also developed Ru(II) and Ir(III) catalysts (I-86a‒d and I-
87) based on mono- and dimethylated pyridyl-1,2,3-triazolium salts and 
[Ru(p-cymene)Cl2]2 and [Cp*IrCl2]2 precursors, respectively. These 
complexes have been demonstrated to be the most active water oxidation 




Scheme 1.14 Synthetic routes of 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine ligand 
supported transition metal complexes. (i) [Re(CO)5Cl], MeOH, reflux, 24 h; (ii) 
for I-82a, either AgOTf or AgSbF6, acetone/CH2Cl2 (1:1), 1 h, r.t.; for I-82b‒c, 
[Cu(MeCN)4](BF4), CHCl3/MeCN (1:1), 1 h, r.t.; (iii) RuCl3⋅H2O, EtOH/H2O, 
80°C, 24 h; [Fe(H2O)6](BF4)2, CH3CN, r.t., 1 h; (iv) NiBr2·3H2O, MeOH, 
reflux, 1 h; (v) (a) [Ru(p-cymene)Cl2]2, DMF, 75°C, 6 h; (b) 2,2'-bipyridine-
4,4'-dicarboxylic acid, DMF, 140°C, 3 h; (c) NH4NCS,145°C, 5 h; (v) MeOTf, 
CH2Cl2; (vii) (a) Ag2O, [Ru(p-cymene)Cl2]2, CH2Cl2, 35°C, 2 d; (b) AgOTf, 
MeCN, reflux, 18 h; (viii) Ag2O, [Cp*IrCl2]2, MeCN, reflux, 18 h; (ix) for I-
88a, (a) Ru(bpy)Cl2 or Ru(dmbpy)Cl2, EtOH, MW, 125°C, 1 h; (b) NH4PF6, 
r.t., 2 h; for I-88b, (a) Ru(bpy)Cl2 or Ru(dmbpy)Cl2, 2-methoxyethanol/H2O, 
90°C, 24 h; for I-88c‒e, (a) either (ppy)2Ir(µ-Cl)2Ir(ppy)2 or (F2ppy)2Ir(µ-
Cl)2Ir(F2ppy)2, CHCl3/MeOH (3:1), 40°C, 3 h; (b) either NH4PF6 or NH4BF4, 
H2O, 1 h; (x) for I-89a‒f, (M = Pd) Pd(cod)Cl2 or Pd(CH3CN)2Cl2, CH2Cl2 or 
CH3CN, r.t., 1 h; for I-89a‒f, (M = Pt) K2[PtCl4], H2O/EtOH (1:1), 60°C, 16 h, 
or Pt(DMSO)2Cl2, MeNO2, 5–15 h, reflux; for I-89g, [Pd(cod)MeCl], CH2Cl2, 





The related 'inverse' [2-(4-R-1H-1,2,3-triazol-1-yl)methyl]pyridine ligands 
have also been well studied. Compared with 'regular' pyridyl-triazole ligands, 
they are more flexible and generally behaves as N-N six membered chelates 
through N2 nitrogen atoms of 1,2,3-triazole unit and pyridyl N donors. A 
range of transition metal complexes of octahedral (Cu(II)43,150,179,186,187, 
Co(II)187,188, Ni(II)188, Ru(II)150,189), tetrahedral (Ag(I)150,179 and Zn(II)188), and 
square planar (Ag(I), Pd(II) and Pt(II)150,181,182,190-192) coordination geometries 
have all been prepared and characterized crystallographically. Although 
'inverse' pyridyl-triazole ligands generally act as bidentate chelates, in some 
cases, they will bind as monodentate donors, such as coordination with Rh(II) 
centers by only pyridyl N donors in complex I-93, and coordination with Pd(II) 
ion through N3 atom of the 1,2,3-triazole unit with protonated pyridyl N atom 
under acid aqueous condition in complex I-98.190 These ligands have also been 
shown to coordinate through all three N atoms simultaneously. For example, 
reaction of 'inverse' ligand (R = Ph) with AgNO3 or AgSbF6 precursors 
provides dinuclear or trinuclear Ag(I) complexes (I-92a‒b), respectively, in 
which it displays both chelating and bridging coordination modes. 
Meanwhile, these resulting complexes have found applications in various 
areas. For instance, the cationic complex [Pd(η3-C3H5)(L)](BF4) (R = Ph) (I-
96) exhibits good activity in Suzuki‒Miyaura coupling of aryl bromides with 
phenyl boronic acid.193 Ru(II) complexes with 'inverse' ligands (I-95a‒c) show 




Scheme 1.15 Synthetic routes of [2-(4-R-1H-1,2,3-triazol-1-
yl)methyl]pyridine ligand supported transition metal complexes. (i) for I-
91a‒b, either CuCl2, MeOH, r.t., 1 h or CuCl2, EtOH/CHCl3, 60°C, 1 h; for I-
91c, CoCl2, acetone, r.t., 24 h; (ii) for I-92a, AgNO3, MeOH, r.t., 24 h; for I-
92b, AgSbF6, acetone/CH2Cl2 (1:1), 1 h, r.t.; (iii) [Rh2(O2CCH3)4], 
H2O/MeOH (1:1), 1 h, reflux, 5 min; (iv) AuCl3, MeOH, r.t., 2 h or KAuCl4, 
H2O/MeOH, r.t., 2 h; (v) for I-95a, [Ru(p-cymene)Cl2]2, EtOH, r.t., 2 d; for I-
95b, [Ru([9]aneS3)(DMSO-S)2Cl](OTf), MeOH, reflux, 2 h; for I-95c, [trans-
Ru(DMSO-S)4Cl2], H2O, r.t., 24 h; (vi) AgBF4, [Pd(η
3-C3H5)Cl]2, 
MeOH/CH2Cl2, r.t., 2 h; (vii) for I-97a, (M = Pd) Pd(cod)Cl2 or 
Pd(CH3CN)2Cl2, CH2Cl2 or CH3CN, r.t., 1 h; for I-97b‒c, (M = Pt) K2[PtCl4] 
H2O/EtOH (1:1), 60°C, 16 h, or Pt(DMSO)2Cl2, CH2Cl2 or CH3CN, r.t., 2‒13 
d; (viii) HCl(aq), H2O, hot, 5 min; (ix) [Pd(CH3CN)4](BF4)2, CH3CN, r.t., 1 h.
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While the pyridyl-1,2,3-triazole ligands are the most abundant type of 
bidentate click ligands, amine-1,2,3-triazole, phosphine-1,2,3-triazole, 
cyclometallated phenyl-1,2,3-triazole, NHC-1,2,3-triazole and bi-1,2,3-
triazole scaffolds have all been reported and several examples will be shown 
in the following part. 
Pericas et al. have synthesized the L-proline derived bidentate amine-1,2,3-
triazole ligands (I-100 and I-101a‒d) and examined their use as chiral ligands 
in ruthenium catalyzed asymmetric transfer hydrogenation reaction.194 Both 
ligands are active catalysts, especially I-101, which show excellent catalytic 
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activities and enantiomeric selectivity for a variety of ketone substrates. 
Moreover, Gautier et al. have prepared a series of 'regular' and 'inverse' 
bidentate amine-triazole ligands and used them to produce cisplatin like 
platinum complexes.195 Eisenberg and coworkers have synthesized a family of 
heteroleptic Cu(I) amido-1,2,3-triazole complexes, which are potential 
candidates for OLED devices.196 
Several related phosphine-1,2,3-triazole ligands and corresponding Pd(II) allyl 
complexes (I-104a‒c and I-105a‒c) have been synthesized by Reek and 
coworkers.132 Phosphine-1,2,3-triazole ligands is coordinated in a 
monodentate mode through P-donor in neutral complexes I-104a‒c, while they 
exhibit a standard bidentate mode by P donor and N3 atom of the 1,2,3-
triazole unit in complexes I-105a‒c. These Pd(II) complexes have also been 
exploited in catalysis and they proved to be highly active catalysts for the 
allylic alkylation of cinnamyl acetate with sodium diethylmethylmalonate to 
give linear product. Matano et al. have also synthesized a family of hybrid bi-, 
tri- and polydentate phosphole-1,2,3-triazole ligands and corresponding Pd(II) 
or Pt(II) complexes.197 
Inspired by their potentially interesting photophysical and catalytic properties, 
a number of phenyl-1,2,3-triazoles174,198-200 and phenyl-1,2,3-triazol-5-
ylidenes158,201 supported cyclometallated chelate complexes have been 
synthesized. For example, Schubert and De Cola et al. have prepared a range 
of Ir(III) complexes including the dichloride bridged dimers (106a‒c), a 
fluorinated Ir(III) dimer bridged by one 1,2,3-triazole unit, and diverse 
heteroleptic monoiridium complexes.198 
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In related work, Elsevier et al. have synthesized a series of Pd(II) NHC-
triazole complexes with different anions (I-107), which are highly active 
precatalysts in the transfer hydrogenation reaction of alkyne to selectively 
provide Z-alkene products.202 The ligands show bidentate coordination mode 
through the C2 carbon of carbene and N3 nitrogen of triazole unit. 
 
Scheme 1.16 Structures of bidentate 1,2,3-triazole ligand supported transition 
metal complexes 
 
The final class of bidentate triazole ligands are bis-1,2,3-triazoles and several 
bis-1,2,3-triazole ligand systems have been readily prepared, which have been 
shown in Scheme 1.17. Most of bis-triazole ligands are symmetric and can be 
considered as pyridyl analogues. For example, König and Monkowius et al. 
synthesized bis-triazole ligands I-108a‒c which are also bipyridyl analogues, 
and applied them to support stable Ru(II), Cu(I) and Re(I) complexes by both 
N3 nitrogen atoms of two triazole units.168,203,204 However, the photophysical 
properties of these bis-triazole supported complexes are completely different 
from their analogues, and they are not emissive in solution or solid state. 
Other bis-triazole ligands I-109a‒c have been synthesized by Eisenberg and 
coworkers, and I-109c has been used to react with CuI providing expected 
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dimeric diiodide-bridged complex, in which the ligand acted as a bidentate 
chelate by N3 atoms of triazole units. However, the other ligands formed 
tetranuclear Cu(I) clusters where 1,2,3-triazoles presented both chelating and 
bridging coordination modes.205 Moreover, Crowley et al. have also 
synthesized a family of bis-triazoles (I-110a‒f), and they can support Ag(I) 
M2L2 metallomacrocycles and Pd(II) M2L4 helical cages with bis-monodentate 
coordination mode.147,151,206 
 
Scheme 1.17 Structures of bidentate 1,2,3-triazole ligand supported transition 
metal complexes145 
 
1.2.3 Tridentate ligands containing 1,2,3-triazole units 
Apart from abundant bidentate triazole ligands, a range of tridentate 
hybridised triazole ligands have also been synthesized and characterized. 
Tridentate click ligands containing one 1,2,3-triazole unit will be introduced 
firstly. (Scheme 1.18) Mindt and Schibli have developed a series of tridentate 
'regular' amino acid derived mono-1,2,3-triazole ligands for Re(I) and 99Tc(I) 
complexes as novel radiopharmaceuticals conjugating a wide range of 
biotargeting molecules.28,164,207-211 Recently, they also developed a one-pot 
procedure allowing the in situ generation of both ligands and complexes (I-
111), which further improved the synthetic efficiency.212 Chen et al. have 
prepared a hybrid NHC-triazole ligand and its corresponding Ag(I), Pd(II) and 
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Pt(II) complexes. Among them, the Pd(II) complex (I-112) was found to be 
highly active catalyst for the Suzuki-Miyaura cross coupling reactions of aryl 
bromide and 1,1-dibromo-1-alkenes in neat water.213 Besides, Gandelman et al. 
have reported a series of pincer click ligands with two phosphine donors 
appended to the triazole unit (I-113a‒b).214-217 The triazole unit could bind to 
the metal center as a triazolidene, or as an abnormal carbene after a alkylation 
post modification, and the corresponding square planar Pd(II) and Pt(II) 
complexes (I-114/115a‒b) have been synthesized and characterized. Pd(II) 
complexes of this type have shown excellent catalytic activity for the Heck 
reaction. Chandrasekher and coworkers have presented three octahedral Fe(II) 
complexes (I-116a‒c) with 'super-hybrid' tridentate ligands containing pyridyl, 
pyrazolyl and triazolyl N donors.218 The X-ray crystal structures indicated the 
complexes I-116a‒b were low spin while I-116c was high spin at 100 K, and 
they all showed reversible spin crossover behavior with a wide hysteresis loop. 
 
Scheme 1.18 Structures and synthetic route of tridentate mono-1,2,3-triazole 
ligand supported transition metal complexes. (i) for I-114a, (tmeda)PdCl2, 
Et3N, DMF, 70 °C; for I-114b, (cod)PtCl2, Et3N, DMF, 70 °C; (ii) for I-115a, 




Secondly, tridentate click ligands containing two 1,2,3-triazole units will be 
presented. 'Regular' 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine ligands as readily 
tunable analogues of terpyridine, and related 'inverse' 2,6-bis(4-R-1,2,3-
triazol-1-ylmethyl)pyridine ligands are classic instances in this type. For 
regular 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine ligands, they commonly 
coordinated to metal centers through the pyridyl and N3 atoms of triazole units, 
acting as terpy like tridentate chelators. A wide range of corresponding 
transition metal complexes have been prepared, including Eu(III)219,220, 
Ru(II)221, Cu(II)179,222, Zn(II)221, Fe(II)219-221 and Ag(I)179 complexes. (Scheme 
1.19) Such ligands were firstly prepared to support Fe(II) and Eu(III) 
complexes by Flood and Hecht in 2007.219,220 Then, Schubert et al. have 
applied such ligands to synthesize a series of heteroleptic Ru(II) complexes, 
which comprised either a 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine and a 
terpyridine, or two different 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine ligands.223 
This group has also prepared a N-methylated bis-triazole ligand (CNC typed 
ligand), which reacting with Ru(terpy)Cl2 precursor to give heteroleptic Ru(II) 
complex (I-121).224 Currently, more thorough explorations of such ligands 
bearing various electron-donating and electron-withdrawing substituents on 
the central pyridine ring or the triazole rings or both have been reported.221 
Their 1:1 ratio reaction with Cu(II) and Zn(II) precursors provided five 
coordinated complexes (I-119), while 2:1 ratio reaction with Cu(II), Fe(II) and 
Ru(II) generated a series of octahedral complexes (I-120 and I-122). Various 
spectroscopic and magnetic investigations were carried out to examine the 
effect of electron-donating/withdrawing substituents to complex properties. 
This kind of ligands have also been used to prepare metallostar 
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compounds.225,226 Moreover, Crowley et al. provided an interesting tetrameric 
structure (I-123) using AgSbF6 and tridentate bis-triazole ligand, in which two 
Ag(I) centers were bridged by 1,2,3-triazole units and the whole structure was 
further stabilized by π-π stacking interactions.179  
 
Scheme 1.19 Synthetic routes of 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine ligand 
supported transition metal complexes. (i) for I-117a, Eu(ClO4)3, EtOH, reflux, 
3 h; for I-117b, Eu(OTf)3, THF, r.t., 10 min; (ii) Ru(terpy)Cl3, catalytic N-
ethyl morpholine, MeOH, reflux, 24 h, NH4PF6; (iii) for I-119a, CuCl2, 
EtOH/CHCl3 (1:1), 60 °C, 1 h; for I-119b, ZnBr2, THF, r.t.; (iv) for I-120a, 
Cu(BF4)2, MeCN, py; for I-120b and I-120e, Ru(DMSO)4Cl2, CH2Cl2, reflux, 
2 h; for I-120c, Ru(DMSO)4Cl2, MeCN, reflux, 1 h; for I-120d, 
Ru(DMSO)4Cl2, MeCN, reflux, 6 h; (v) Me3OBF4, CH2Cl2, Ar, r.t., 12 h; (vi) 
(a) Ag2O, MeCN, mol sieves, Ar, reflux, 12 h; (b) Ru(terpy)(DMSO)Cl2, 
CH2Cl2, Ar, sealed tube, 70 °C, 5 d; (c) NH4BF4; (vii) for I-122a‒b, M = Fe(II), 
FeSO4, H2O, EtOH, 55 °C, 30 min, KPF6; for I-122a‒b, M = Ru(II), 
Ru(DMSO)4Cl2, ethylene glycol, MeOH, H2O, 100 °C, 2.5 h, NH4PF6; for I-
122c‒e, Fe(OTf)2(MeCN)2, MeCN, r.t., 10 min; for I-122f, Ru(DMSO)4Cl2, 
AgOTf, DMF, reflux, 12 h; for I-122g‒h, Ru(DMSO)4Cl2, ethylene glycol, 
reflux, 2 h, NH4PF6; for I-122i, Ru(DMSO)4Cl2, DMF, reflux, 2 h, NH4PF6; 
for I-122j, Ru(DMSO)4Cl2, ethylene glycol, 180 °C, 30 min, NH4PF6; for I-





The inverse 2,6-bis(4-R-1,2,3-triazol-1-ylmethyl)pyridine ligands, I-124a‒b, 
have also been studied.179,227 In Crowley's work, the coordination chemistry of 
these ligands have been explored with Cu(II) and Ag(I), and expected 
monomers were obtained. However, I-124a was demonstrated to support 
polymeric Ag(I) complex (I-125) with a 4,4 net structure and the tetrahedral 
Ag(I) centers were completed by pyridyl-triazolyl (N2) chelate from one 
ligand and two other N3 of triazole units from other ligands. In Zhu's works, 
octahedral Cu(II), Fe(II) and Co(II) complexes (I-126a‒c), and trigonal 
bipyramidal Cu(II) complex with CuCl2 (I-127) have all been synthesized and 
determined by X-ray diffraction analysis. 
 
Scheme 1.20 Synthetic routes of 'inverse' 2,6-bis(4-R-1,2,3-triazol-1-
ylmethyl)pyridine ligand supported transition metal complexes. (i) AgSbF6, 
acetone, CH2Cl2, r.t., 1 h; (ii) M(ClO4)2, MeOH, r.t.; (iii) CuCl2, EtOH/CHCl3 
(1:1), 60 °C, 1 h.145 
 
Thirdly, one typical CuCl complex I-128 supported by tridentate click ligand 
containing three 1,2,3-triazole units has also been reported by Pericas and 
coworkers. (Scheme 1.21) This compound is an outstanding catalyst for 
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CuAAC reaction with very low catalyst loading in water or under neat 
conditions.142  
 
Scheme 1.21 Structure of tridentate tris-1,2,3-triazole ligand supported Cu(I) 
complex145 
 
1.2.4 Polydentate ligands containing 1,2,3-triazole units 
Although there have been many polydentate ligands containing one 1,2,3-
triazole unit reported, most of them were used as metal ion sensors or 
bioconjugated ligands which can be readily radiolabled.228-231    
For polydentate ligands containing two triazole units, a series of their 
supported transition metal complexes, including Cu(II)232, Zn(II)233,234, 
Fe(II)233, Mn(II)233 and Ni(II)234 complexes, have been investigated. Joly et al. 
have reported a distorted octahedral Cu(II) complexes with a triazole 
appended aza-crown ligand (I-129),232 while Hao and Wang have presented a 
family of octahedral transition metal complexes (Mn(II), Ni(II), Zn(II) and 
Fe(II); I-131a‒d) with salen-like tetradentate ligands, in which two triazole 
units were incorporated into an ethylene diamine skeleton.233 In each case, the 
metal center was coordinated by two amine N donors and two N3 atoms of 
triazole units from a single ligand, and the remaining two cis sites were 
occupied by solvent molecules or anions. Among them, Mn(II) complexes 
have shown excellent catalytic activities for the epoxidation reaction of 
terminal olefins. Gomes et al. have also synthesized the similar tetradentate 
35 
 
ligands, in which the ethylene diamine skeleton was replaced by a more 
complicated bis(imino)acenaphthene skeleton.234 The corresponding cationic 
Zn(II) complexes (I-133) were obtained during the ligand preparation process 
because of the presence of ZnCl2 salts. These Zn(II) complexes were treated 
by potassium oxalate (K2C2O4) to provide the free ligands, and reaction of 
ligands with NiBr2(DME) precursors produced pseudooctahedral Ni(II) 
complexes [Ni(L)Br2] (I-134a), in which Ni(II) center was coordinated by four 
N donors from a single triazole ligand and two axial bromide ions. 
Recrystallization of I-134a in air leaded to an distorted octahedral Ni(II) 
complex [Ni(L)(H2O)Br]Br (I-134b), with two forms existing the asymmetric 
unit. Both Ni(II) complexes were catalytic active for the addition 
polymerization reaction of styrene and norbornene with MAO as cocatalyst. 
 
Scheme 1.22 Structures and synthetic routes of polydentate 1,2,3-triazole 
ligand supported transition metal complexes. (i) Mn(OTf)2/ Ni(ClO4)2/ 
Zn(ClO4)2/FeCl2-AgSbF6, MeCN, r.t., 24 h. 
 
A number of potentially polydentate ligands containing three 1,2,3-triazole 
units have been reported.235 Among them, tris(benzyltriazolylmethyl)amine 
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(TBTA) and related compounds are the most common ligands used in 
coordination chemistry. (Scheme 1.23) For instances, Sarkar et al. have 
prepared a series of spin crossover Co(II) complexes bearing TBTA and 
related ligands.236 A mononuclear high-spin 1:1 Co(II) complexes I-135 can 
be converted to the low-spin 1:2 Co(II) complex I-136a by adding another 
equivalent ligand. In these two complexes, the geometry of Co(II) center has 
changed from an unusual seven-coordinate capped octahedral geometry to 
distorted octahedral geometry completed by central amine N donor and two 
N3 atoms of triazole units from two ligands. The different spin crossover 
property of these two complexes may due to π-stacking and T-stacking 
interactions between the uncoordinated benzyltriazole groups of ligands of 
adjacent molecules. This propose was confirmed by the high-spin Co(II) ions 
in I-136b‒c, which are incapable of such interactions. Donnelly and Williams 
have synthesized one mononuclear Cu(II) complex (I-137) and one air-
sensitive dinuclear Cu(I) complexes (I-138) with TBTA ligand, which are both 
success catalysts for the model CuAAC reaction.127 In Cu(II) complex, Cu(II) 
center showed a trigonal bipyramidal geometry completed by three N3 atoms 
of triazole units and apical central amine nitrogen from a single ligand, and 
another apical chloride. While the Cu(I) center was a distorted tetrahedral 
geometry in Cu(I) complex coordinated by the only triazolyl group, three N3 




Scheme 1.23 Synthetic routes of tripodal tetradentate 1,2,3-triazole ligand 
supported transition metal complexes. (i) 1 eq Co(ClO4)2, MeCN, r.t., 2 h; (ii) 
for I-136a, 0.5 eq Co(ClO4)2, MeCN, r.t., 2 h; for I-136b, 0.5 eq, Co(ClO4)2, 
MeOH, reflux, 1 h; for I-136c, 0.5 eq Co(ClO4)2, CH2Cl2, r.t., 2 h; (iii) CuCl2, 
MeCN; (iv) [Cu(MeCN)4]BF4, MeCN.
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According to the systematic introduction of CuAAC reaction and its usage in 
the construction of hybridised triazole ligands in the former sections. A 
diverse array of 'regular' and 'inverse' mono-, bis-, tri-, and polydentate ligands 
containing 1,2,3-triazole units have been synthesized and applied to form 
various transition metal complexes with different coordination modes. 
Currently, these triazole ligands supported complexes are beginning to find 
applications in catalysis, photophysics, magnetism and biological agents, 
destined for more important roles in coordination chemistry in future. 
1.3 The objective of this thesis 
Since the integrated 1,2,3-triazole ligands have attracted considerable interest 
over the last few years, and various transition metal complexes bearing 1,2,3-
triazole ligands have been reported and well discussed. However, comparison 
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with other kinds of nitrogen-rich azole ligands, such as imidazole, pyrazole 
and 1,2,4-triazole, 1,2,3-triazole based ligands are still very new. This area 
still has much room for further research. Meanwhile, apart from several 
examples, very little is known about their luminescent and magnetic properties, 
and catalytic activities of triazole ligand supported first transition metal 
complexes. In fact, easy modification and functionalization, as one of the most 
important features of triazole based ligands, provide 1,2,3-triazole based 
complexes with great possibility to have optimal activities. Therefore, easy 
tuning to obtain optimized activities is the integrally significant property of 
1,2,3-triazole based complexes. 
The objective of this thesis is to develop and expand the structural studies of 
new transition metal complexes (Mn, Fe, Co, Ni, Cu, Zn and Pt) containing 
multi-functionalized 1,2,3-triazole ligands and to investigate their specific 
properties, including catalytic activities in metal catalyzed reactions. More 
specifically, the aims of this study are: 
• Synthesis of novel multi-functionalized mono-/bis- and conjugated 
1,2,3-triazole based ligands 
• Preparation of new transition metal complexes (Mn, Fe, Co, Ni, Cu, Zn 
and Pt) containing the hybridized 1,2,3-triazole ligands 
• Investigation of the catalytic activities of Cu(I) and Pt(II) complexes in 
CuAAC reaction and hydrosilylation reaction, respectively. 
• Study of photoluminescent property of Cu(I), Zn(II) and Pt(II) 
complexes and comparison with reported analogues. 
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• Examination of magnetic properties of Cu(II), Co(II) and Ni(II) 
complexes and comparison with closely related complexes in 
literature. 
The transition metal complexes synthesized in this present study, which 
should exhibit some interesting features in both structure and property, will 
extend the scope of existed complexes using 1,2,3-triazole based ligands. And 
the study of catalytic activities may provide a great opportunity for 1,2,3-
triazole based complexes as potential catalysts. In addition, the catalytic 
reactions chosen in this study are mainly for their practical and industrial 
significance and underlying challenges. 
This thesis comprises of seven chapters. Chapter one presents the general 
introduction of triazole-based ligands and corresponding transition metal 
complexes and provides closely related literature. The following chapters 
report a series of novel 1,2,3-triazole ligands and their synthetic routes; 
subsequently, also focus on the preparation of a range of functionalized 1,2,3-
triazole based transition metal complexes and the study of their 
characterizations, catalytic activities and other properties, respectively. The 
design and synthesis of novel hybridized 1,2,3-triazole ligands will be 








Chapter 2 Design and synthesis of hybrid 1,2,3-triazole 
ligands 
2.1 Introduction 
Metal coordination complexes and molecular materials with unique 
architectures have occupied crucial positions in various research areas, such as 
molecular recognition, gas storage, catalysis, electrical conductivity, 
photoluminescence, molecular magnet technology and biochemistry.237, 238, 239, 
4-13,240 In these functional coordination materials, supporting/bridging ligands 
are the most vital factor for their architectures and outstanding properties.2,3 
For example, the functionalized N-heterocyclic azoles, like imidazole, 
pyrazole, triazole and tetrazole, are quite popular due to their remarkable 
advantages owing to easy preparation, great affinity to 3d transition metals and 
good solubility.14,15 Among the azole molecules, hybrid 1,2,3-triazole is 
relatively less explored. In addition, the two sp2- hybridized nitrogen atoms 
(most basic N3 and neglected N2) confer highly versatile coordination modes 
in cooperation with other functional groups towards transition metal 
coordination.28,145,241 Meanwhile, 1,2,3-triazole can be conveniently obtained 
by copper-catalyzed azide-alkyne cycloaddition (CuAAC) reactions, this is 
generally recognized as the premier example of atom economical reactions 
coupled with excellent organic or inorganic functional group 
tolerance.22,23,35,242,243 Thanks to the modular and reliable CuAAC reaction, 
diverse multi-functionalized 1,2,3-triazole based ligand systems could be 
created rapidly through modular building blocks.181,196,206,213,234,236,244-249 In 
return, this will accelerate the process of discovery and optimization of new 
metal chelating systems and provide more chance for developing novel 
41 
 
coordination materials with optimal properties. Currently, compared to other 
N-donor ligand systems, hybridised 1,2,3-triazole ligands have not been 
studied well and the research about them still have a long way to go. In this 
thesis, a series of novel hybrid 1,2,3-triazole ligands with systematic types 
have been designed and synthesized. They have been characterized by X-ray 
structure determination together with a wide range of chemical and physical 
measurements. The new transition metal complexes and coordination 
materials based on these new triazole ligands are shown to exhibit excellent 
properties and applications. 
 
2.2 Results and Discussion 
Benefiting from the convenient click-inspired copper-catalyzed azide-alkyne 
cycloaddition reaction (CuAAC), three types of new functionalized triazole 
based ligands were designed and synthesized from corresponding halide, NaN3, 
and alkyne catalyzed by a copper source. They are flexible mono-triazole 
based ligands, flexible bis-triazole based ligands and conjugated bis-triazole 
based ligands. In the following, we will discuss their synthesis and structures. 
The first type is categorized as flexible mono-triazole based ligands and the 
synthesized ligands could further be subdivided into three ligand systems on 
the basis of different framework and functional groups. The first system 
contains seven ligands L1‒L7, which are all functionalized by 
pyridylthiomethyl, phenyl or pyridyl and triazole groups (Scheme 2.1). The 
second system inclusive of ligands L8 and L9 have similar framework to the 
first system, except that the pyridylthiomethyl group is replaced by 
phenyloxymethyl group (Scheme 2.1). The framework of the third system is a 
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little bit different from the others, four involved ligands (L10‒L13) are 
functionalized by (N-phenyl-N-pyridyl)aminomethyl, phenyl or pyridyl and 
triazole groups which are all N-donors (Scheme 2.1). Ligands in the third 
system are designed to be more bulky than the two prevailing systems. It 
should be noted that respective phenyl/pyridyl groups, the existence of 
nitrogen donor and the difference of its position will affect their overall 
coordination capacity and coordination modes to transition metals. The 
comparison of ligands in every system could provide the experimental proof 
for their coordinate-structural relationship and useful information for general 
coordination rule. Moreover, comparison among three ligand systems will 
afford helpful information about coordination and link abilities of S, O and N 
donors. The structures of all ligands are confirmed and characterized by NMR 
and ESI spectral analysis. The single-crystal of L8 has been obtained and the 









Fig 2.1 (a) Crystal structure of L8. (b) A segment of crystal packing in L8. 
 
The second type is flexible bis-triazole based ligand system, which contains 
five ligands L16‒L20. These ligands are functionalized by pyridylthiomethyl, 
triazole and methylene groups (Scheme 2.2). The carbon number of bridging 
methylene group in five ligands is different, which are proven to influence the 
coordination assemblies of corresponding complexes. The single-crystal 
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structures of ligand L16 and L19 have also been confirmed by single crystal 



















Scheme 2.2 Synthetic route of flexible bis-triazole ligands L16‒L20 
 
 
Fig 2.2 (a) Crystal structure of L16. (The ring C1 to C5 was disordered into 
two positions with the occupancy ratio = 52:48. Restraints in bond length and 
thermal parameters were applied to the disordered parts.) (b) A segment of 




Fig 2.3 (a) Crystal structure of L19. (b) A segment of crystal packing in L19. 
 
Lastly, the third type is conjugated bis-triazole ligand system, which is 
designed and synthesized as terpyridine analogues (Scheme 2.4). One 
conjugated tri-triazole based ligand L21 was also synthesized, which was 
functionalized by pyridyl and triazolyl groups. (Scheme 2.3) Containing a 
number of coordination sites, ligand L21 was supposed to form metal organic 
frameworks (MOFs) with transition metals. However, its solubility is quite 
poor and cannot dissolve in most of organic solvents except for DMF. In this 
system, three ligands L22‒L24 are also included. Due to the advantages of 
easy functionalization and modification, these kinds of pincer type triazole 
ligands are the excellent new candidates for Pt(II) complexation and their 
application in photo luminescent study, including cyclometallation. The 




Scheme 2.3 Synthetic route of conjugated tri-triazole ligand L21 
 
 
Scheme 2.4 Synthetic routes of conjugated bis-triazole ligands L22‒L24 
 
2.3 Conclusion  
Assisted by modular CuAAC click reactions, three types of novel hybrid 
1,2,3-triazole based ligands have been designed and synthesized in this chapter. 
Different frameworks used in these ligand systems comprise of several 
functional groups, such as sulphur, pyridyl and methylene groups, have been 
introduced to feed the different coordination requirements. All ligands are 
characterized by NMR and ESI, and some single crystal structures were also 
obtained and demonstrated interesting structural information. These ligands 
will be used as functional ligands for metal complexes construction in the 
whole thesis. Accordingly, their structure features, catalytic activities, 
photoluminescent and magnetic properties will also been investigated 
respectively, which will be presented in the next chapters. In Chapter 3, 
hybridised 1,2,3-triazoles supported novel luminescent Cu(I) POLOs and their 
catalytic activities will be reported firstly. 
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2.4 Experimental Section 
Materials and physical measurements 2-(2-propynylthio)pyridine, 4-(2-
propynylthio)pyridine, (2-propynyloxy)benzene and Pd(PPh3)2Cl2 were 
synthesized according to the literature procedure.250,251 
Synthesis of 1-benzyl-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole (L1). 
2-(2-propynylthio)pyridine (5 mmol, 746 mg) was mixed with benzyl bromide 
(5 mmol, 855 mg) and NaN3 (6 mmol, 390 mg) in a mixture of t-BuOH/H2O 
(1:4, 25 mL), followed by the addition of K2CO3 (6 mmol, 829 mg), 
CuSO4⋅5H2O (0.25 mmol, 62 mg) and sodium ascorbate (0.5 mmol, 99 mg). 
The mixture was stirred at r.t. for 24 h. The residue was extracted with ethyl 
acetate (3×30 mL) and the extracts were washed with water (3×10 mL) and 
dried over anhydrous MgSO4. The product was purified by column 
chromatography on silica gel. Yield: 0.99g, 70 %. Anal. Calcd. for C15H14N4S 
(282.36): C, 63.80; H, 5.00; N, 19.84; S, 11.36. Found: C, 64.00; H, 4.89; N, 
19.72; S, 10.93 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.40 and 8.38 (d, 1H, 
py-H), 7.49-7.43 (dd, 1H, py-H), 7.40 (s, 1H, triazole-H), 7.35-7.33 (m, 3H, 
ph-H and py-H), 7.22-7.15 (m, 3H, ph-H), 6.99-6.95 (dd, 1H, py-H), 5.45 (s, 
2H, N-CH2), 4.48 (s, 2H, S-CH2). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 
149.31 (s, C (2-py)), 148.41 (s, CH (2-py)), 145.86 (s, CH (2-py)), 136.03 (s, 
C (Ph)), 134.68 (s, C (triazole)), 129.02 (s, CH (Ph)), 128.61 (s, CH (Ph)), 
127.90 (s, CH (Ph)), 122.34 (s, CH (triazole)), 122.18 (s, CH (2-py)), 119.62 
(s, CH (2-py)), 54.06 (s, NCH2), 24.69 (s, SCH2). ESI-MS (m/z, %) required 
for C15H14N4S (282.36): [L1 + H
+] (283.1, 100), [L1 + Na+] (305.1, 56). 
Synthesis of 1-(2-picolyl)-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole 
(L2). Ligand L2 was synthesized using a similar procedure to L1 by replacing 
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benzyl bromide with 2-picolyl chloride hydrochloride (5 mmol, 820 mg). 
Yield: 0.85 g, 60 %. Anal. Calcd. for C14H13N5S (283.35): C, 59.34; H, 4.62; 
N, 24.72; S, 11.31. Found: C, 59.87; H, 4.43; N, 24.70; S, 11.01 %. 1H NMR 
(500 MHz, CDCl3): δ (ppm) 8.52 (d, 1H, Py-H), 8.38 (d, 1H, Py-H), 7.62 (s, 
1H, triazole-H), 7.63−7.59 (m, 1H, Py-H), 7.44−7.41 (m, 1H, Py-H), 
7.21−7.18 (m, 1H, Py-H), 7.14−7.12 (d, 1H, Py-H), 7.08−7.06 (d, 1H, Py-H), 
6.96−6.93 (m, 1H, Py-H), 5.44 (s, 2H, N-CH2), 4.47 (s, 2H, S-CH2). 
13C NMR 
(125.77 MHz, CDCl3): δ (ppm) 157.86 (s, SCN), 154.42 (s, C (2-Py)), 149.53 
(s, S-CH (2-Py)), 149.25 (s, CH (2-Py)), 145.77 (s, triazole C), 137.20 (s, S-
CH (2-Py)), 135.96 (s, CH (2-Py)), 123.21 (s, Triazole CH), 122.99 (s, CH (2-
Py)), 122.16 (s, S-CH (2-Py)), 122.08 (s, CH (2-Py)), 119.55 (s, S-CH (2-Py)), 
55.44 (s, NCH2), 24.55 (s, SCH2). ESI-MS (m/z, %) required for C14H13N5S 
(283.35): [2L2 + Na+] (588.6, 100), [L2 + H+] (284.0, 16), [L2 + Na+] (306.0, 
9). 
Synthesis of 1-(3-picolyl)-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole 
(L3). Ligand L3 was synthesized using a similar procedure to L1 by replacing 
benzyl bromide with 3-picolyl chloride hydrochloride (5 mmol, 820 mg). 
Yield: 0.85 g, 60 %. Anal. Calcd. for C14H13N5S (283.35): C, 59.34; H, 4.62; 
N, 24.72; S, 11.31. Found: C, 59.52; H, 4.51; N, 23.92; S, 10.65 %. 1H NMR 
(500 MHz, CDCl3): δ (ppm) 8.57 and 8.56 (d, 1H, 3-py-H), 8.52 (s, 1H, 3-py-
H), 8.38 and 8.37 (d, 1H, 2-py-H), 7.52 and 7.50 (d, 1H, 3-py-H), 7.46−7.43 
(m, 1H, 2-py-H), 7.45 (s, 1H, triazole-H), 7.27−7.24 (m, 1H, 3-py-H), 7.15 
and 7.13 (d,  1H, 2-py-H), 6.98−6.95 (m, 1H, 2-py-H), 5.46 (s, 2H, NCH2), 
4.47 (s, 2H, SCH2). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 157.73 (s, SCN), 
150.04 (s, CH (3-py)), 149.27 (s, CH (2-py)), 148.91 (s, CH (3-py)), 146.31 (s, 
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triazole C), 136.05 (s, CH (2-py)), 135.56 (s, CH (3-py)), 130.48 (s, triazole 
CH), 123.83 (s, C (3-py)), 122.35 (s, CH (3-py)), 122.15 (s, CH (2-py)), 
119.66 (s, CH (2-py)), 51.36 (s, NCH2), 24.45 (s, SCH2). ESI-MS (m/z, %) 
required for C14H13N5S (283.35): [L3 + H
+] (284.0, 17), [L3 + Na+] (306.0, 
100), [2L3 + Na+] (588.7, 32). 
Synthesis of 1-(4-picolyl)-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole 
(L4). Ligand L4 was synthesized using a similar procedure to L1 by replacing 
benzyl bromide with 4-picolyl chloride hydrochloride (5 mmol, 820 mg). 
Yield: 0.92 g, 65 %. Anal. Calcd. for C14H13N5S (283.35): C, 59.34; H, 4.62; 
N, 24.72; S, 11.31. Found: C, 59.11; H, 4.55; N, 24.52; S, 11.20 %. 1H NMR 
(500 MHz, CDCl3): δ (ppm) 8.55 (d, 2H, 4-Py-H), 8.38 (d, 1H, 2-Py-H), 7.44-
7.47 (m, 1H, 2-Py-H), 7.48 (s, 1H, triazole-H), 7.15 (d,  1H, 2-Py-H), 6.99 (d, 
2H, 4-Py-H), 6.95-6.98 (t, 1H, 2-Py-H), 5.46 (s, 2H, N-CH2), 4.49 (s, 2H, S-
CH2). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 157.74 (s, SCN), 150.41 (s, C 
(4-Py)), 149.29 (s, C (2-Py)), 146.48 (s, C (4-Py)), 143.64 (s, C (2-Py)), 
136.05 (s, triazole C), 122.78 (s, C (4-Py)), 122.22 (s, triazole CH), 121.89 (s, 
C (2-Py)), 119.69 (s, C (2-Py)), 52.54 (s, NCH2), 24.49 (s, SCH2). ESI-MS 
(m/z, %) required for C14H13N5S (283.35): [L4 + H
+] (284.1, 100), [L4 + Na+] 
(306.0, 28), [2L4 + Na+] (588.6, 33). 
Synthesis of 1-benzyl-4-(4-(methylthio)-pyridine)-1H-1,2,3-triazole (L5). 
4-(2-propynylthio)pyridine (1 mmol, 149 mg) was mixed with benzyl bromide 
(1 mmol, 171 mg) and NaN3 (1.2 mmol, 78 mg) in a mixture of t-BuOH/H2O 
(1:4, 5 mL), followed by the addition of K2CO3 (1.2 mmol, 166 mg), 
CuSO4⋅5H2O (0.05 mmol, 12 mg) and sodium ascorbate (0.1 mmol, 20 mg). 
The mixture was stirred at r.t. for 24 h. The residue was extracted with ethyl 
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acetate (3×10 mL) and the extracts were washed with water (3×10 mL) and 
dried over anhydrous MgSO4. The product was purified by column 
chromatography on silica gel. Yield: 0.11 g, 39 %. 1H NMR (500 MHz, 
CDCl3): δ (ppm) 8.37-8.35 (m, 2H, py-H), 7.37 (s, 1H, triazole-H), 7.36-7.32 
(m, 3H, py-H and ph-H), 7.22-7.18 (m, 2H, ph-H), 7.14-7.12 (m, 2H, ph-H), 
5.47 (s, 2H, NCH2), 4.28 (s, 2H, SCH2). 
13C NMR (125.77 MHz, CDCl3): δ 
(ppm) 149.29 (s, C (4-py)), 147.67 (s, CH (4-py)), 144.19 (s, C (ph)), 134.31 
(s, C (triazole)), 129.07 (s, CH (ph)), 128.75 (s, CH (ph)), 127.86 (s, CH (ph)), 
122.02 (s, CH (triazole)), 120.74 (s, CH (py)), 54.21 (s, NCH2), 25.90 (s, 
SCH2). ESI-MS (m/z, %) required for C15H14N4S (282.36): [L5 + H
+] (283.1, 
100), [L5 + Na+] (305.0, 32). 
Synthesis of 1-(2-picolyl)-4-(4-(methylthio)-pyridine)-1H-1,2,3-triazole 
(L6). Ligand L6 was synthesized using a similar procedure to L5 by replacing 
benzyl bromide with 2-picolyl chloride hydrochloride (1 mmol, 164 mg). 
Yield: 0.10 g, 35 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.59 and 8.58 (d, 
1H, (2-py)-H), 8.39 and 8.38 (d, 2H, (4-py)-H), 7.70-7.67 (m, 1H, (2-py)-H), 
7.67 (s, 1H, triazole-H), 7.29-7.26 (m, 1H, (2-py)-H), 7.18-7.17 (m, 2H, (4-
py)-H), 7.15 and 7.14 (d, 1H, (2-py)-H), 5.62 (s, 2H, NCH2), 4.33 (s, 2H, 
SCH2). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 154.15 (s, C (2-py)), 149.81 
(s, C (4-py)), 149.32 (s, CH (4-py)), 147.85 (s, CH (2-py)), 144.23 (s, CH (2-
py)), 137.37 (s, C (triazole)), 123.49 (s, CH (triazole)), 122.89(s, CH (2-py)), 
122.35 (s, CH (2-py)), 120.87 (s, CH (4-py)), 55.71 (s, NCH2), 25.97 (s, 
SCH2). ESI-MS (m/z, %) required for C14H13N5S (283.35): [L6 + H
+] (284.1, 
100), [L6 + Na+] (306.1, 45). 
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Synthesis of 1-(4-picolyl)-4-(4-(methylthio)-pyridine)-1H-1,2,3-triazole 
(L7). Ligand L7 was synthesized using a similar procedure to L5 by replacing 
benzyl bromide with 4-picolyl chloride hydrochloride (1 mmol, 164 mg). 
Yield: 0.11 g, 39 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.61-8.59 (m, 2H, 
S-py-H), 8.40-8.38 (m, 2H, py-H), 7.46 (s, 1H, triazole-H), 7.17-7.15 (m, 2H, 
S-py-H), 7.04-7.02 (m, 2H, py-H), 5.51 (s, 2H, NCH2), 4.32 (s, 2H, SCH2). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 150.61 (s, CH (py)), 149.42 (s, CH 
(S-py)), 147.55 (s, C (S-py)), 144.91 (s, C (py)), 143.28 (s, C (triazole)), 
122.47 (s, CH (triazole)), 121.96 (s, CH (py)), 120.82 (s, CH (S-py)), 52.84 (s, 
NCH2), 25.85 (s, SCH2). ESI-MS (m/z, %) required for C14H13N5S (283.35): 
[L7 + H+] (284.1, 100). 
Synthesis of 1-benzyl-4-(methyloxybenzene)-1H-1,2,3-triazole (L8). (2-
Propynyloxy)benzene (5 mmol, 661 mg) was mixed with benzyl bromide (5 
mmol, 855 mg) and NaN3 (6 mmol, 390 mg) in a mixture of t-BuOH/H2O (1:4, 
25 mL), followed by the addition of K2CO3 (6 mmol, 829 mg), CuSO4⋅5H2O 
(0.25 mmol, 62 mg) and sodium ascorbate (0.5 mmol, 99 mg). The mixture 
was stirred at r.t. for 24 h. The residue was extracted with ethyl acetate (3×30 
mL) and the extracts were washed with water (3×10 mL) and dried over 
anhydrous MgSO4. The product was purified by column chromatography on 
silica gel. Yield: 0.89 g, 67 %. Anal. Calcd. for C16H15N3O (265.31): C, 72.43; 
H, 5.70; N, 15.84. Found: C, 72.52; H, 5.66; N, 15.34 %. 1H NMR (500 MHz, 
CDCl3): δ (ppm) 7.53 (s, 1H, triazole-H), 7.39-7.35 (m, 3H, ph-H), 7.30-7.26 
(m, 4H, ph-H), 6.97-6.95 (m, 3H, ph-H), 5.52 (s, 2H, NCH2), 5.18 (s, 2H, 
OCH2). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 158.14 (s, C (O-ph)), 
144.63 (s, C (triazole)), 134.42 (s, C (ph)), 129.47 (s, CH (O-ph)), 129.09 (s, 
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CH (ph)), 128.75 (s, CH (ph)), 128.05 (s, CH (ph)), 122.53 (s, CH (triazole)), 
121.19 (s, CH (O-ph)), 114.72 (s, CH (O-ph)), 61.99 (s, OCH2), 54.17 (s, 
NCH2). ESI-MS (m/z, %) required for C16H15N3O (265.31): [L8 + H
+] (266.0, 
7), [L8 + Na+] (288.1, 6), [2L8 + H+] (530.7, 7), [2L8 + Na+] (552.9, 100). 
Synthesis of 1-(4-picolyl)-4-(methyloxybenzene)-1H-1,2,3-triazole (L9). 
Ligand L9 was synthesized using a similar procedure to L8 by replacing 
benzyl bromide with 4-picolyl chloride hydrochloride (5 mmol, 820 mg). 
Yield: 0.94 g, 71 %. 1H NMR (300 MHz, CDCl3): δ (ppm) 8.60-8.56 (m, 2H, 
py-H), 7.74-7.68 (m, 2H, ph-H), 7.48 and 7.45 (d, 1H, triazole-H), 7.35 and 
7.32 (d, 2H, py-H), 7.24-7.22 (m, 3H, ph-H), 4.67 (s, 2H, NCH2), 4.48 (s, 2H, 
OCH2). 
13C NMR (75.48 MHz, CDCl3): δ (ppm) 156.50 (s, C (ph)), 155.64 (s, 
C (py)), 149.56 (s, CH (py)), 149.34 (s, C (triazole)), 137.01 (s, CH (ph)), 
136.96 (s, CH (triazole)), 122.94 (s, CH (py)), 122.72 (s, CH (ph)), 121.91 (s, 
CH (ph)), 55.57 (s, OCH2), 46.59 (s, NCH2). ESI-MS (m/z, %) required for 
C15H14N4O (266.30): [L9 + H
+] (267.1, 100). 
Synthesis of N-phenyl-N-(2-propynyl)pyridin-2-amine.
252
 In the glovebox, 
a solution of N-phenylpyridin-2-amine (10 mmol, 1.70 g) in about 20 mL THF 
(dry) was added NaH (12 mmol, 0.24 g), and the mixture was stirred at r.t. for 
1 h. The reaction mixture was added propargyl bromide solution (80 % w. t. in 
toluene) (16 mmol, 1.90 g) using standard Schlenk techniques under a 
nitrogen atmosphere. The mixture was stirred at 80 °C for 4 h. After cooling to 
r.t., the mixture was quenched with water, evaporated to remove THF and 
diluted with ethyl acetate. Then the mixture was washed with water and brine 
two times respectively, and dried over MgSO4. The pure compound was 
gotten by filtration, concentration under vacuum and purifying by silica gel 
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column. Yield: 1.32 g, 63 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.29 and 
8.28 (d, 1H, py-H), 7.45-7.42 (m, 2H, py-H), 7.38-7.27 (m, 4H, ph-H), 6.68-
6.65 (dd, 1H, ph-H), 6.47 and 6.46 (d, 1H, py-H), 4.75 and 4.74 (d, 2H, NCH2), 
2.17-2.16 (t, 1H, CH). ESI-MS (m/z, %) required for C14H12N2 (208.26): [P + 
H+] (209.2, 100). 
Synthesis of 1-benzyl-4-( N-phenyl-N-(2-pyridyl)aminomethyl)-1H-1,2,3-
triazole (L10).253 A stirred solution of benzyl bromide (1.1 mmol, 188 mg) in 
DMF/H2O (5 mL, 4:1) mixed solvents was added by NaN3 (1.2 mmol, 78 mg), 
Na2CO3 (1.5 mmol, 159 mg), CuSO4⋅5H2O (0.4 mmol, 64 mg) and sodium 
ascorbate (0.8 mmol, 158 mg). N-phenyl-N-(2-propynyl)pyridyl-2-amine (1 
mmol, 208 mg) was added and the reaction mixture was stirred at r.t. for 20 h. 
The suspension was then partitioned between aqueous NH4OH/EDTA solution 
(100 mL) and ethyl acetate (100 mL) and the layers were separated. The 
organic phase was washed with distilled water (100 mL) and brine (100 mL), 
dried over MgSO4 and the solvent was removed under reduced pressure. The 
product was purified by column chromatography on silica gel. Yield: 0.20 g, 
59 %. Anal. Calcd. for C21H19N5 (341.41): C, 73.88; H, 5.61, N, 20.51. Found: 
C, 73.50; H, 5.71; N, 23.12 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.19 and 
8.18 (d, 1H, py-H), 7.45 (s, 1H, triazole-H), 7.37-7.16 (m, 11H, aryl-H), 6.63-
6.60 (t, 1H, ph-H), 6.50 and 6.48 (d, 1H, py-H), 5.46 (s, 2H, NCH2-Ph), 5.26 
(s, 2H, NCH2-triazole). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 157.84 (s, C 
(py)), 147.55 (s, C (N-ph)), 146.28 (s, CH (py)), 145.05 (s, CH (py)), 136.73 
(s, C (ph)), 134.95 (s, C (triazole)), 129.71 (s, CH (N-ph)), 128.92 (s, CH (ph)), 
128.44 (s, CH (ph)), 127.67 (s, CH (ph)), 126.94 (s, CH (N-ph)), 125.84 (s, 
CH (triazole)), 122.90 (s, CH (N-ph)), 113.52 (s, CH (py)), 109.50 (s, CH 
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(py)), 53.87 (s, NCH2-triazole), 45.68 (s, NCH2Ph). ESI-MS (m/z, %) required 
for C21H19N5 (341.41): [L10 + H
+] (342.1, 100), [2L10 + Na+] (704.9, 72). 
Synthesis of 1-(2-picolyl)-4-(N-phenyl-N-(2-pyridyl)aminomethyl)-1H-
1,2,3-triazole (L11). Ligand L11 was synthesized using a similar procedure to 
L10 by replacing benzyl bromide with 2-picolyl bromide hydrobromide (1.1 
mmol, 278 mg). Yield: 0.16 g, 47 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 
8.55 and 8.54 (d, 1H, py-H), 8.19 and 8.18 (d, 1H, py-H), 7.64-7.61 (m, 1H, 
py-H), 7.64 (s, 1H, triazole-H), 7.36-7.17 (m, 7H, aryl-H), 7.02 and 7.01 (d, 
1H, py-H), 6.62-6.60 (m, 1H, ph-H), 6.49 and 6.48 (d, 1H, py-H), 5.58 (s, 2H, 
NCH2-py), 5.27 (s, 2H, NCH2-triazole). 
13C NMR (125.77 MHz, CDCl3): δ 
(ppm) 157.86 (s, C (N-py)), 154.84 (s, C (py)), 149.56 (s, C (ph)), 147.62 (s, 
CH (py)), 146.40 (s, CH (N-py)), 145.11 (s, C (triazole)), 137.25 (s, CH (N-
py)), 136.79 (s, CH (py)), 129.74 (s, CH (ph)), 126.97 (s, CH (ph)), 125.87 (s, 
CH (triazole)), 123.56 (s, CH (py)), 123.20 (s, CH (py)), 122.06 (s, CH (ph)), 
113.59 (s, CH (N-py)), 109.54 (s, CH (N-py)), 55.49 (s, NCH2-triazole), 45.76 
(s, NCH2-py). ESI-MS (m/z, %) required for C20H18N6 (342.40): [L11 + H
+] 
(343.1, 18), [L11 + Na+] (365.1, 100), [2L11 + Na+] (706.9, 63). 
Synthesis of 1-(3-picolyl)-4-(N-phenyl-N-(2-pyridyl)aminomethyl)-1H-
1,2,3-triazole (L12). Ligand L12 was synthesized using a similar procedure to 
L10 by replacing benzyl bromide with 3-picolyl chloride hydrochloride (1.1 
mmol, 180 mg). Yield: 0.17 g, 50 %. Anal. Calcd. for C20H18N6 (342.40): C, 
70.16; H, 5.30, N, 24.54. Found: C, 70.43; H, 5.35; N, 23.58 %. 1H NMR (500 
MHz, CDCl3): δ (ppm) 8.60 and 8.59 (d, 1H, py-H), 8.55 and 8.54 (d, 1H, py-
H), 8.20 and 8.19 (d, 1H, py-H), 7.51 (s, 1H, triazole-H), 7.38-7.20 (m, 8H, 
aryl-H), 6.64-6.62 (m, 1H, ph-H), 6.51 and 6.49 (d, 1H, py-H), 5.50 (s, 2H, 
56 
 
NCH2-py), 5.27 (s, 2H, NCH2-triazole). 
13C NMR (125.77 MHz, CDCl3): δ 
(ppm) 157.82 (s, C (N-py)), 150.04 (s, CH (py)), 148.90 (s, C (ph)), 147.58 (s, 
CH (N-py)), 146.73 (s, CH (py)), 145.04 (s, CH (N-py)), 136.82 (s, CH (py)), 
135.47 (s, C (py)), 130.74 (s, C (triazole)), 129.78 (s, CH (ph)), 126.91 (s, CH 
(ph)), 125.94 (s, CH (py)), 123.83 (s, CH (triazole)), 122.91 (s, CH (ph)), 
113.65 (s, CH (N-py)), 109.57 (s, CH (N-py)), 51.33 (s, NCH2-triazole), 45.71 
(s, NCH2-py). ESI-MS (m/z, %) required for C20H18N6 (342.40): [L12 + H
+] 
(343.2, 20), [L12 + Na+] (365.1, 100), [2L12 + Na+] (707.0, 30). 
Synthesis of 1-(4-picolyl)-4-(N-phenyl-N-(2-pyridyl)aminomethyl)-1H-
1,2,3-triazole (L13). Ligand L13 was synthesized using a similar procedure to 
L10 by replacing benzyl bromide with 4-picolyl chloride hydrochloride (1.1 
mmol, 180 mg). Yield: 0.16 g, 47 %. Anal. Calcd. for C20H18N6 (342.40): C, 
70.16; H, 5.30, N, 24.54. Found: C, 68.36; H, 4.08; N, 26.13 %. 1H NMR (500 
MHz, CDCl3): δ (ppm) 8.57 and 8.56 (d, 2H, py-H), 8.20 and 8.19 (d, 1H, N-
py-H), 7.52 (s, 1H, triazole-H), 7.38-7.34 (m, 2H, ph-H), 7.32-7.28 (m, 1H, N-
py-H), 7.27-7.25 (m, 2H, ph-H), 7.22-7.19 (m, 1H, N-py-H), 6.98 and 6.97 (d, 
2H, py-H), 6.64-6.61 (m, 1H, ph-H), 6.51 and 6.49 (d, 1H, N-py-H), 5.49 (s, 
2H, NCH2-py), 5.29 (s, 2H, NCH2-triazole). 
13C NMR (125.77 MHz, CDCl3): 
δ (ppm) 157.87 (s, C (N-py)), 150.45 (s, CH (py)), 147.60 (s, C (ph)), 146.87 
(s, CH (N-py)), 145.04 (s, C (py)), 143.92 (s, CH (N-py)), 136.85 (s, C 
(triazole)), 129.81 (s, CH (ph)), 126.91 (s, CH (py)), 125.97 (s, CH (triazole)), 
123.36 (s, CH (ph)), 121.83 (s, CH (N-py)), 113.72 (s, CH (N-py)), 109.66 (s, 
CH (N-py)), 52.51 (s, NCH2-triazole), 45.71 (s, NCH2-py). ESI-MS (m/z, %) 
required for C20H18N6 (342.40): [L13 + H
+] (343.1, 70), [L13 + Na+] (365.1, 
100), [2L13 + H+] (685.0, 11), [2L13 + Na+] (706.7, 27). 
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Synthesis of 1-(2-picolyl)-4-(hydroxymethyl)-1H-1,2,3-triazole (L14). 
According to the literature method,254 2-picolyl chloride hydrochloride (5 
mmol, 0.82 g), 18-crown-6 (cat.) and tetrabutylammonium iodide (cat.) were 
dissolved in t-BuOH, and N, N-diisopropylethylamine (5 mmol, 0.65 g) and 
sodium azide (6 mmol, 0.39 g) were added, respectively. The reaction mixture 
was stirred for a short period, propargyl alcohol (7.5 mmol, 0.42 g) and 
catalyst copper acetate 0.2 M aqueous solution (0.25 mmol, 1.25 mL) were 
added. The yellow solution with white solid was stirred at room temperature 
for 48 h. After the reaction, the suspension was filtered, washed by t-BuOH 
and dried over anhydrous MgSO4. The crude product was purified by column 
chromatography on silica gel. Yield: 0.67 g, 70%. 1H NMR (500 MHz, 
CDCl3): δ (ppm) 8.56 (d, 1H, Py-H), 7.71 (s, 1H, Triazole-H), 7.69-7.66 (m, 
1H, Py-H), 7.26-7.24 (m, 1H, Py-H), 7.18-7.20 (d, 1H, Py-H), 5.62 (s, 2H, N-
CH2), 4.76 (s, 2H, O-CH2), 3.48 (s, 1H, OH). 13C NMR (125.77 MHz, 
CDCl3): δ (ppm) 154.24 (s, CH2 (Py-C) N), 149.68 (s, Py-C), 148.16 (s, 
Triazole C), 137.42 (s, Py-C), 123.46 (s, Triazole CH), 122.52 (s, Py-C), 
122.41 (s, Py-C), 56.29 (s, NCH2), 55.51 (s, OCH2). ESI-MS (m/z, %) 
required for C9H10N4O (190.20): [L14 + Na
+] (213.1, 100), [2L14 + Na+] 
(403.1, 89). Anal. Calcd. for C9H10N4O (190.20): C, 56.83; H, 5.30; N, 29.46. 
Found: C, 56.40; H, 4.53; N, 29.22 %. 
Syntheis of 1-(2-picolyl)-4-hexyl-1H-1,2,3-triazole (L15). 2-Picolyl bromide 
hydrobromide (2 mmol, 0.51 g), Na2CO3 (2 mmol, 0.21 g), NaN3 (2.2 mmol, 
0.14 g) and 1-octyne (4 mmol, 0.44g) were placed in a reaction tube 
containing a mixed solvent of CH3OH/H2O (v:v, 1:1, 4 mL). CuI (0.13 mmol, 
0.025 g) was added, and the reaction mixture was stirred at 50 °C for 20 h on a 
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MultiMax reactor. The product was extracted with ethyl acetate for three times. 
The combined organic extract was washed with brine, dried with anhydrous 
MgSO4, filtered and purified by column chromatography on silica. Yield: 0.37 
g, 76 %. 1H NMR (400 MHz, CDCl3): δ (ppm) 8.58 (s, 1H, CHCHN of py-H), 
7.69, 7.67 and 7.65 (t, 1H, py-H, J = 8 Hz), 7.41(s, 1H, triazole-H), 7.25 and 
7.23 (d, 1H, py-H, J = 8 Hz), 7.15 and 7.13(d, 1H, py-H, J = 8 Hz), 5.61(s, 2H, 
py-CH2), 2.71, 2.69 and 2.67 (t, 2H, triazole-CH2-CH2, J = 8 Hz), 1.68-1.60 
(m, 2H, triazole-CH2-CH2), 1.35-1.25 (m, 6H, CH2CH2CH2CH3), 0.87, 0.86 
and 0.84 (t, 3H, CH3, J = 6 Hz). 
13C NMR (100.6 MHz, CDCl3): δ (ppm) 
155.1 (s, py-C), 149.7 (s, py-CH), 149.2 (s, py-CH), 137.4 (s, triazole-C), 
123.4 (s, triazole-CH), 122.5 (s, py-CH) and 121.3 (s, py-CH), 55.7 (s, 
NCH2py), 31.7 (s, triazole-CH2), 29.5 (s, CH2CH2CH3), 29.0 (s, triazole-
CH2CH2CH2), 25.9 (s, triazole-CH2CH2), 22.7 (s, CH2CH3), 14.1 (s, CH3). 
ESI-MS (m/z, %) required for C14H20N4 (244.34): [L15 + H
+] (245.1, 1 00). 
Synthesis of 1,1-bis (4-(2-(methylthio)-pyridine)-1H-1,2,3-triazolyl) 
methane (L16).
253
 The prepared alkyne viz. 2-(2-propynylthio) pyridine (5 
mmol, 746 mg) was mixed with 1,1-dibromomethane (2.5 mmol, 435 mg) and 
NaN3 (6 mmol, 390 mg) in a mixture solvent of DMF/ H2O (2:1, 30 ml), 
followed by the addition of K2CO3 (6 mmol, 829 mg), CuSO4⋅5H2O (2.5 
mmol, 624 mg) and sodium ascorbate (5 mmol, 991 mg). The reaction was 
stirred at r.t. for 96 h. The residue was then partitioned between aqueous 
NH4OH/EDTA (100 mL) solution and ethyl acetate (100 mL) and layers 
separated. Repeated extraction three times and combined the organic phase. 
The extracts were washed with water (2×100 mL) and brine (100mL) and 
dried over anhydrous MgSO4. The product was purified by column 
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chromatography on silica gel. Yield: 0.41g, 42 %. 1H NMR (500 MHz, 
CDCl3): δ (ppm) 8.42 (d, 2H, Py-H), 7.74 (s, 2H, Triazole-H), 7.49-7.45 (m, 
2H, Py-H), 7.15 (d, 2H, Py-H), 7.01-6.99 (m, 2H, Py-H), 6.62 (s, 2H, 
Triazole-CH2), 4.46 (s, 4H, S-CH2). 13C NMR (125.77 MHz, CDCl3): δ 
(ppm) 157.36 (s, SCN), 149.43 (s, p-C (2-Py)), 147.36 (s, o-C (2-Py)), 136.13 
(s, Triazole C), 122.75 (s, Triazole CH), 122.29 (s, m-C (2-Py)), 119.85 (s, m-
C (2-Py)), 60.53 (s, NCH2), 24.13 (s, SCH2). ESI-MS (m/z, %) required for 
C17H16N8S2 (396.49): [L16 + H
+] (396.9, 11), [L16 + Na+] (419.0, 100), 
[2L16 + Na+] (814.1, 23). Anal. Calcd. for C17H16N8S2 (396.49): C, 51.50; H, 
4.07; N, 28.26; S, 16.17. Found: C, 55.21; H, 5.05; N, 23.31; S, 13.51 %. 
Synthesis of 1,2-bis (4-(2-(methylthio)-pyridine)-1H-1,2,3-triazolyl) ethane 
(L17). Ligand L17 was synthesized via a similar procedure to L16 by 
replacing dibromomethane with 1,2-dibromoethane (2.5 mmol, 470 mg). 
Yield: 0.49 g, 48%. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.42 (d, 2H, Py-H), 
7.49-7.45 (m, 2H, Py-H), 7.15 (s, 2H, Triazole-H), 7.15-7.13 (d, 2H, Py-H), 
7.01-6.98 (m, 2H, Py-H), 4.77 (s, 4H, S-CH2), 4.37 (s, 4H, Triazole -CH2). 
13C 
NMR (125.77 MHz, CDCl3): δ (ppm) 157.67 (s, SCN), 149.39 (s, CH (2-Py)), 
145.95 (s, CH (2-Py)), 136.08 (s, Triazole C), 123.60 (s, Triazole CH), 122.12 
(s, CH (2-Py)), 119.72 (s, CH (2-Py)), 49.46 (s, NCH2), 24.22 (s, SCH2). ESI-
MS (m/z, %) required for C18H18N8S2 (410.52): [L17 + H
+] (411.0, 47), [L17 
+ Na+] (433.1, 100). Anal. Calcd. for C17H16N8S2 (396.49): C, 52.66; H, 4.42; 
N, 27.30; S, 15.62. Found: C, 55.43; H, 5.01; N, 25.18; S, 13.94 %. 
Synthesis of 1,3-bis (4-(2-(methylthio)-pyridine)-1H-1,2,3-triazolyl) 
propane (L18). Ligand L18 was synthesized via a similar procedure to L16 
by replacing dibromomethane with 1,3-dibromopropane (2.5 mmol, 505 mg). 
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Yield: 0.56g, 53%. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.45 (d, 2H, Py-H), 
7.53 (s, 2H, Triazole-H), 7.49-7.45 (m, 2H, Py-H), 7.18 (d, 2H, Py-H), 7.00-
6.97 (m, 2H, Py-H), 4.50 (s, 4H, S-CH2), 4.26-4.23 (m, 4H, N-CH2), 2.50-
2.41 (m, 2H, C-CH2-C). 13C NMR (125.77 MHz, CDCl3): δ (ppm) 157.86 (s, 
SCN), 149.41 (s, p-C (2-Py)), 145.80 (s, o-C (2-Py)), 136.09 (s, Triazole C), 
123.13 (s, Triazole CH), 122.22 (s, m-C (2-Py)), 119.72 (s, m-C (2-Py)), 46.63 
(s, NCH2), 30.43 (s, SCH2), 24.48 (s, C-CH2-C). ESI-MS (m/z, %) required 
for C19H20N8S2 (424.55): [L18 + H
+] (425.0, 42), [L18 + Na+] (447.1, 100), 
[2L18 + Na+] (869.8, 26). Anal. Calcd. for C19H20N8S2 (424.55): C, 53.75; H, 
4.75; N, 26.39; S, 15.11. Found: C, 53.57; H, 5.23; N, 23.22; S, 13.62 %. 
Synthesis of 1,4-bis (4-(2-(methylthio)-pyridine)-1H-1,2,3-triazolyl) 
butane (L19). Ligand L19 was synthesized via a similar procedure to L16 by 
replacing dibromomethane with 1,4-dibromobutane (2.5 mmol, 540 mg). 
Yield: 0.64 g, 58 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.44 (d, 2H, Py-H), 
7.49-7.45 (m, 2H, Py-H), 7.42 (s, 2H, Triazole-H), 7.17 (d, 2H, Py-H), 7.00-
6.98 (m, 2H, Py-H), 4.49 (s, 4H, S-CH2), 4.27-4.24 (m, 4H, N-CH2), 1.85-1.83 
(m, 4H, C-CH2CH2-C). 
13C NMR (125.77 MHz, CDCl3): δ (ppm) 158.02 (s, 
SCN), 149.39 (s, C (2-Py)), 145.84 (s, C (2-Py)), 136.09 (s, Triazole-C), 
122.34 (s, Triazole CH), 122.23 (s, C (2-Py)), 119.71 (s, C (2-Py)), 49.24 (s, 
NCH2), 27.01 (s, SCH2), 24.61 (s, C-CH2CH2-C). ESI-MS (m/z, %) required 
for C20H22N8S2 (438.57): [L19 + H
+] (439.1, 5), [L19 + Na+] (461.1, 100), 
[2L19 + Na+] (898.0, 37). Anal. Calcd. for C19H20N8S2 (424.55): C, 54.77; H, 
5.06; N, 25.55; S, 14.62. Found: C, 54.79; H, 4.69; N, 24.21; S, 13.40 %. 
Synthesis of 1,5-bis (4-(2-(methylthio)-pyridine)-1H-1,2,3-triazolyl) 
pentane (L20). Ligand L20 was synthesized via a similar procedure to L16 by 
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replacing dibromomethane with 1,5-dibromopentane (2.5 mmol, 575 mg). 
Yield: 0.74 g, 65 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.44 (d, 2H, Py-H), 
7.50-7.46 (m, 2H, Py-H), 7.43 (s, 2H, Triazole-H), 7.18 (d, 2H, Py-H), 7.00-
6.98 (m, 2H, Py-H), 4.50 (s, 4H, S-CH2), 4.24-4.21 (m, 4H, N-CH2), 1.89-1.83 
(m, 4H, NCH2-CH2), 1.27-1.24 (m, 2H, NCH2CH2-CH2). 
13C NMR (125.77 
MHz, CDCl3): δ (ppm) 158.08 (s, SCN), 149.39 (s, C (2-Py)), 145.66 (s, C (2-
Py)), 136.12 (s, Triazole C), 122.30 (s, Triazole CH), 122.21 (s, C (2-Py)), 
119.71 (s, C (2-Py)), 49.81 (s, NCH2), 29.48 (s, SCH2), 24.62 (s, NCH2-CH2), 
23.34 (s, NCH2CH2-CH2). ESI-MS (m/z, %) required for C21H24N8S2 
(452.60): [L20 + Na+] (475.1, 100), [2L20 + Na+] (926.1, 16). Anal. Calcd. for 
C21H24N8S2 (452.60): C, 55.73; H, 5.34; N, 24.76; S, 14.17. Found: C, 55.39; 
H, 5.07; N, 23.75; S, 13.91 %. 
Synthesis of 1,3,5-tris (1-(4-picolyl)-1H-1,2,3-triazol-4-yl) benzene 
(L21).253,255 Solid 1, 3, 5-tribromobenzene (6 mmol, 1.89 g) was dissolved in 
50 mL of freshly distilled Et3N under nitrogen. CuI (10 mg) and Pd(PPh3)2Cl2 
(80 mg) were added to the stirred solution. Ethynyltrimethylsilane (24 mmol, 
2.36 g) was added, and the mixture was heated at 50 °C for 6 h. After cooling, 
the resulting precipitate of diethylamine hydrobromide was removed by 
filtration and washed with ether. The combined filtrates were evaporated to 
dryness under reduced pressure and the residue was chromatographed on a 
column (Al2O3, hexane) to yield 1, 3, 5-tris ((trimethylsilyl) ethynyl) benzene 
as an intermediate. Yield: 1.65g, 75 %. 
Hydrolysis of the intermediate (4.5 mmol, 1.65 g) was carried out by treatment 
with a mixture consisting of dichloromethane (20 mL), methanol (50 mL) and 
1M NaOH aqueous solution (30 mL) under stirring for 3 h at r.t. A standard 
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work-up procedure involving evaporation of the organic solvent, extraction of 
the residue with ether drying (MgSO4), and removal of the solvent under 
reduced pressure yield pale yellow solid in essentially pure form. Yield: 0.55 g, 
81 %. 1H NMR (300 MHz, CDCl3): δ (ppm) 7.56 (s, 3H, ph-H), 3.10 (s, 3H, 
CH). 
To a stirred solution of 4-picolyl chloride hydrochloride (10 mmol, 1.64 g) in 
DMF/H2O (4:1, 30 mL), was added NaN3 (12 mmol, 0.78 g), K2CO3 (12 
mmol, 1.66 g), CuSO4⋅5H2O (1.5 mmol, 0.24 g) and sodium ascorbate (3 
mmol, 0.60 g). The 1,3,5-triethynylbenzene (3 mmol, 0.46 g) was added and 
the reaction mixture was stirred at reflux (100 °C) for 36 h under nitrogen. 
After cooling to room temperature, the suspension was then partitioned 
between aqueous NH4OH/EDTA (200 mL) and EA (200 mL) and the layer 
separated. The organic phase was washed with water and brine, dried over 
MgSO4 and the solvent was removed under reduced pressure. The crude 
product purified by column chromatography on silica gel. Yield: 0.17 g, 10 %. 
Anal. Calcd. for C30H24N12 (552.59): C, 65.21; H, 4.38; N, 30.42. Found: C, 
65.23; H, 4.22; N, 29.78 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.66 and 
8.65 (d, 6H, py-H), 8.29 (s, 3H, ph-H), 7.94 (s, 3H, triazole-H), 7.18 and 7.17 
(d, 6H, py-H), 5.62 (s, 6H, CH2). ESI-MS (m/z, %) required for C30H24N12 
(552.59): [L21 + H+] (553.0, 79), [2L21 + H+] (1104.9, 100), [3L21 + H+] 
(1657.8, 19). 
Synthesis of 2,6-bis (1-ethyl-1H-1,2,3-triazol-4-yl) pyridine (L22).253,256 A 
suspension consisting of 2, 6-dibromopyridine (4 mmol, 0.95 g), Pd (PPh3)2Cl2 
(0.4 mmol, 0.28 g), CuI (0.8 mmol, 0.15 g) in THF/i-Pr2NH (1:1, 0.15 M) was 
degassed by bubbling nitrogen for 20 min. The reaction mixture was placed 
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under nitrogen and heated to 50 °C. Ethynyltrimethylsilane (10 mmol, 0.98 g) 
was added via syringe, and the reaction was stirred for 18 h. The volatiles 
were then removed in vacuo and the crude product was washed with water 
twice, extracted with dichloromethane twice, dried over MgSO4 and 
concentrated under reduced pressure. The brown solid obtained was purified 
by column, eluent dichloromethane/hexane (1:1) to give a yellow product. 
Yield: 0.81 g, 75 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 7.59-7.56 (t, 1H, 
py-H), 7.38 and 7.37 (d, 2H, py-H), 0.25 (s, 18H, Si-CH3). ESI-MS (m/z, %) 
required for C15H21NSi2 (271.50): [Py-2SiMe3 + H
+] (272.2, 100). 
A suspension consisting 2,6-bis ((trimethylsilyl) ethynyl) pyridine (3 mmol, 
0.81 g) and K2CO3 (12 mmol, 1.66 g) in ethyl ether/methanol (1:2, 0.05 M) 
was stirred at room temperature for 1 h. The suspension was diluted with ether 
and washed three times with water, once with brine. The organic layer was 
dried over MgSO4 and concentrated to afford light brown solid. Yield: 0.31 g, 
81 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 7.66-7.63 (t, 1H, py-H), 7.44 (d, 
2H, py-H), 3.15 (s, 2H, CH). 
To a stirred solution of 1-bromoethane (6 mmol, 0.65 g) in DMF/H2O (4:1, 20 
mL) was added NaN3 (6 mmol, 0.39 g), K2CO3 (4.8 mmol, 0.66 g), 
CuSO4⋅5H2O (1 mmol, 0.25 g) and sodium ascorbate (2 mmol, 0.40 g) under 
nitrogen. The 2,6-diethynylpyridine (2 mmol, 0.25 g) was added and the 
reaction mixture was stirred at reflux for 36 h. After cooling to room 
temperature, the suspension was then partitioned between aqueous 
NH4OH/EDTA (200 mL) and ethyl acetate (200 mL) and the layer separated. 
The organic phase was washed with water and brine, dried over MgSO4. The 
solvent was removed under reduced pressure. Chromatography gave the pale 
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yellow solid. Yield: 0.25 g, 46 %. Anal. Calcd. for C13H15N7 (269.31): C, 
57.98; H, 5.61; N, 36.41. Found: C, 56.56; H, 5.48; N, 36.04 %. 1H NMR (500 
MHz, CDCl3): δ (ppm) 8.18 (s, 2H, triazole-H), 8.10 and 8.08 (d, 2H, py-H), 
7.88-7.85 (t, 1H, py-H), 4.52-4.47 (m, 4H, CH2), 1.64-1.61 (t, 6H, CH3).
 13C 
NMR (125.76 MHz, CDCl3): δ (ppm) 150.05 (s, py-C), 148.42 (s, py-C), 
137.75 (s, py-C), 121.34 (s, triazole-C), 119.29 (s, triazole-CH), 45.45 (s, 
CH2), 15.51 (s, CH3). ESI-MS (m/z, %) required for C13H15N7 (269.31): [L22 
+ Na+] (292.2, 100). 
Synthesis of 1,3-bis (1-ethyl-1H-1,2,3-triazol-4-yl) benzene (L23).253,255,256 
A suspension consisting of 1, 3-diiodobenzene (5 mmol, 1.65 g), Pd 
(PPh3)2Cl2 (0.15 mmol, 0.11 g), CuI (0.6 mmol, 0.11 g) and i-Pr2NH (40 mmol, 
4.05 g) in THF (30 mL) was degassed by bubbling nitrogen for 20 min. The 
reaction mixture was placed under nitrogen and heated to 70 °C. 
Ethynyltrimethylsilane (11 mmol, 1.08 g) was added via syringe, and the 
reaction was stirred for 6 h. The volatiles were then removed in vacuo and the 
crude product was washed with water twice, extracted with dichloromethane 
twice, dried over MgSO4 and concentrated under reduced pressure. The brown 
solid obtained was purified by column with eluent of DCM/Hexane (1:1) to 
give a yellow solid. Yield: 0.95 g, 70 %.  
Hydrolysis of the intermediate (3.5 mmol, 0.95 g) was carried out by treatment 
with a mixture consisting of dichloromethane (20 mL), methanol (50 mL) and 
1M NaOH aqueous solution (30 mL) under stirring for 3 h at r.t.. A standard 
work-up procedure involving evaporation of the organic solvent, extraction of 
the residue with ether drying (MgSO4), and removal of the solvent under 
reduced pressure yield pale yellow solid in essentially pure form. Yield: 0.38 g, 
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86 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 7.62 (s, 1H, ph-H), 7.47-7.45 (m, 
2H, ph-H), 7.30-7.27 (t, 1H, py-H), 3.09 (s, 2H, CH). 
To a stirred solution of 1-bromoethane (9 mmol, 0.98 g) in DMF/H2O (30 mL, 
v:v 4:1) was added NaN3 (9 mmol, 0.59 g), K2CO3 (7.2 mmol, 1.00 g), 
CuSO4⋅5H2O (1.5 mmol, 0.37 g) and sodium ascorbate (3 mmol, 0.59 g) under 
nitrogen. The 1,3-diethynylbenzene (3 mmol, 0.38 g) was added and the 
reaction mixture was stirred at reflux for 36 h. After cooling to room 
temperature, the suspension was then partitioned between aqueous 
NH4OH/EDTA (200 mL) and ethyl acetate (200 mL) and the layer separated. 
The organic phase was washed with water and brine, dried over MgSO4. And 
the solvent was removed under reduced pressure. Column chromatography on 
silica gel gave the yellow solid. Yield: 0.48 g, 60 %. Anal. Calcd. for 
C14H16N6 (268.32): C, 62.67; H, 6.01; N, 31.32. Found: C, 62.83; H, 5.39; N, 
30.98 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.29 (s, 1H, ph-H), 7.86 (s, 2H, 
triazole-H), 7.83-7.81 (d, 2H, ph-H), 7.50-7.47 (t, 1H, ph-H), 4.50-4.45 (m, 
4H, CH2), 1.63-1.60 (t, 6H, CH3).
 13C NMR (125.77 MHz, CDCl3): δ (ppm) 
147.54 (s, triazole-C), 131.31 (s, ph-C), 129.40 (s, triazole-CH), 125.29 (s, ph-
C), 122.91 (s, ph-C), 119.20 (s, ph-C), 45.40 (s, CH2), 15.50 (s, CH3). ESI-MS 
(m/z, %) required for C14H16N6 (268.32): [L23 + H
+] (269.1, 66), [L23 + Na+] 
(291.1, 15), [2L23 + H+] (536.8, 83), [2L23 + Na+] (558.7, 100). 
Synthesis of 2,6-bis (1-phenyl-1H-1,2,3-triazol-4-yl) pyridine (L24).
179,223
 A 
50 mL two-neck round bottomed flask equipped with a magnetic stirrer, an 
nitrogen inlet and a reflux condenser was loaded with ethanol-water (15 mL, 
v:v 7:3), bromobenzene (9 mmol, 1.41 g), CuI (0.3 mmol, 0.06 g), sodium 
ascorbate (0.15 mmol, 0.03 g), N, N'-dimethylethylenediamine (0.45 mmol, 
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0.04 g) and sodium azide (18 mmol, 1.17 g). Stirring at r.t. under nitrogen for 
30 min resulted in a blue solution. After refluxing the reaction mixture under 
nitrogen for 2 h, further sodium ascorbate (0.15 mmol, 0.03 g) and 2,6-
diethynylpyridine (3 mmol, 0.38 g) were added. The reaction mixture was 
refluxed for 4 h and then stirred at r.t. for 12 h. The reaction mixture was then 
poured into aqueous NH4OH/EDTA (1.0 M, 100 mL), the resulting precipitate 
was isolated by filtration and washed well with water, then vacuum dried. The 
separation followed by column chromatography on silica gel and re-
precipitation into diethylether, yielded the product. Yield: 0.46 g, 42 %. Anal. 
Calcd. for C21H15N7 (365.39): C, 69.03; H, 4.14, N, 26.83. Found: C, 71.13; H, 
4.91; N, 22.37 %. 1H NMR (500 MHz, CDCl3): δ (ppm) 8.66 (s, 2H, triazole-
H), 8.21 and 8.20 (d, 2H, py-H), 7.95-7.92 (t, 1H, py-H), 7.84 and 7.83 (d, 4H, 
ph-H), 7.57-7.54 (t, 4H, ph-H), 7.48-7.45 (t, 2H, ph-H). 13C NMR (125.77 
MHz, CDCl3): δ (ppm) 149.78 (s, py-C), 148.87 (s, py-CH), 137.90 (s, ph-C), 
136.98 (s, triazole-C), 129.80 (s, ph-CH), 128.92 (s, ph-CH), 120.53 (s, ph-
CH), 120.12 (s, triazole-CH), 119.78 (s, py-CH). ESI-MS (m/z, %) required 
for C21H15N7 (365.39): [L24 + H
+] (366.1, 3), [L24 + Na+] (388.1, 100), 
[2L24 + Na+] (753.2, 76). 
X-ray crystallography 
Table 2.1 Crystallographic data and refinement parameters for ligands L8, 
L16 and L19. 
 
Complex L8 L16 L19 
Formula C16H15N3O C17H16N8S2 C20H22N8S2 
MW 265.31 396.50 438.58 
T / K 100(2) 100(2) 223(2) 
Crystal size / 
mm3 0.50 × 0.14 × 0.08 0.60 × 0.23 × 0.10 0.36 × 0.24 × 0.10 
Crystal system Orthorhombic Monoclinic Monoclinic 
Space group P 212121 P 21/n P 21/c 
a / Å 5.6827(7) 13.500(2) 5.512(2) 
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b / Å 8.0024(11) 5.6661(9) 25.524(10) 
c / Å 29.160(4) 23.135(4) 7.743(3) 
α / ° 90 90 90 
β / ° 90 101.383(3) 109.287(9) 
γ / ° 90 90 90 
V / Å3 1326.1(3) 1734.8(5) 1028.2(7) 
Z 4 4 2 
Dcalc / g·cm
−3 1.329 1.518 1.417 
µ / mm−1 0.086 0.329 0.285 
θ range / ° 1.40−27.50 2.83−27.50 1.60−27.50 
Reflections 
collected 
9343 11743 7055 
Independent 
reflections [Rint] 
3046 [0.0335] 3977 [0.0304] 2342[0.0427] 
Parameters 181 290 136 
GOF 1.130 1.035 1.099 
R1(I > 2σ(I)) 0.0457 0.0379 0.0536 














Chapter 3 Hybridised 1,2,3-triazoles supported novel 
Cu(I) complexes: structures, luminescent and catalytic 
properties 
3.1 Introduction 
The copper catalyzed azide-alkyne cycloaddition (CuAAC) reaction has 
attracted significant attention over the past decade due to its mild and green 
synthesis conditions, high efficiency and regioselectivity, and therefore 
considered to be the premier example of the click reaction.22,23,29,35,242,257 
This reaction has not only been widely used in biological applications and 
modification of material surfaces, polymers and 
nanoparticles,178,181,247,249,258-260 but also provides an excellent approach to 
design and synthesize novel triazole containing metal chelators that joins 
different functional groups together for the purpose of generating new 
coordination sites.28,261 Central to this evolution is its facility in creating 
functional small molecules for targeted applications.14,262 This demands 
that the new hybrid ligands have to support functional materials for the 
next generation of applications.29,263-266 Accordingly, various types of 
copper catalysts have been explored for this reaction, such as simple Cu(II) 
salt together with a reducing agent, catalytic organometallic Cu(I) 
precursors, as well as nanostructured copper catalysts.24,35,254,267-271 For the 
well-defined copper catalyst systems, phosphine-,47,48,272 N-heterocyclic 
carbene-,54,273,274 imidazole-,95,275,276 sulfated-,56,141 nitrogen-based 
molecules26,31,57,65,88,104,122,126,227,277 are the most used ligands. As products 
of CuAAC reaction, several triazole containing multidentate ligands have 
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been used to synthesize novel transition metal complexes, which have also 
indicated interesting structural features, photoluminescent and catalytic 
properties.178,247,249,258,259 For example, pyrazolyl functionalized triazole 
ligands supported Rh and Ir complexes in hydroamination, pyridyl-triazole 
based Ni complexes as catalysts for ethylene oligomerisation, pyridyl-
triazole based Cu luminescent coordination polymers, etc. Copper 
complexes have enormous potential in catalysis area due to their ready 
availability and good catalytic activities in various catalytic reactions.29,278-
281 The heterocyclic donors (hard and soft) containing ligands should be the 
most successful supports for catalytic reactions. In this line, nitrogen 
donating ligands are particularly promising as they form stable Cu(I) 
complexes under straightforward synthetic conditions with a range of 
ligand-dependent structural variations.26,31,57,65,88,104,122,126,227,277 Recent 
progresses also suggest that Cu(I) triazole complexes are active towards 
CuAAC reactions.46,56,127,137,141,142,282 Meanwhile, sulphur and oxygen 
containing hybrid ligands are attractive for their hard and soft structural 
features as well as hemilabile functions accompanied by a range of such 
ligands as supports for metal catalyzed reactions.29,283-288 We have also 
been exploring a tridentate SNS ligand supported Cu(I)/(II) complexes with 
good catalytic activities towards the model product of 1-benzyl-4-phenyl-
1H-1,2,3-triazole in aqueous conditions without base and reducing agent.25 
This opened up more opportunities for more new hybrid triazoles to be 
used in green catalysis. Here we reported the click-synthesis via CuAAC 
reaction of three multi-hybridised triazole ligands by a single-step as a 
defining hallmark of click reactions. We investigated their complexation to 
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give interesting Cu(I) clusters (Cu4I4) or cluster (Cu6I6 and Cu2I2) based 
one-dimensional (1-D) coordination polymers with 18-metallocycles which 
have been crystallographically established, and their catalytic activity in 
azide-alkyne cycloaddition reactions. This “click-and-click” dual-step 
paves a green path to make new click catalysts assembled from ligands 
made from CuAAC click synthesis. It further charts a new direction of 
click-type catalysis in materials research beyond catalysis, as evidenced 
from the promising photoluminescent-activity shown herein. 
 
3.2 Results and Discussion 
3.2.1 Ligand synthesis and their coordination modes in Cu(I) complexes  
The coordination modes of two new thioether-tethered 1,2,3-triazole-pyridyl 
ligands 1-(2-picolyl)-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole (L2), 1-(4-
picolyl)-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole (L4) and one pyridyl 
and hydroxy fuctionalized triazole ligand 1-(2-picolyl)-4-(hydroxymethyl)-
1H-1,2,3-triazole (L14) which were synthesized from CuAAC reactions are 
shown in Scheme 3.1. Ligand L2 was designed to have a chelating function 
with a 2-picolyl adjacent to the triazole whereas L4 has a bridging potential 
with a 4-picolyl function. Both L2 and L4 carry a 2-(methylthio)pyridine at 
the 4-position to promote oligomeric or polymeric formation. However, 
comparison with L2, while 2-(methylthio)pyridine group is replaced by 
hydroxymethyl group in L14, only [Cu4I4] oligomer is formed without 
polymeric assembly, containing hydroxymethyl as pendant groups which were 





Scheme 3.1 Coordination modes of L2, L4 and L14 in 1‒3. 
 
3.2.2 X-ray crystal & molecular structures of Cu(I) complexes 
Mix of corresponding ligands with CuI in acetonitrile followed by a liquid-gas 
diffusion procedure gives crystals of Cu(I) complexes 1‒3, respectively. 
Complex 1 crystallizes in the triclinic space group P1, and shows a 
polymeric propagation of [Cu6I6] oligomers which is reminescent of the POLO 
(polymer of oligomers) assemblies found in the Ag(I)289 and Cu(I) systems246 
(Fig 3.1a & b). As expected, the 2-nitrogen of triazole and the picolyl nitrogen 
form a chelate whereas the 3-nitrogen of the triazole bridges the neighbouring 
copper. This chelate-bridging function together with the remote bridging 2-
pyridyl enables two [Cu3I3] to gel into a step-like [Cu6I6] double-chain 
aggregate (Fig 3.1a). The ligand L2 cross-connects neighbouring hexanuclear 
[Cu6] units into a new form of POLO (Fig 3.1b), which is unprecedented 
among the 1-D polymers of Cu(I) complexes. In details, all the Cu1, Cu2 and 
Cu3 show distorted tetrahedral geometries with different coordination 
environments. There are two chelating N (N1 and N3) atoms from L2, one µ2-
I and one µ3-I bridges for Cu1 center, one N (N4) atom from L2 and three µ3-I 
bridges for Cu2 center, and one N (N5) atom from another L2, one  µ2-I and 
two µ3-I bridges for Cu3 center. The dihedral angles of I−Cu−I with N−Cu−N 
planes for Cu1, N−Cu−I with I−Cu−I planes for Cu2 and Cu3 are 98.3, 97.2 
and 90.7°, which define the distortion of the tetrahedron geometries of Cu1, 
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Cu2 and Cu3, respectively. Ligand L2 show chelate-bridging mode using the 
pyridyl-triazole groups (N1, N3 and N4) between Cu1 and Cu2 centers, which 
are also bridged by a µ3-I (I2) bridge. Cu3 with Cu1 and Cu2 are linked via 
one µ2-I (I1) and two µ3-I (I2 and I3) bridges, and forms Cu3I3 stair-like 
cluster, it is further to link neighbouring cluster via two µ3-I (I3) bridges, and 
completes the Cu6I6 aggregate (Fig. 3.1a). Four L2 ligands coordinate to the 
Cu6I6 cluster and bridge neighbouring Cu6I6 clusters, and form the present 
Cu6I6 cluster based 1-D chain (Fig. 3.1b). There also exist two kinds of 
intermolecular π⋅⋅⋅π interactions (displacement angles290 15.3 and 20.4°, 
centroid-centroid distances290 3.45 and 3.75 Å, respectively) between the two 
triazole rings and two pyridyl rings of L2 ligands from neighbouring three 
chains, respectively, which help to complete a 3-D architecture (Fig 3.2a). A 
segment of crystal packing structure is also shown in Fig 3.2b. Among the CuI 
based clusters and polymeric structures, polymers with the zigzag [CuI]n chain, 
[CuI]n columnar chain, staircase [CuI]n chain and rhombic [Cu4I4]n chains are 
known.291,292 However, only limited hybrid triazole ligands were used in the 
polymeric structure assembly and complex 1 is also a rare form of polymeric 
assemblies supported by triazole ligands, with a related assembly found in the 








Fig 3.1 (a) Symmetric unit of 1 (ave dCu-Cu = 2.90 Å). (Cu1−N3 2.073(4), 
Cu1−N1 2.078(3), Cu1−I1 2.5289(8), Cu1−I2 2.6898(9), Cu2−N4 2.053(4), 
Cu2−I3A 2.5852(8), Cu2−I3 2.6200(8), Cu2−I2 2.7494(9), Cu3−N5B 
2.061(4), Cu3−I1 2.6288(8), Cu3−I3 2.7089(9), Cu3−I2 2.7101(8); 
N3−Cu1−N1 91.7(1), N3−Cu1−I1 124.6(1), N1−Cu1−I1 115.9(1), 
N3−Cu1−I2 96.3(1), N1−Cu1−I2 108.2(1), I1−Cu1−I2 116.20(2), 
N4−Cu2−I3A 116.5(1), N4−Cu2−I3 111.2(1), I3A−Cu2−I3 112.77(2), 
N4−Cu2−I2 96.6(1), I3A−Cu2−I2 108.18(2), I3−Cu2−I2 110.36(3), 
N5B−Cu3−I1 114.8(1), N5B−Cu3−I3 109.2(1), I1−Cu3−I3 104.74(2), 
N5B−Cu3−I2 106.9(1), I1−Cu3−I2 112.19(2), I3−Cu3−I2 108.88(3)) (b) 
Inter-connection of hexanuclear [Cu6I6] moieties through bridging hybrid 





Fig 3.2 (a) Interchain π⋅⋅⋅π interactions in 1. (b) A segment of crystal 
packing in 1. 
 
X-ray structure of 2 suggests a simpler and more direct form of 
coordination polymer whose formation benefit from the bridging function 
of picolyl and 3-triazole nitrogen donors leaving not only the thio but also 
its associated pyridyl as pendants. This creates a series of rhomboidal 
[Cu2I2] units polymerise to repeating 18-metallocycles. Different from 1, 
complex 2 crystallizes in the monoclinic space group P21/c, in which there 
is one crystallographically independent Cu(I) center in the asymmetric unit 
(Fig 3.3a). The Cu(I) center shows a distorted tetrahedral geometry with 
two triazole and 4-pyridyl N atoms from two L4 ligands and two µ2-I 
bridges. The dihedral angle (89.7°) of I−Cu−I with N−Cu−N planes defines 
the distortion of the tetrahedron geometry Cu(I) center. The ligand L4 
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indicates bridging mode by using triaozle and 4-pyridyl N donors, together 
with the µ2-I bridges, they link the Cu(I) centers to form an Cu2I2 rhomboid 
dimer based 1D coordination polymer (Fig 3.3b). There exist 
intermolecular π⋅⋅⋅π interactions (displacement angle290 14.4−21.7°, 
centroid-centroid distance290 3.50 Å) between the triazole and 4-pyridyl 
rings of L4 ligands from neighboring chains, which form an interesting 
supramolecular 2-D layer (Fig 3.4). The weak π⋅⋅⋅π interactions between 
the 2-pyridyl rings of neighbroing layers contribute to a three-dimensional 
supramolecular architecture.  
Among the CuI based clusters and polymeric structures, the isolation of 1 
and 2 demonstrated that these triazole-based hybrid ligands have the 
necessary credentials to promote coordination polymer formation. Their 
several degrees of flexibility support the self-assembly process, namely, (a) 
either nitrogen donor in 2- and 3-positions or both of them can coordinate, 
and (b) either pyridyl nitrogen (as picolyl and methylthiopyridine) or both 
of them can also coordinate. These, coupled with the flexible thioether 
spacer help the ligands adjust the coordination mode to adapt to the 
structure demands. Originally, we designed these hybrid triazole ligands 
with the hard and soft NS donors which are supposed to play a hemilable 
feature in both coordination and catalysis. However, the thioether sulfur is 
uncoordinative, at least in the solid-state. There are a few factors could 
affect the resulted coordination structures, the chelating and/or bridging 
modes of ligands L2 and L4, the rigid sites (2-pyridyl groups), the 





Fig 3.3 (a) Basic building block of 2 (dCu-Cu = 2.72 Å). (Cu1−N1 2.061(2), 
Cu1−N5B 2.092(2), Cu1−I1A 2.6041(4), Cu1−I1 2.6420(5), Cu1−Cu1A 
2.7162(7); N1−Cu1−N5B 96.79(8), N1−Cu1−I1A 115.48(6), 
N5B−Cu1−I1A 108.50(6), N1−Cu1−I1 110.38(6), N5B−Cu1−I1 105.42(6), 
I1A−Cu1−I1 117.64(1)) (b) Polymerisation of [Cu2I2] moieties through 






Fig 3.4 Intermolecular π⋅⋅⋅π interactions in 2. 
 
The complex 3 also crystallizes in the triclinic space group P1, however, 
different from the former two polymeric propagations, only [Cu4I4] stair-like 
oligomer aggregate is formed. Both two kinds of cooper centres Cu1 and Cu2 
are four coordinated and show distorted tetrahedral geometry. Cu1 centre is 
coordinated by one µ2-I (I1), one µ3-I (I2) bridges and a chelate formed by 2-
nitrogen of triazole and the picolyl nitrogen from one ligand L14. Meanwhile, 
Cu2 centre is coordinated by 1-nitrogen of triazole and three bridged iodide 
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atoms µ2-I (I1) and µ3-I (I2 and I2A). Ligand L14 also show chelate-bridging 
mode using the pyridyl-triazole groups (N1, N2 and N4) to link Cu1 and 
Cu2A centres which is similar to ligand L2. Cu1 and Cu2A centres are also 
bridged by a µ3-I (I2) at same time to form Cu2I2 cluster, which is further 
linked with neighbouring cluster via two µ2-I (I1 and I1A) bridges to construct 
the Cu4I4 aggregate (Fig 3.5a). There exist one kind of intermolecular π⋅⋅⋅π 
stacking interactions in 3 between neighbouring two pyridyl groups 
(displacement angles290 13.5°, centroid-centroid distances290 3.66 Å) which 
help to build 1-D chains (Fig 3.5b). In the crystal structure of complex 3, three 
nitrogen donor sites are all coordinated to the copper (I) metal centres, but the 
hydroxy groups are free, which are connected with dimethylfomamide (DMF) 
molecules by O−H⋅⋅⋅O hydrogen bonding interactions (∠OHO 165°, O⋅⋅⋅O 











Fig 3.5 (a) The structure of 3 with [Cu4I4] moiety. (Cu1−N4 2.072(2), 
Cu1−N2 2.080(2), Cu1−I1 2.5496(3), Cu1−I2 2.7227(3), Cu2−N1A 
2.048(2), Cu2−I1 2.6015(3), Cu2−I2 2.6598(3), Cu2−I2A 2.7251(4); 
N4−Cu1−N2 90.53(7), N4−Cu1−I1 120.18(5), N2−Cu1−I1 131.64(5), 
N4−Cu1−I2 105.14(5), N2−Cu1−I2 95.47(5), I1−Cu1−I2 109.20(1), 
N1A−Cu2−I1 121.41(5), N1A−Cu2−I2 102.25(5), I1−Cu2−I2 109.58(1), 
N1A−Cu2−I2A 95.78(5), I1−Cu2−I2A 109.50(1), I2−Cu2−I2A 118.30(1)) 





Fig 3.6 Intermolecular hydrogen bonding interactions linked DMF 
molecules in 3. 
 
3.2.3 Powder X-Ray Diffraction, Thermogravimetric Analysis and 
Photoluminescence 
Complexes 1 and 2 show fair agreement between their experimental and 
calculated X-ray powder diffraction patterns, supporting reasonable phase 
purity. For complex 3, the difference between X-ray powder diffraction 
pattern and calculated one is due to cocrystallization of dimethylfomamide 
solvent molecules in single crystal growth procedure (Fig 3.7). The 
thermogravimetric (TG) curves of 1‒3 over 35–1000 °C are given in the 
Fig 3.8, all complexes exhibit good thermal stability (up to ~240 °C). All 
ligands in solution and complexes in solid-state show broad 
photoluminescent emissions at r.t. (Fig 3.9 & 3.10). The maximum 
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emissions are 428, 403 and 425 nm under the excitation wavelengths of 
340, 335 and 340 nm for L2, L4 and L14, respectively. Complexes 1‒3 
show maximum at 474, centered at 487 and maximum at 483 nm under the 
excitation wavelengthes of 310, 376 and 310 nm, respectively. The 
photoluminescent emissions of the complexes 1‒3 are similar to that of 
polymeric [CuIPy]n (dCu-Cu of 2.88 Å, maximum emission at 449nm) with 
repeating [CuI]294. The ligand emissions likely arise from π−π* excited 
states. The emissions of 1‒3 are likewise assigned to a 3(XLCT) metal-to-
ligand charge transfer, or cluster-centered 3(CC) excited states (HE band) 
and the present shorter dCu-Cu (2.71 and 2.88 Å in 1, 2.72 Å in 2 and 2.64 
and 2.76 Å in 3) accounts for the longer wavelength.205,295-299 
 
 
Fig 3.7  Powder XRD patterns of 1‒3. (T = Theoretical profile with 
reference to the experimentally determined structure by single-crystal 





Fig 3.8 Thermogravimetric analysis profiles for 1−3. 
 
 
Fig 3.9 Photoluminescence properties of L2, L4 and L14 in ethanol 





Fig 3.10 Solid state emission spectra of 1 (maximum at 474 nm), 2 
(centered at 487 nm) and 3 (maximum at 483 nm) at r.t. (Excitation 
wavelength λex = 310 & 376 & 310 nm, respectively) 
 
3.2.4 Catalytic investigation of complexes 1‒3 in azide-alkyne 
cycloaddition reaction 
As introduced before, the CuAAC reaction is the most efficient click 
reaction having large amount of applications. Kinds of Cu(I) and Cu(II) 
sources including hybrid Cu(I) and Cu(II) complexes have been used as 
catalysts in this reaction.24-27,300 The catalytic potential of 1‒3 was explored 
towards one-pot AAC reaction under base-free conditions. For all three 
complexes, the AAC rection was optimized by the model reaction of benzyl 
chloride, NaN3 and phenylacetylene with a low catalyst loading of 0.5 
mol% under different temperature and solvents conditions. Poor to 
moderate yields were obtained with mixed solvent MeCN/H2O or pure 
water, but a strong acceleration was observed in MeOH/H2O mixture. 
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Higher temperature (50°C) and longer reaction time (24h) would increase 
the conversion of reactants until quantitative conversions (Table 3.1).  
Table 3.1 Catalyst optimization studies of 1‒3 for one pot AAC reaction. 
 
Entry Solvent T / °C t / h 
Conversion / % 





8 6 7 
2 50 29 45 35 
3 MeCN/ 
H2O 
30 trace trace trace 




30 5 24 13 31 
6 30 24 85 76 82 
7 50 1 23 30 34 
8 50 3 79 89 77 
9 50 5 78 98 83 
10 50 24 100 100 100 
Reaction condition: solvent - H2O (2 mL); MeCN:H2O (v:v, 2:1, 6 mL); 
MeOH:H2O (v:v, 1:1, 2 mL). 
 
Under optimized conditions, the catalytic performance of 1‒3 were 
investigated and presented in Table 3.2. For phenylacetylene, all 1‒3 show 
near-quantitative yields for picolyl bromides (entries 2−4, 11), nitrile and 
alkyl substituted benzyl bromides (entries 5 and 6), and fluorine-containing 
benzyl bromides (entries 7−9). For alkyl akynes with the similar substituted 
benzyl bromides, yields vary from moderate (63−88 %) to quantitative 
(entries 12−19). Similar use of CuI is effective but the yields are generally 
moderate towards many substrates under different conditions including 
ionic liquid/water and TEA with DMF.65,301 There is also potential 
formation of side products such as polynuclear acetylide complexes, 1-
iodoallynes and 5-iodotriazoles.29,302 Use of  CuI (6 mol % loading) shows 
comparable activity (78% isolated yield versus 78 % and 82 % with 1 and 2 
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respectively). (Entry 17) 
The catalysts 1‒3 are air and moisture stable and can be conveniently 
synthesized, which can tolerate a range of aryl, alkyl and heterocyclic 
bromides (Table 3.2) under mild reaction conditions. They are active 
towards fluoro-substituted aryl and heteroaryl substrates (Entries 8−10, 
2−4, 18). These three complexes contribute new well-defined active 
catalysts for AAC reactions. It is likely that the active species are generated 
from fragmentation of the POLO polymers in solution (ESI). The efficacy 
of 1‒3 is generally comparable to established tri-triazole, N-heterocyclic 
carbene and other nitrogen-based ligand coordinated Cu(I) 
catalysts51,54,142,273. All reactions proceeded smoothly and the products were 
isolated in good yields in high purity upon extraction and column 
chromatography. This system is effective under base-free and aqua 
compatible conditions, both of which are important parameters in green 
catalysis. 
Table 3.2 Catalytic activities of 1‒3 in the one pot AAC reaction. 
 
Entry Product 
Conversion / % 
1 2 3 
1 
 
100 100 100 
2a 
 
100 100 100 
3a 
 
100 100 100 
4a  100 100 100 
5 
 





In homogenous catalysis, ligand design is among the key that influences 
catalytic efficacy. There are many organic transformations that can be 
benefited from the presence of catalytic quantities of metal complexes, ‘click 
reaction’ is one of the typical examples. This is important especially in today’s 
challenges of waste-free and byproduct-free industrial processes. In this work, 
6 
 
100(93b) 100(94b) 100 (93b) 
7  100 100 100 
8 
 
100(94b) 100(96b) 100(94b) 
9 
 
100(93b) 100(94b) 100(94b) 
10 
 
100 100 100 
11 
 
100(92b) 100(93b) 100(94b) 
12  100 93 100 
13a  90 94 92 
14 
 
88 84(68 b) 92 
15 
 
63 66 60 
16 
 
98 95 100 
17a,c  89(78
b) 92(82b) ‒ 
18 
 
70 67 72 
19a 
 
100 100(89b) 100 
a Na2CO3 (1 mmol) was added when organic bromide HBr salt was used. 
b Isolated yield. c
Isolated yield of 78% was achieved by using CuI as catalyst at 6% loading.  
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three multi-functionalized triazole multidentated ligands were synthesized by 
click reaction and their Cu(I) complexes show interesting cluster and cluster 
based polymeric structures. The specific solid optical properties of CunIn 
clusters in Cu(I) complexes are also investigated. Meanwhile, both POLOs 
and clusters are effective towards catalytic azide-alkyne cycloaddition in 
mixed solvent MeOH/H2O under different substrates without any extra 
reducing agent needed. This dual-click approach replicates the summative 
approach to generate succeeding generation of click-active molecules and 
materials from click products. The multi-hybridised triazoles presented herein 
are not only catalytically active ligands but are also flexible spacers that can 
self-assemble into Cu(I) coordination polymers using their coordinative and 
geometrically flexible hemilabile functional donors. The concept demonstrated 
herein has potential to be extended to other molecular material systems. 
 
3.4 Experimental Section  
Materials and physical measurements 
The synthesis of precusors and ligands have been presented in chapter 1. 
Synthesis of complex [Cu6I6(L2)2]n (1). A solution of CuI (0.6 mmol, 114 
mg) in CH3CN (5 mL) was added to a solution of L2 (0.2 mmol, 57 mg) in 
CH3CN (5 mL) under stirring. The mixture was stirred at r.t. in air 
overnight. The suspension was filtered under suction and washed by 
CH3CN and then Et2O. The solid was collected and dried under vacuum. 
Diffusion of Et2O to its DMF solution at r.t. afforded single crystals after 
about one week. Yield: 145 mg, 85 %. Anal. Calcd. for C14H13Cu3I3N5S 
(854.67): C, 19.67; H, 1.53; N, 8.19; S, 3.75. Found: C, 19.94; H, 1.47; N, 
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8.31; S, 3.76 %. ESI-MS (m/z, %): [H(L2)]+ (284.0, 7), [Cu(L2)]+ (346.0, 
20), [Cu(L2)(CH3CN)]
+ (387.2, 4), [Cu2I(L2)]
+ (535.9, 17), [Cu(L2)2]
+ 
(628.9, 100), [Cu3I2(L2)]
+ (727.6, 4), [Cu2I(L2)2]
+ (818.8, 3), [Cu3I2(L2)2]
+ 
(1010.5, 8). IR (KBr)/cm-1: 1597m, 1584m, 1554m and 1536m (νC=C and 
νC=N), 1473m, 1451m, 1420m, 1310m (νaryl), 1285m, 1254m, 1220m, 
1161m, 1136m, 1096m, 1068m, 1051m, 1014m and 970m (νC−C and νC−N), 
878m, 822m, 753s, 692m, 604m, 490m, 441m and 414m (νC−H on aryl 
ring). 
Synthesis of complex [Cu2I2(L4)2]n (2). Complex 2 was synthesized from 
a similar procedure to 1 by replacing L2 with L4. Yield: 76 mg, 80 %. 
Anal. Calcd. for C14H13CuIN5S (473.79): C, 35.49; H, 2.77; N, 14.78; S, 
6.77. Found: C, 35.50; H, 2.68; N, 14.55; S, 6.52 %. ESI-MS (m/z, %): 
[H(L4)]+ (284.0, 10), [Cu(L4)]+ (346.0, 9), [Cu(L4)(CH3CN)]
+ (386.7, 6), 
[Cu(L4)2]
+ (629.0, 100). IR (KBr)/cm-1: 3154m and 3059m (νC−H on C=C), 
2972w and 2922w (νC−H on CH2 and CH3), 1612m, 1576m and 1555m 
(νC=C and νC=N), 1498m, 1455s, 1413m, 1392m, 1346w (νaryl), 1285m, 
1255m, 1218m, 1155m, 1126m, 1062m, 1041m, 1012m, 984m and 964w 
(νC−C and νC−N), 824m, 779m, 758m, 740m, 719m, 619m, 578m and 482m 
(νC−H on aryl ring). 
Synthesis of complex [Cu4I4(L14)2] (3). Complex 3 was synthesized from 
a similar procedure to 1 by replacing L2 with L14. Yield: 80 mg, 70 %. 
Anal. Calcd. for C18H20Cu4I4N8O2 (1142.19): C, 18.93; H, 1.76; N, 9.81. 
Found: C, 19.06; H, 1.82; N, 9.88 %. ESI-MS (m/z, %): [H(L14)]+ (191.0, 
7), [Cu(L14)(CH3CN)]
+ (293.9, 10), [Na(L14)2]
+ (403.0, 6), [Cu(L14)2]
+ 
(443.1, 100), [Cu2I(L14)2]
+ (632.8, 15), [Cu3I2(L14)2]
+ (824.5, 17). IR 
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(KBr)/cm-1: 3442m (νO−H), 3122w, 3057w (νC−H on C=C), 2996w, 2937w 
(νC−H on CH2 and CH3), 2362w, 2336w, 1596m, 1542m (νC=C and νC=N), 
1467m, 1438m, 1379m, 1356m, 1313m (νaryl), 1227m, 1196m, 1136m, 
1102m, 1055m, 1035m, 997m, 943m, 906w (νC−C and νC−N), 826m, 763m, 
720m, 661m, 599m, 404m (νC−H on aryl ring). 
General procedures for CuAAC reactions: The catalytic reactions were 
conducted by MultiMAX reactors at 800 rpm. In a reaction tube fitted with a 
screw cap, an organic halide (chloride or bromide), NaN3, alkyne and 1, 2 or 3 
were added to a solvent of MeCN/H2O(v/v 2:1, 6 mL), MeOH/H2O(v/v 1:1, 2 
mL) or pure water (2 mL). The reaction mixture was stirred at 30 or 50 °C. 
The conversions were determined by GC-MS and isolated yields were 
determined after column chromatographic separation. 
 
X-ray crystallography  
Table 3.3 Crystallographic data and refinement parameters for complexes 
1‒3. 
 
Complex 1 2 3 
Formula C14H13Cu3I3N5S C14H13CuIN5S C24H34Cu4I4N10O4 
MW 854.67 473.79 1288.37 
T / K 100(2) 100(2) 100(2) 
Crystal size / 
mm3 0.26 × 0.18 × 0.16 0.58 × 0.26 × 0.14 0.26 × 0.22 × 0.16 
Crystal system Triclinic Monoclinic Triclinic 
Space group P1 P 21/c P1 
a / Å 9.364(2) 9.615(1) 8.953(1) 
b / Å 10.719(3) 14.644(2) 9.439(1) 
c / Å 11.179(3) 11.579(2) 11.146(1) 
α / ° 76.506(5) 90 88.995(1) 
β / ° 85.625(5) 103.514(3) 78.424(1) 
γ / ° 69.340(5) 90 86.755(1) 
V / Å3 1020.8(5) 1585.3(4) 921.3(1) 
Z 2 4 1 
Dcalc / g·cm
−3 2.781 1.985 2.322 
µ / mm−1 7.745 3.459 5.673 
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θ range / ° 1.87−27.50 2.28−27.49 2.16−27.50 
Reflections 
collected 
13603 10906 12167 
Independent 
reflections [Rint] 
4684 [0.0300] 3620 [0.0233] 4236[0.0228] 
Parameters 235 199 211 
GOF 1.083 1.118 1.418 
R1(I > 2σ(I)) 0.0287 0.0247 0.0179 





















Chapter 4 Tuning the M(II) (M = Zn, Cd) coordination 
assembly by adjusting the spacers of 2-
pyridylthiomethyl functionalized 1,2,3-triazoles 
4.1 Introduction 
Design of novel N-donating spacers for functional supramolecular 
architectures has attracted much attention in the past few decades due to their 
fascinating metallosupramolecular structures and potential applications in gas 
storage, catalysis, drug delivery, magnetism and luminescence.1-3,303,304,4-13 
Multi-topic pyridine, imidazole, pyrazole and 1,2,4-triazole are among the 
most frequently used ligands, and diverse coordination architectures have been 
generated.14-18 Aided by the promising CuAAC click reaction22,23,243,305, 1,4-
disubstituted-1,2,3-triaozles and modified materials have been 
comprehensively studied.24,28,35,145,262,264,266,306,307 As building blocks in various 
functional coordination architectures, hybridized 1,2,3-triazoles are relatively 
uncommon among other hybrid nitrogen spacers. From the above mentioned 
ligands, the pyridyl, pyrazole, benzyltriazolyl, functionalized 1,2,3-triazoles 
have already demonstrated great potentials.150,179,181,189,205,260,308,309 Typical 
examples are the Pd2 (functionalized) metallosupramolecular cages, 
ferromagnetic Cu2 dimer, multi-dimensional Cu(I) POLO (polymer of 
oligomers) structures and Cu(II) chiral chains.147,206,246,310-312 Triazole-based 
Zn(II) and Cd(II) coordination architectures are also 
promising.221,228,233,234,244,245,313-317 Alkylthio-substituted nitrogen-heterocyclic 
compounds have also shown potential applications in macrocycles and as 
intermediates for perfumes, drugs and fine chemicals.318-320 In this work, new 
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bis-type and mono-type 1,2,3-triazoles and their Zn(II) and Cd(II) 
coordination architectures were constructed and studied. These novel bis-type 
spacers comprise of two triazole moieties linked by a hydrocarbon skeletal 
spacer and functionalized by potential hemilabile 2-pyridylthiomethyl 
moieties and varies the carbon number of methylene unit to achieve selectivity 
in a self-assembly process. As potential coordinating and/or modifying groups, 
(2-pyridinyl)thiomethyl moiety have presented initial tuning capabilities in the 
Cu(I) coordination polymeric structures. The assembly results of d10 metals as 
evidenced in Zn(II) and Cd(II) complexes demonstrated the potential of new 
spacers in supporting macrocyclic and polymeric assemblies as well as a 
combination of these. The ligand effects including the “bridge” effects have 
also been discussed and compared with existing literature reports. 
 
4.2 Results and Discussion 
4.2.1 Ligand synthesis and their coordination modes in Zn(II) and Cd(II) 
complexes 
The ligands can be easily prepared from the cycloaddition reaction of 
dibromoalkanes or picolyl chloride, NaN3 and 2-(2-Propynylthio)pyridine 
under click conditions. The Zn(II) and Cd(II) complexes 4−10 ([Zn2Cl4(L17)] 
(4), [Zn2Cl4(L19)] (5), [Zn2Cl4(L20)2] (6), [ZnCl2(L3)]n (7), [Zn2Cl4(L4)2] (8), 
[Cd(OH2)2(L4)2]n⋅2n(ClO4) (9) and [Cd(L14)2(CH3CH2OH)2(ClO4)2] (10)) can 
be prepared from corresponding metal precursors and related ligands in 
ethanol with good yields, followed by gas-liquid diffusion procedure to give 
high quality single crystals. The coordination modes of respective ligands in 
corresponding complexes 4‒10 have been shown in scheme 4.1. All 
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complexes 4−10 are white or pale color in solid state, and they are air stable 
and luminescent active. Structurally, all Zn(II) centres show distorted 
tetrahedral geometry with [N2Cl2] coordination environment and Cd(II) 
centers are octahedral geometry. 
 
Scheme 4.1 Coordination modes of respective ligands in 4−10. 
 
4.2.2 Powder X-Ray Diffraction, Thermogravimetric Analysis and 
Photoluminescence 
The powder XRD for complexes 4−8 have been shown in Fig 4.1. There is 
good agreement between the experimental and calculated powder XRD 
patterns, which supporting fair phase purity. For Cd(II) complex 9, although 
there is a little bit difference between experimental and calculated patterns, the 
EA data show fair purity. For complex 10, the powder XRD spectrum is hard 




Fig 4.1 Powder XRD patterns of 4−9. (T = theoretical profile referenced to the 
experimentally determined structure by single-crystal XRD; E = experimental 
data) 
 
The thermogravimetric analysis (Fig 4.2) shows that all Zn(II) complexes 4−8 
are stable up to about 280 °C. TGA profile of 9 indicates a weight lost of ~3.4 % 
(calculated 3.9 %) between 110−160 °C, which can be assigned to the lost of 
coordinated water. Upon dehydration, the sample is further stable up to 
~260 °C, at which it shows a sharp weight drop and loses much of its mass. 
This is probably due to explosive decomposition of the perchlorate compound. 
Both ligands and Zn(II) and Cd(II) complexes exhibit broad 
photoluminescence at room temperature. Ligands (L17, L19, L20 and L3) 
show broad photoluminescent emissions between 350−500 nm under 
excitation wavelengths of 330−340 nm in CH2Cl2 (0.01M) at r.t. (Fig. 4.3). 
Zn(II) and Cd(II) complexes 4−9 exhibit enhanced broad solid state 
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photoluminescence at r.t. (Fig 4.4). These emission spectra are similar, having 
the λmax at ~420 nm (excitation wavelength λex = 280 nm). The emission peaks 
probably originate from the intra-ligand π*→π transition. The considerable 
luminescent enhancement of complexes may be attributed to the constrained 
rigidity of the ligands in the coordination spheres, which effectively reduced 
loss of energy by radiationless decay. 
 
 




Fig 4.3 Photoluminescent properties of ligands. (Excitation wavelength = 334, 
340, 338 and 330 nm, respectively; Emission maximum wavelength = 406, 
414, 406 and 400 nm, respectively) 
 
 
Fig 4.4 Solid state emission spectra of 4−9. (Excitation wavelength = 280 nm; 





4.2.3 Single-crystal structures of Zn(II) and Cd(II) complexes 
Complex 4 crystallizes in a monoclinic space group P 2/c. It shows a bis-
chelating ligand L17 bridged dinuclear Zn(II) structure (Fig 4.5a). Both 
Zn(II) centers show distorted tetrahedral coordinating geometries with 
same coordination environments. Each Zn(II) center is completed by a 
triazolyl-pyridyl chelate and two terminal chlorides. Selective bond lengths 
have been listed. There are intermolecular π⋅⋅⋅π stacking interactions 
between two parallel 2-pyridyl groups (displacement angle290 19.7°, 
centroid-centroid distance290 3.69 Å) of neighboring dinuclear moieties, 
and intermolecular C−H⋅⋅⋅Cl hydrogen bonding interactions (between 
hydrogen of triazole group and coordinated chloride) (∠CHCl 142°, C⋅⋅⋅Cl 
3.44 Å, H⋅⋅⋅Cl 2.64 Å) in the lattice which enables the dinuclear structures 
to form a 1-D macrocyclic assembly (Fig 4.5b). With the help of three 
other kinds of C−H⋅⋅⋅Cl hydrogen bonding interactions (∠CHCl 124°, 
C⋅⋅⋅Cl 3.37 Å, H⋅⋅⋅Cl 2.71 Å, between CH2 group and coordinated chloride; 
∠CHCl 172°, C⋅⋅⋅Cl 3.68 Å, H⋅⋅⋅Cl 2.73 Å, between m-C(2-pyridyl) and 
coordinated chloride; ∠CHCl 135°, C⋅⋅⋅Cl 3.67 Å, H⋅⋅⋅Cl 2.94 Å, between 
p-C(2-pyridyl) and coordinated chloride), three dimensional 




Fig 4.5 (a) Molecular structure of 4. Zn⋅⋅⋅Zn, 6.2 Å. (Zn1‒N1 2.021(2), 
Zn1‒N4 2.066(2), Zn1‒Cl1 2.2102(7), Zn1‒Cl2 2.2516(8); N1‒Zn1‒N4 
110.77(9), N1‒Zn1‒Cl1 107.40(7), N4‒Zn1‒Cl1, 111.60(7), N1‒Zn1‒Cl2 
107.86(7), N4‒Zn1‒Cl2 102.85(7), Cl1‒Zn1‒Cl2 116.28(3)) (b) 
Intermolecular π⋅⋅⋅π stacking interactions in 4. (c) Supramolecular 
interactions in 4. 
 
Zn(II) complex 5 crystallizes in a monoclinic space group C 2/c (Fig 4.6). 
It shows a similar dinuclear structure as 4. Zn(II) centers also show 
distorted tetrahedral coordinating geometries. Each dinuclear complex is 
connected with neighboring units via two kinds of lattice hydrogen bonding 
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interactions (C⋅⋅⋅Cl 3.60 and 3.51 Å, H⋅⋅⋅Cl 2.86 and 2.64 Å, ∠CHCl 132 




Fig 4.6 (a) Molecular structure of 5. Zn⋅⋅⋅Zn, 11.2 Å. (Zn1‒N2 2.038(3), 
Zn1‒N1 2.050(3), Zn1‒Cl1 2.2312(9), Zn1‒Cl2 2.2644(9); N2‒Zn1‒N1 
105.07(11), N2‒Zn1‒Cl1 114.04(8), N1‒Zn1‒Cl1 113.43(8), N2‒Zn1‒Cl2 
108.82(9), N1‒Zn1‒Cl2 105.85(8), Cl1‒Zn1‒Cl2 109.21(3)) (b) H-bond 
unit. (c) Supramolecular interactions in 5. 
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Complex 6 crystallizes in a monoclinic space group P 21/n (Fig 4.7). It shows 
a Zn(II) cyclic dinuclear structure, which is bridged by two L20 ligands. The 
distorted tetrahedral Zn(II) coordination environment is completed by a 
triazole-nitrogen donor from each ligand and two terminal chlorides. 
 
 
Fig 4.7 (a) Molecular structure of 6. Zn⋅⋅⋅Zn, 12.1 Å. (Zn1‒N1 2.0501(17), 
Zn1‒N7A 2.0615(17), Zn1‒Cl2 2.2169(6), Zn1‒Cl1 2.2231(6); N1‒Zn1‒N7A 
97.10(7), N1‒Zn1‒Cl2 111.58(5), N7A‒Zn1‒Cl2 110.66(5), N1‒Zn1‒Cl1 
111.05(5), N7A‒Zn1‒Cl1 106.81(5), Cl2‒Zn1‒Cl1 117.59(2)) (b) A segment 
of crystal packing in 6. 
 
Complex 7 crystallizes in a monoclinic space group P 21/c (Fig 4.8). It is a 
1-D helical coordination polymer. Each distorted tetrahedral Zn(II) centre 
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is coordinated by the nitrogen donors from triazole and distal 3-pyridyl of 
L3 and two terminal chlorides. There are equal left- and right-handed 
helical chains in 7, showing a 1-D spiral propagation assembly. There exist 
interchain π⋅⋅⋅π stacking interactions between 3-pyridyl and 2-pyridyl 
groups from different lines to form a 3-D network (displacement angle290 
14.8/5.1°, centroid-centroid distance290 3.58 Å and plane-plane distance 
3.46/3.57 Å; displacement angle290 17.9/30.3°, centroid-centroid distance290 
3.83 Å and plane-plane distance 3.65/3.31 Å). 
Complex 8 crystallizes in the monoclinic space group P 21/n (Fig 4.9). By 
comparison with complex 7, the 3-pyridyl group of L3 has been changed to 
4-pyridyl group, in which the double-bridge configuration of L4 results in a 
dinuclear frame with a metallomacrocyclic cavity, a totally different 
structure from 7. Each tetrahedral Zn(II) centre is completed by the 
nitrogen donors from triazole and 4-pyridyl group of L4 and two terminal 
chlorides. The 4-pyridyl functionalized 1,2,3-triazole ligands with flexible 
alkyl groups (n-butyl, n-pentyl, n-hexyl) show similar bridging modes and 
form 1-D polymeric structures with Zn(II) centers.245 Here the formation of 
cyclic Zn(II) dinuclear structure could be due to the steric influence of the 
bigger pending 2-pyridylthiomethyl groups, which prohibit the further 
extension of higher dimensional forms. There are additional interdimer 
π⋅⋅⋅π stacking interactions between 4-pyridyl groups (displacement angle290 
20.0°, centroid-centroid distance290 3.85 Å and plane-plane distance 3.62 





Fig 4.8 (a) Molecular structure of 7. Zn⋅⋅⋅Zn, 7.5 Å. (Zn1‒N4A 2.042(2), 
Zn1‒N1 2.053(2), Zn1‒Cl1 2.2256(8), Zn1‒Cl2 2.2324(7); N4A‒Zn1‒N1 
107.92(8), N4A‒Zn1‒Cl1 104.61(6), N1‒Zn1‒Cl1 111.90(6), 
N4A‒Zn1‒Cl2 109.73(6), N1‒Zn1‒Cl2 108.55(6), Cl1‒Zn1‒Cl2 





Fig 4.9 (a) Molecular structure of 8. Zn⋅⋅⋅Zn, 8.7 Å. (Zn1‒N1 2.0494(15), 
Zn1‒N4A 2.0504(14), Zn1‒Cl1 2.2158(5), Zn1‒Cl2 2.2220(4); 
N1‒Zn1‒N4A 99.17(6), N1‒Zn1‒Cl1 106.71(4), N4A‒Zn1‒Cl1 107.23(4), 
N1‒Zn1‒Cl2 114.24(4), N4A‒Zn1‒Cl2 108.94(4), Cl1‒Zn1‒Cl2 





Fig 4.10 (a) Molecular structure of 9. Cd⋅⋅⋅Cd 9.5 Å. (Cd1‒N4B 2.3204(17), 
Cd1‒N4C 2.3205(17), Cd1‒O1 2.3246(17), Cd1‒O1A 2.3247(17), Cd1‒N1A 
2.3762(18), Cd1‒N1 2.3762(18); N4B‒Cd1‒N4C 180.0, N4B‒Cd1‒O1 
90.79(6), N4C‒Cd1‒O1 89.21(6), N4B‒Cd1‒O1A 89.21(6), N4C‒Cd1‒O1A 
90.79(6), O1‒Cd1‒O1A 179.998(2), N4B‒Cd1‒N1A 86.55(6), 
N4C‒Cd1‒N1A 93.44(6), O1‒Cd1‒N1A 94.48(7), O1A‒Cd1‒N1A 85.52(7), 
N4B‒Cd1‒N1 93.45(6), N4C‒Cd1‒N1 86.55(6), O1‒Cd1‒N1 85.52(7), 
O1A‒Cd1‒N1 94.48(7), N1A‒Cd1‒N1 180.0) (b) The 2-D H-bonding 




Complex 9 crystallizes in the triclinic space group P1 (Fig 4.10). Cd(II) 
centre shows a little distorted octahedral geometry, which is completed by four 
nitrogen atoms from four different L4 ligands and two oxygen atoms from 
coordinated water. Among these four coordinated ligands, two in opposite 
positions are coordinated by N1 of triazole part and the other by N4 of 4-
pyridyl group. Supported by the same ligand L4, its double-bridge 
macrocyclic formation is similar to that of 8. However, unlike 8, in an 
octahedral Cd(II) sphere, the metal has room to accommodate two more 
nitrogen donors at the equatorial trans position, thereby providing the sites 
needed for L4 bridged 1-D polymeric propagation. Complex 9 can hence be 
viewed as the polymer of macrocycles, or the polymeric version of 8 along 
crystallographic a direction.  The remaining axial sites of Cd(II) are taken up 
by two coordinated water. The inter-chained perchlorate anions in polymers 
connected 1-D polymeric chains to 2-D network along orthogonal b-axis by 
two kinds of hydrogen bonds between oxygen atomes of perchlorate and 
hydrogen atoms of these coordinated aqua ligands (O⋅⋅⋅O 2.82 and 2.81 Å, 
H⋅⋅⋅O 2.12 and 2.05 Å, ∠OHO 161 and 171°, respectively). 
Complex 10 crystallizes in the triclinic space group P1 (Fig 4.11). It is a 
mono nuclear structure and the Cd(II) centre shows distorted octahedral 
geometry, which is completed by two triazolyl-hydroxyl chelate from two L14 
ligands and two coordinated ethanol molecules (Fig 4.11a). There exist lattice 
intermolecular hydrogen bonding interactions (N⋅⋅⋅O 2.66 Å, H⋅⋅⋅N 1.83 Å, 
∠NHO 175°) between the N atoms of pending 4-pyridyl groups and H atoms 
of hydroxyl groups, which help to construct the 1-D H-bonding chains (Fig 
4.11b). In addition, perchlorate anions in complex 10 are also linked with 
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coordinated enthanol molecules by hydrogen bonding interactions (O⋅⋅⋅O 2.79 
Å, H⋅⋅⋅O 2.01 Å, ∠OHO 154°). The crystal packing structure is shown in Fig. 
11c. In the crystal, there also exist several kinds of disorders. The anion was 
disordered with the O atoms occupied two positions with occupancy ratio = 
89:11. The C atoms of the ethanol also disordered into two positions with 
occupancy ratio = 56:44. H atoms of O atoms were located from different map 
refined with restraints in bond lengths and thermal parameters. Restraints in 
bond lengths and thermal parameters were also applied to the disordered anion. 
All Zn(II) centres in 4−8 show tetrahedral geometry with two N donors and 
two terminal chloride, supporting both open (viz. 4 and 5) and macrocyclic 
(viz. 6 and 8) dinuclear forms as well as 1-D polymeric assemblies (7). 
Comparison with the structural features of complexes 4−8, it is easily to 
find that these coordination assemblies could be influenced by tuning the 
carbon number of bridging methylene group and also the N position of 
pyridyl group. With a even carbon chain-spacer (i.e. C2 in 4 and C4 in 5), 
the two triazoles chelate at the opposite ends, viz. anti, to give an open 
dinuclear form. With an odd carbon chain-spacer (i.e. C5 in 6), the two 
triazoles approach and coordinate at the same side, viz. syn, which then 
results in a metallocyclic dinuclear assembly. Even for complexes 4 and 5, 
both containing even carbon chain-spacers, different carbon numbers also 
result in the different intermolecular interations, which further lead to the 
different packing structures. Meanwhile, the 3-pyridyl group supported 
triazole adopts single bridges in the 1D helical polymer of 7, but 4-pyridyl 
group supported ligands show double bridges and form cyclic dimers in 8. 
An octahedral metal such as Cd(II) in 9 provides two additonal sites 
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compared with four coordinated Zn(II) center in 8 for the hybrid nitrogen 
ligands to support polymeric chain formation. Comparison of 8 and 9 
provides an unusual example of di- and poly-meric relationship in 
congeneric Zn(II) and Cd(II). However, when pyridyl and hydroxy 
functionalized triazole ligands (L14) is used in Cd(II) complexes 10, only 
mononuclear structure is obtained with 2-pyridyl group as pendant group 
which is involved in intermolecular hydrogen bonding interactions to 
stablize the structure. In 10, two additonal sites of Cd(II) are occupied by 
two ethanol solvent molecules instead of extra ligands. The 2-
pyridylthiomethyl can be pendant (6−9) or N-coordinative (4−5). The latter 
functions as a chelate in the proximity of a triazole moiety. This flexibility 
gives the hybrid ligands an additonal dimension of flexibility. The pendant 
mode provides basic sites for further materials aggregation or polymeric 




Fig 4.11 (a) Molecular structure of 10. Cd⋅⋅⋅Cd  Å. (Cd1‒N1A 2.258(3), 
Cd1‒N1 2.258(3), Cd1‒O1A 2.298(2), Cd1‒O1 2.298(2), Cd1‒O2 2.317(2), 
Cd1‒O2A 2.317(2); N1A‒Cd1‒N1 180.0, N1A‒Cd1‒O1A 72.18(9), 
N1‒Cd1‒O1A 107.82(9), N1A‒Cd1‒O1 107.82(9), N1‒Cd1‒O1 72.18(9), 
O1A‒Cd1‒O1 180.00(12), N1A‒Cd1‒O2 88.72(10), N1‒Cd1‒O2 91.28(9), 
O1A‒Cd1‒O2 88.87(9), O1‒Cd1‒O2 91.13(9), N1A‒Cd1‒O2A 91.28(9), 
N1‒Cd1‒O2A 88.72(9), O1A‒Cd1‒O2A 91.13(9), O1‒Cd1‒O2A 88.87(9), 
O2‒Cd1‒O2A 180.00(12)) (b) The 1-D H-bonding network in 10. (c) A 
segment of crystal packing in 10 with H-bonding interactions. 
 
4.3 Conclusion 
Using easily accessible 'click' syntheses (CuAAC reaction), trifunctional 
hybrid ligands with three functional donors in thiopyridyl/ hydroxyl, triazole 
and picolyl moieties have been designed and synthesized. Within a single 
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ligand framework, they provide a range of possibilities in the self-assembly of 
zinc and cadmium complexes ranging from linear to metallocycles dimers and 
polymeric structures. It is found that minor variation of ligands, such as 
lengthening the hydrocarbon skeletal spacer or changing N position of pyridyl 
group, would give significant influence on the structures of complexes. This 
means the structure of complexes could be affected to some extent by 
controlling the design of ligands. When these assemblies are supplemented by 
intermolecular interactions such as π⋅⋅⋅π stacking and H-bonding interactions, 
we witness the formation of not only dimer and 1-D propagation assemblies, 
but also their 1-D polymeric and extended 3-D network. Their formation is 
meaningful and will have great potential in molecular and hybrid materials 
self-assembly chemistry. They could promote the exploration of variously 
novel supramolecular construction from new ligands which can be 
conveniently prepared from click reactions. 
4.4 Experimental Section  
Materials and physical measurements 
The synthesis of precursors and ligands have been presented in chapter 1.  
Synthesis of complexes [Zn2Cl4(L17)] (4), [Zn2Cl4(L19)] (5), [Zn2Cl4(L20)2] 
(6), [ZnCl2(L3)]n (7), [Zn2Cl4(L4)2] (8) and [Cd(OH2)2(L4)2]n⋅2n(ClO4) (9). 
A general procedure: an ethanol solution (5 mL) of ZnCl2 (0.4 mmol, 55 mg) 
for 4 and 5, ZnCl2 (0.2 mmol, 28 mg) for 6−8 or Cd(ClO4)2·6H2O (0.1 mmol, 
42 mg) for 9 was added into the ethanol solution (5 mL) of respective ligands 
(0.2 mmol) upon stirring. The mixture was stirred at r.t. overnight. The 
suspension was filtered under vacuum, and washed by ethanol and diethyl 
ether. The solid product was collected and dried under vacuum. Diffusion of 
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diethyl ether to its dimethylformamide (DMF) solution at r.t. afforded crystals 
of 4−9 after about two weeks. For 4, yield: 108 mg, 79 %. Anal. Calcd. for 
C18H18Cl4N8S2Zn2 (683.09): C, 31.65; H, 2.66; N, 16.40; S, 9.39. Found: C, 
31.26; H, 2.98; N, 15.32; S, 8.96 %. ESI-MS (m/z, %): [Zn(L1)]2+ (237.1, 10), 
[Zn(L1)2]
+ (442.1, 42), [ZnCl(L1)]+ (509.1, 100), [Zn2Cl3(L1)]
+ (646.9, 38), 
[Zn3Cl5(L1)]
+ (782.7, 5), [Zn(L1)4]
2+ (852.2, 17), [ZnCl(L1)2]
+ (921.0, 51), 
[Zn2Cl3(L1)2]
+ (1056.9, 16), [Zn3Cl5(L1)2]
+ (1192.8, 15), [Zn4Cl7(L1)2]
+ 
(1328.7, 5). IR/cm-1: 1588m, 1461m, 1431m, 1250m, 1167m, 1091m, 1051m, 
1020m and 781m. For 5, yield: 117 mg, 82 %. Anal. Calcd. for 
C20H22Cl4N8S2Zn2 (711.14): C, 33.78; H, 3.12; N, 15.76; S, 9.02. Found: C, 
33.85; H, 3.04; N, 15.41; S, 8.48 %. ESI-MS (m/z, %): [Zn(L2)]2+ (251.0, 9), 
[Zn(L2)2]
2+ (470.2, 11), [ZnCl(L2)]+ (537.0, 100), [Zn2Cl3(L2)]
+ (674.9, 36), 
[Zn(L2)3]
2+  (689.2, 11), [ZnCl(L2)2]
+ (977.1, 56), [Zn2Cl3(L2)2]
+ (1113.0, 23), 
[Zn3Cl5(L2)2]
+ (1250.9, 19). IR/cm-1: 3128m, 3083m, 1586m, 1561m, 1457m, 
1421m, 1258m, 1094m, 1053m, 1026m, 878m, 835m and 786m. For 6, yield: 
208 mg, 88 %. Anal. Calcd. for C42H48Cl4N16S4Zn2 (1177.77): C, 42.83; H, 
4.11; N, 19.03; S, 10.89. Found: C, 42.46; H, 3.95; N, 18.75; S, 10.23 %. ESI-
MS (m/z, %): [Zn(L3)]2+ (258.1, 22), [Zn(L3)2]
2+ (484.2, 23), [ZnCl(L3)]+ 
(551.1, 100), [Zn2Cl3(L3)]
+ (688.9, 17), [Zn(L3)3]
2+  (710.2, 22), [ZnCl(L3)2]
+ 
(1005.2, 60), [Zn2Cl3(L3)2]
+ (1141.0, 16). IR/cm-1: 1578m, 1556m, 1455m, 
1414m, 1285m, 1224m, 1122m, 1087m, 776m and 738m. For 7, yield: 68 mg, 
81 %. Anal. Calcd. for C14H13Cl2N5SZn (419.64): C, 40.07; H, 3.12; N, 16.69; 
S, 7.64. Found: C, 39.69; H, 3.09; N, 16.17; S, 7.19 %. ESI-MS (m/z, %): 
[Zn(L4)2]
2+ (315.1, 46), [ZnCl(L4)]+ (382.1, 33), [ZnCl(L4)2]
+ (665.1, 100), 
[Zn2Cl3(L4)2]
+ (802.9, 34), [Zn3Cl5(L4)2]





+ (1221.9, 4). IR/cm-1: 3053m, 1612m, 1583m, 1558m, 
1486m, 1459m, 1417m, 1289m, 1220m, 1200m, 1132m, 1077m, 988m, 825m, 
774m, 742m and 696m. For 8, yield: 143 mg, 85 %. Anal. Calcd. for 
C28H26Cl4N10S2Zn2 (839.28): C, 40.07; H, 3.12; N, 16.69; S, 7.64. Found: C, 
39.92; H, 3.08; N, 16.67; S, 7.33 %. ESI-MS (m/z, %): [Zn(L5)2]
2+ (315.1, 28), 
[ZnCl(L5)]+ (382.0, 54), [ZnCl(L5)2]
+ (665.1, 100), [Zn2Cl3(L5)2]
+ (802.9, 38). 
IR/cm-1: 1618m, 1575m, 1451m, 1414m, 1230m, 1147m, 1120m, 1078m, 
1031m, 788m, 765m and 485m. For 9, yield: 69 mg, 76 %. Anal. Calcd. for 
C28H30CdCl2N10O10S2 (914.04): C, 36.79; H, 3.31; N, 15.32; S, 7.02. Found: C, 
36.83; H, 3.42; N, 15.17; S, 6.82 %. ESI-MS (m/z, %): [Cd(L5)2]
2+ (340.1, 19), 
[Cd(L5)3]
2+ (481.1, 13), [Cd(ClO4)(L5)]
+ (496.0, 8), [Cd(ClO4)(L5)2]
+ (779.0, 
100), [Cd2(ClO4)3(L5)2]
+ (1088.7, 8). IR/cm-1: 3499m, 3433m, 1620m, 1581m, 
1556m, 1456m, 1429m, 1285m, 1230m, 1085bm, 1044m, 987m, 797m, 764m, 
719m, 627m and 480m. 
Synthesis of complexes [Cd(L14)2(CH3CH2OH)2(ClO4)2] (10). The ethanol 
solution (5 mL) of Cd(ClO4)2·6H2O (0.1 mmol, 41.9 mg) was added into the 
ethanol solution (5 mL) of ligand L14 (0.2 mmol, 38.0 mg) under stirring. The 
reaction mixture was stirred at r.t. in the air condition for overnight. The 
solution was concentrated under vacuum, then diethyl ether was slowly added 
into the residue, and the suspension was stirred for overnight and collected by 
filtration under vacuum. The collected powder was recrystallized in ethanol 
and diethyl ether and dried under vacuum. Diffusion of diethyl ether to its 
ethanol solution at r.t. afforded crystals after two days. Yield: 48 mg, 61 %. 
Anal. Calcd. for C22H32CdCl2N8O12 (783.86): C, 33.71; H, 4.11; N, 14.30. 





2+ (402.9, 18), [Cd(L14)4]
2+ (437.1, 40), 
[Cd(L14)(L14‒H)]+ (493.1, 21), [Cd(L14)(L14‒H)(CH3CH2OH)]
+ (539.1, 19), 
[Cd(ClO4)(L14)2]
+ (593.0, 100), [Cd(ClO4)(L14)3]
+ (783.0, 40). IR/cm-1: 
3147w, 3078w, 2964w, 2932w, 2839w, 2766w, 2650w, 2448w, 2364w, 
2016w, 1881w, 1797w, 1750w, 1595m, 1574m, 1558m, 1479m, 1441m, 
1426m, 1367m, 1303m, 1231m, 1141m, 1080m, 1048w, 1004m, 941w, 877w, 
826m, 791m, 769m, 713m, 627m, 594m, 491m, 463m.  
 
X-ray crystallography 
Table 4.1 Crystallographic data and refinement parameters for complexes 
4−10. 
 









MW 683.06 711.12 1177.74 419.62 
T / K 100(2) 100(2) 100(2) 273(2) 
Cryst. syst. Monoclinic Monoclinic Monoclinic Monoclinic 
Space 
group 
P2/c C2/c P21/n P21/c 
a / Å 13.584(3) 19.461(2) 11.151(2) 9.136(1) 
b / Å 7.9537(15) 11.650(1) 16.620(2) 13.020(2) 
c / Å 12.942(2) 14.041(1) 14.029(2) 13.870(2) 
α / ° 90 90 90 90 
β / ° 115.153(4) 121.981(2) 107.922(3) 92.449(2) 
γ / ° 90 90 90 90 
V / Å3 1265.7(4) 2700.2(4) 2473.8(6) 1648.4(3) 
Z 2 4 2 4 
Dcalc / g 
cm−3 









Parameters 154 163 307 208 
GOF 1.096 1.028 1.035 1.055 
R1  
[I > 2σ (I)] 
0.0307 0.0463 0.0341 0.0370 
wR2  
[I > 2σ (I)] 
0.0845 0.1073 0.0831 0.0890 
    








MW 839.25 914.04 783.86 
T / K 100(2) 100(2) 100(2) 
Cryst. syst. Monoclinic Triclinic Triclinic 
Space group P21/n P-1 P-1 
a / Å 8.9397(5) 9.5285(5) 8.5517(9) 
b / Å 17.7137(9) 9.8326(5) 9.1195(9) 
c / Å 10.9396(6) 10.8532(6) 11.3642(12) 
α / ° 90 108.834(1) 92.762(2) 
β / ° 100.914(1) 110.173(1) 107.703(2) 
γ / ° 90 90.357(1) 113.949(2) 
V / Å3 1701.0(2) 895.41(8) 756.47(14) 
Z 2 1 1 
Dcalc / g cm




11963(0.0249) 11498(0.0257) 5368(0.0327) 
Parameters 208 249 260 
GOF 1.043 1.067 1.044 
R1  
[I > 2σ (I)] 
0.0264 0.0307 0.0440 
wR2  
[I > 2σ (I)] 











Chapter 5 Isostructural coordination assemblies (M = 
Mn(II), Fe(II), Co(II) and Ni(II)) directed by 
hybridised pyridyl 1,2,3-triazole spacers 
5.1 Introduction 
Metallosupramolecular materials are gaining appeal in recent decades for their 
fascinating coordination structures and the potential applications notably in 
catalysis, magnetism and luminescence.321,322,5,6,8 Different types of ligands 
combined with metals of varied geometries have resulted in an array of 
coordination structural assemblies.2,3,240,323 One of the most effective 
approaches in such synthesis is through the exploitation of the chelating and 
bridging modes of the hybrid ligands. Multitopic pyridine, imidazole, pyrazole, 
1,2,4-triazole and the more recent hybrid 1,2,3-triazoles are typical 
examples.14,15 These hybrid 1,2,3-triazole ligands28,145,262 are not just powerful, 
which have various coordination modes, but also convenient building blocks 
as they are readily synthesized from high-yielding and high-tolerant copper-
catalyzed azide-alkyne cycloadditional reaction (CuAAC).22-24,35,243 The 
molecular materials thus synthesized could benefit from the functional 
properties they inherit from the ligands, and influenced by the metal 
characters.246,324 Several examples of hybridised 1,2,3-triazole spacers 
supported first transition metal complexes (Mn(II), Fe(II), Co(II) and Ni(II)) 
have also been reported.177,178,236,244,325-329 Simple as they appear, the outcome 
of the assembly is largely unpredictable because the coordination modes of 
such spacers are changeable, which is further complicated by the changeable 
metal coordination environment.205,245,312 We are hence interested to explore 
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the use of hybrid spacer ligands that could direct the structural outcome of the 
materials. Success in this endeavour would mark a major step forward in the 
self-assembly of molecular materials with desirable structural and functional 
outcomes. We already demonstrated that two positional isomers of pyridyl and 
thioether hybridised 1,2,3-triazole ligands, viz. 1-(4-picolyl)-4-(2-
(methylthio)-pyridine)-1H-1,2,3-triazole (L4) and 1-(2-picolyl)-4-(2-
(methylthio)-pyridine)-1H-1,2,3-triazole (L2), were able to direct and 
differentiate such structural outcomes towards Cu(I). Two different types of 1-
D coordination polymers have been obtained as a result. Their potential uses 
as luminescent polymers and the next generation of click catalysts have been 
demonstrated.8 Herein, the coordinative ability of these two spacers towards 
other metals such as Mn(II), Fe(II), Co(II) and Ni(II) will also be described 
and nine complexes 11‒19 ([Mn(L4)2(H2O)2(ClO4)2]n (11), [Mn(L4)Cl2]n (12), 
[Fe(L4)2(H2O)2(ClO4)2]n (13), [Co(L4)2(H2O)2(ClO4)2]n (14), 
[Ni(L4)2(H2O)2(NO3)2]n (15), [Mn2(L2)2(CH3OH)2Cl4] (16), 
[Fe(L2)2(CH3OH)2(ClO4)2] (17), [Co(L2)2(H2O)2(ClO4)2] (18) and 
[Ni(L2)2(NO3)2] (19)) have been prepared accordingly. Use of the 4-picolyl as 
a coordinative pendant enables the spacer to function as an open-bridge that 
promotes polymeric propagation, whereas its 2-picolyl isomer favours the 
chelating mode that support discrete mononuclear entities. It is also evident 
that the intra- and inter-molecular H-bonding interactions could also influence 
these coordination modes. 
 
5.2 Results and Discussion 
5.2.1 Synthesis, Powder XRD and TGA 
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The ligands L4 and L2 can be easily prepared using our former reported 
procedure in chapter 1. Complexation of ligand L4 with corresponding 
metal precursors in alcohol (MeOH or EtOH) invariably gives 1-D 
coordination polymers 11‒15. (Although crystal data of complex 13 are not 
good enough to use, we can still identify the structure of it, which is similar 
to complex 11.) Under similar condition, L2 with same metal precursors 
result in the dinuclear complex 16 and mononuclear complexes 17‒19. All 
complexes are air stable (at r.t.) and isolated in good yields. High quality 
single crystals are obtained from slow recrystallizations (Experimental 
section). Structurally, the metal centres in nine complexes except 12 and 16 
invariably show distorted octahedral geometry with [N4O2] coordination 
environment. However, due to nitrate anion instead of oxygen atoms from 
solvents coordinated to Ni(II) centre in 19, this complex shows the 
interesting butterfly structure. Differently, when MnCl2 was used as metal 
precursor, owing to the bridging property of chloride, Mn(II) centres in 
complex 12 show distorted square pyramidal geometry with [N2Cl(µ-Cl)2] 
coordination environment, while in complex 16 show distorted octahedral 
geometry with [N2OCl(µ-Cl)2] coordination environment (Scheme 5.1). 
 
Scheme 5.1 Structural motifs of ligands L4 and L2 with different metal 




Most experimental powder XRD patterns generally match those 
theoretically computed data, thus supporting reasonable phase purity (Fig 
5.1). However, in some cases, although the freshly prepared single crystals 
were collected for the powder XRD, it is still hard to obtain exact match 
pattern. This may due to facile escape of free solvents in the lattice, as well 
as the molecular packing change.330 The thermogravimetric analysis of 
powder samples of complexes 11−19 were carried out to establish greater 
insights into the thermal stability of the complexes (Fig 5.2). TGA profile 
of 11 shows a weight loss of ~7.8 % (calcd 4.2 %) between 120‒150 °C, 
attributed to loss of coordinated water molecules, and an explosive 
decomposition after ~240 °C. Complexes 12 and 19 are stable up to about 
270 °C and 220 °C. Complex 13 dramatically decomposes after ~170 °C, 
the worst thermal stability of it among all nine complexes may be owing to 
the perchlorate anions. Complex 14 is mildly hydrophilic, and is reflected 
in the weight drop due to removal of the surface moisture at the beginning 
of the heating process, similar observation is also made on 18. The 
following weight loss in 14 of ~4.3 % (calculated 4.2 %) in 130‒170 °C 
due to loss of coordinated hydrates. Similarly, TGA profile of 15 indicates 
a weight loss of ~ 4.7 % (calculated 4.6 %) in the region 100‒140 °C, 
which can also be assigned to the dehydration. TGA profile of 16 indicates 
a weight lost of ~ 4.6 % (calculated 7.3 %) between 100‒150 °C, which can 
be assigned to partially lost of coordinated methanol molecules. The weight 
loss of ~3.2 % (calculated 7.2 %) of 17 in 120‒150 °C is traced to partial 
loss of coordinated MeOH, followed immediately by degradation of the 
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complex structure. Complex 18 shows a similar dehydration of ~4.3 % 
(calculated 4.2 %) between 130-170 °C, and rapid explosive degradation 
after ~270 °C, which is also expected for many perchlorate materials.  
 
 
Fig 5.1 Powder XRD patterns of 11, 14, 15, 17 and 18. (T = theoretical 
profile referenced to the experimentally determined structure by single-





Fig 5.2 TGA profiles of 11−19. 
 
5.2.2 Single-crystal structures 
[Mn(L4)2(H2O)2(ClO4)2]n (11) crystallizes in a monoclinic crystal system 
with space group of C2/c. In complex 11, the asymmetric unit contains half 
a cation of C28H26N10S2Mn(H2O)2, two halves of anions ClO4 and half a 
water. H atoms of the water were located from different map and refined 
with restraints in thermal parameters. H atoms of the half occupied water 
cannot be located. It is a 1-D Mn(II) coordination polymer propagated by 
double-bridging of two spacers across two metal centers. The bridge is 
based on the donicity of 4-pyridyl and 3’-triazole nitrogen atoms of L4. 
The cis-bridging mode results in a 18-member metallomacrocyle, repeating 
along the c direction (Fig 5.3a). The polymer can hence be viewed as a 
chain of replicating metallomacrocyles. The octahedral Mn(II) coordination 
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sphere is based on the [MnN4] core completed by two hydrates in the 
remaining axial sites. The distal thiopyridyl substituent of the spacer is 
uncoordinated, but shows secondary intramolecular O−H⋅⋅⋅N hydrogen 
bonding interactions (∠OHN 175°, O⋅⋅⋅N 2.78 and H⋅⋅⋅N 1.92 Å) of pyridyl 
nitrogen with the coordinated hydrates. The perchlorate anions also interact 
with coordinated hydrates by hydrogen bonding interactions (∠OHO 167°, 
O⋅⋅⋅O 2.73 Å, H⋅⋅⋅O 1.90 Å) (Fig 5.3b). The polymer is connected solely by 
the bridging hybrid spacers, with no M-M bonding (shortest intra- and 
inter-chain Mn⋅⋅⋅Mn distances are ~9.06 and 10.43 Å, respectively). 
[Mn(L4)Cl2]n (12) crystallizes in a triclinic crystal system with space group 
of P-1 and shows a polymeric propagation of [Mn2Cl4] oligomers which 
belongs to the POLO (polymer of oligomers) assemblies.246,289 Complex 12 
was formed when MnCl2 was involved to react with bridging ligand L4 as 
metal precusor instead of Mn(ClO4)2 in complex 11. The formation of 
oligomers [Mn2Cl4] is due to the bridging property of chloride, which 
results in the slightly different structure of complex 12 from former 11. In 
12, there is one crystallographically independent Mn(II) center in the 
asymmetric unit, which is five-coordinated in distorted square pyramidal 
geometry with the Addison parameter τ of 0.25.331 The square base consists 
of two nitrogen atoms (N1 from triazolyl and N4B from 4-pyridyl group) of 
differently bridged L4 ligands, and two µ2-Cl bridges, and the apical 
position is occupied by a terminal chloride. The deviation of Mn(II) center 





Fig 5.3 (a) Molecular structure of 11. Mn⋅⋅⋅Mn, 9.06 Å. (Mn1−O1 
2.1746(17), Mn1‒O1A 2.1746(17), Mn1‒N4B 2.2366(19), Mn1‒N4C 
2.2366(19), Mn1‒N1 2.2941(19), Mn1‒N1A 2.2941(19); O1‒Mn1‒O1A 
180.000(1), O1‒Mn1‒N4B 89.61(7), O1A‒Mn1‒N4B 90.39(7), 
O1‒Mn1‒N4C 90.39(7), O1A‒Mn1‒N4C 89.61(7), N4B‒Mn1‒N4C 
180.00(7), O1‒Mn1‒N1 90.98(7), O1A‒Mn1‒N1 89.02(7), N4B‒Mn1‒N1 
93.94(7), N4C‒Mn1‒N1 86.06(7), O1‒Mn1‒N1A 89.02(7), 
O1A‒Mn1‒N1A 90.98(7), N4B‒Mn1‒N1A 86.06(7), N4C‒Mn1‒N1A 
93.94(7), N1‒Mn1‒N1A 180.000(1)) (b) Intramolecular and intermolecular 
hydrogen bonding interactions in 11. 
 
However, in complex 12, the ligand L4 still indicates bridging coordination 
mode by using triaozle and 4-pyridyl N donors, which is similar to 11, and 
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together with µ2-Cl bridges, they link [Mn2Cl4] oligomers to form a 1-D 
coordination polymer (Fig 5.4a). Between sulpher atoms of ligands and Mn(II) 
centers, there also exist weak interactions (Mn⋅⋅⋅S, 3.21 Å) which may affect 
the packing structure (Fig 5.4b). 
 
Fig 5.4 (a) Molecular structure of 12. Mn1⋅⋅⋅Mn1A, 3.71 Å, Mn1⋅⋅⋅Mn1B, 
9.28 Å. (Mn1‒N1 2.2348(14), Mn1‒N4B 2.2639(14), Mn1‒Cl1 2.3669(5), 
Mn1‒Cl2A 2.4585(5), Mn1‒Cl2 2.5956(5); N1‒Mn1‒N4B 91.58(5), 
N1‒Mn1‒Cl1 102.64(4), N4B‒Mn1‒Cl1 94.03(4), N1‒Mn1‒Cl2A 
149.24(4), N4B‒Mn1‒Cl2A 91.93(4), Cl1‒Mn1‒Cl2A 107.578(18), 
N1‒Mn1‒Cl2 82.97(4), N4B‒Mn1‒Cl2 164.36(4), Cl1‒Mn1‒Cl2 
101.462(17), Cl2A‒Mn1‒Cl2 85.523(15)) (b) Intramolecular weak 
interactions in 12. 
 
Although the good quality crystals of complex 13 have not been obtained, by 
refinement of the existing crystal data, the structure can still be identified 
which is shown in Scheme 5.2. Besides, the characterization of complex 13 
also support the stucture. Still with bridging ligand L4, octahedral Fe(II) 
centers are also bridged by two triazolyl-pyridyl chelates and coordinated by 
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two hydrates in axial sites. A similar polymeric propagation of double-bridge 
macrocycles is also provided. 
 
Scheme 5.2 Structure of 13. (perchlorate anions are omitted for clarity). 
 
[Co(L4)2(H2O)2(ClO4)2]n (14) crystallizes in a monoclinic crystal system with 
space group of C2/c, is a isostructural coordination polymer to 11. The 
formula is C28H26N10S2Co⋅2H2O⋅2ClO4⋅CH3OH and the asymmetric unit 
contains one half of the formula with cobalt metal center at the symmetry 
point. The ClO4 anion is disordered into two positions. One of the positions is 
also filled with a solvent CH3OH. The two positions have occupancy of 0.5 
each (free variable refinement gave 0.51:0.49). Restraints in bond lengths and 
thermal parameters were applied for the disordered atoms. Its formation 
suggests that the spacer property of hybrid ligand L4 is predominant. In the 
absence of other strong donors, it is able to capture metals of different 
electronic configurations (d5 in 11, d6 in 13, d7 in 14 and d8 in 15) and align 
them in a similar polymeric network (Fig 5.5). This demonstrates the potential 
of using hybrid ligand spacers to construct structurally related coordination 
polymers of different electronic functions, or tuning the chain behaviour of the 
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polymer by adjusting the metal character. Intramolecular O−H⋅⋅⋅N H-bonding 
interactions (∠OHN 176°, O⋅⋅⋅N 2.74 and H⋅⋅⋅N 1.90 Å) between coordinated 
hydrates and 2-pyridyl pendant are also found. The perchlorate anions also 
interact with coordinated hydrates by hydrogen bonding interactions (∠OHO 
178°, O⋅⋅⋅O 2.79 Å, H⋅⋅⋅O 1.96 Å). The M...M separations are also similar 
(shortest intra- and inter-chain Co⋅⋅⋅Co distances are ~8.96 and 10.51 Å, 
respectively).
 
Fig 5.5 Molecular structure of 14 with intramolecular hydrogen bonding 
interactions. Co⋅⋅⋅Co, 8.96 Å. (Co1‒O1W 2.071(2), Co1‒O1WA 2.071(2), 
Co1‒N2A 2.143(2), Co1‒N2 2.143(2), Co1‒N5B 2.181(2), Co1‒N5C 
2.181(2); O1W‒Co1‒O1WA 180.00(8), O1W‒Co1‒N2A 89.91(9), 
O1WA‒Co1‒N2A 90.09(9), O1W‒Co1‒N2 90.09(9), O1WA‒Co1‒N2 
89.91(9), N2A‒Co1‒N2 180.0, O1W‒Co1‒N5B 90.71(9), 
O1WA‒Co1‒N5B 89.29(9), N2A‒Co1‒N5B 93.76(9), N2‒Co1‒N5B 
86.24(9), O1W‒Co1‒N5C 89.29(9), O1WA‒Co1‒N5C 90.71(9), 








Fig 5.6 (a) Molecular structure of 15. Ni⋅⋅⋅Ni, 9.31 Å. (Ni1‒O1W 2.049(2), 
Ni1‒O1WA 2.049(2), Ni1‒N5B 2.132(3), Ni1‒N5C 2.132(3), Ni1‒N1 
2.138(3), Ni1‒N1A 2.138(3); O1W‒Ni1‒O1WA 180.000(1), 
O1W‒Ni1‒N5B 90.18(10), O1WA‒Ni1‒N5B 89.82(10), O1W‒Ni1‒N5C 
89.82(10), O1WA‒Ni1‒N5C 90.18(10), N5B‒Ni1‒N5C 180.000(1), 
O1W‒Ni1‒N1 89.33(10), O1WA‒Ni1‒N1 90.67(10), N5B‒Ni1‒N1 
91.03(10), N5C‒Ni1‒N1 88.97(10), O1W‒Ni1‒N1A 90.67(10), 
O1WA‒Ni1‒N1A 89.33(10), N5B‒Ni1‒N1A 88.97(10), N5C‒Ni1‒N1A 
91.03(10), N1‒Ni1‒N1A 180.00(13)) (b) Interchain hydrogen bonding 
interactions in 15. 
 
Crystallizes in a triclinic crystal system with space group of P-1, 
[Ni(L4)2(H2O)2(ClO4)2]n (15) assembles into a similar polymer (Fig 5.6a) with 
intra- and inter-chain Ni⋅⋅⋅Ni separations at ~9.31 and 8.35 Å, respectively (Fig 
5.6b). Different from 11 and 14, there is no significant intramolecular H-
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bonding interaction in 15, but the intermolecular O−H⋅⋅⋅N hydrogen bonding 
interactions (∠OHN 172°, O⋅⋅⋅N 2.84 Å, H⋅⋅⋅N 2.00 Å) remains dominant. 
This lattice cohesion between the coordinated hydrates and the 2-pyridyl 
pendant drives the formation of a 2-D network. (Fig 5.6b) The nitrate anions 
also interact with coordinated hydrates by hydrogen bonding interactions 
(∠OHO 170°, O⋅⋅⋅O 2.68 Å, H⋅⋅⋅O 1.85 Å). 
In order to confirm that the formation and structures of polymers 11‒15 are 
imposed by the open-bridging preference of the spacer L4 arising from the 
positioning of the 4-picolyl residue, we examined the use of an isomeric 
spacer L2 whereby the latter is replaced by a 2-picolyl substituent that should 
not favor an open bridge with the neighboring triazole donor. Complexation 
with same four octahedral metal ions Mn(II), Fe(II), Co(II) and Ni(II) indeed 
gave no polymers but formation of discrete dinuclear and mononuclear 
complexes of [Mn2(L2)2(CH3OH)2Cl4] (16), [Fe(L2)2(CH3OH)2(ClO4)2] (17), 
[Co(L2)2(H2O)2(ClO4)2] (18) and [Ni(L2)2(NO3)2] (19). The triazole group 
responds by switching the donor site from the external (viz. 3 position) to 
internal (viz. 2 position) nitrogen so that a stable 6-membered chelate ring can 
be formed with the picolyl nitrogen and the metal. This switch demonstrates 
the versatility of the titled hybrid ligand and justifies its choice as a responsive 
spacer that uses its different donor atoms to adjust its coordinative modes to 
cooperate with the adjacent functional pendant to adapt to the complexation 
needs to direct to specific structural outcomes. Similar to 11‒15 (except 12), 
complexes 16‒18 show how the two trans-oriented nitrogen donors fix the 
solvate at the axial sites.  
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[Mn2(L2)2(CH3OH)2Cl4] (16) crystallizes in a monoclinic crystal system with 
space group of P21/c, and shows a dinuclear structure, in which methanol is 
selected as coordinating solvate. Each Mn(II) center is distorted octahedral 
coordinating geometry which is completed by one pyridyl-triazolyl chelate, 
two µ2-Cl bridges, one terminal chloride and one methanol molecule (Fig 
5.7a). Complex 16 was synthesized by MnCl2 reacting with chelating ligand 
L2. Owing to two bridging chlorides, two Mn(II) centers are linked together to 
form dinuclear structure which differ from the following mononuclear 
structures. Meanwhile, there exist intramolecular hydrogen bonding 
interactions (∠OHN 167°, O⋅⋅⋅N 2.82 Å, H⋅⋅⋅N 2.00 Å) between coordinated 
methanol and uncoordinated N4 of triazolyl group. Every complex is also 
connected with two free methanol molecules by O−H⋅⋅⋅Cl hydrogen bonding 
interactions (∠OHCl  163°, O⋅⋅⋅Cl 3.17 Å, H⋅⋅⋅Cl 2.36 Å) (Fig 5.7b). 
Crystallized in a triclinic crystal system with space group of P-1, complex 17 
selects methanol as its solvate (Fig 5.8a). Note that the strong O−H⋅⋅⋅N 
hydrogen bonding inclination of the thiopyridyl and coordinated solvate 
witnessed in former polymeric complexes is also evident in 17. However, this 
occurs in an intermolecular form (∠OHN 168°, O⋅⋅⋅N 2.71 Å, H⋅⋅⋅N 1.86 Å), 
thus contributing to a 1-D supramolecular framework of interconnecting 
mononuclear metal spheres (Fig 5.8b). In complex 17, the asymmetric unit 
contains half a C30H34N10O2S2Fe cation, one perchlorate anion and one diethyl 
ether solvent. The C atoms of the methanol group attached to iron (II) center 
were disordered into two positions with occupancy ratio = 50:50 and the 





Fig 5.7 (a) Molecular structure of 16. Mn⋅⋅⋅Mn, 3.73 Å. (Mn1‒O1S 
2.1762(13), Mn1‒N2 2.2612(15), Mn1‒N1 2.2926(15), Mn1‒Cl1 
2.4658(5), Mn1‒Cl2 2.5206(5), Mn1‒Cl2A 2.5629(5); O1S‒Mn1‒N2 
168.67(5), O1S‒Mn1‒N1 91.06(5), N2‒Mn1‒N1 81.76(5), O1S‒Mn1‒Cl1 
97.71(4), N2‒Mn1‒Cl1 91.10(4), N1‒Mn1‒Cl1 90.17(4), O1S‒Mn1‒Cl2 
92.28(4), N2‒Mn1‒Cl2 93.87(4), N1‒Mn1‒Cl2 172.44(4), Cl1‒Mn1‒Cl2 
96.101(16), O1S‒Mn1‒Cl2A 84.71(4), N2‒Mn1‒Cl2A 86.27(4), 
N1‒Mn1‒Cl2A 87.93(4), Cl1‒Mn1‒Cl2A 176.949(18), Cl2‒Mn1‒Cl2A 
85.633(16)) (b) Intramolecular and intermolecular hydrogen bonding 





Fig 5.8 (a) Molecular structure of 17 (ether molecules and perchlorate 
anions are omitted for clarity). Fe⋅⋅⋅Fe, 10.88 Å. (Fe1‒O1SA 2.116(2), 
Fe1‒O1S 2.116(2), Fe1‒N2 2.173(2), Fe1‒N2A 2.173(2), Fe1‒N1A 
2.235(2), Fe1‒N1 2.235(2); O1SA‒Fe1‒O1S 180.000(1), O1SA‒Fe1‒N2 
88.77(9), O1S‒Fe1‒N2 91.23(9), O1SA‒Fe1‒N2A 91.23(9), 
O1S‒Fe1‒N2A 88.77(9), N2‒Fe1‒N2A 180.000(1), O1SA‒Fe1‒N1A 
86.49(9), O1S‒Fe1‒N1A 93.51(9), N2‒Fe1‒N1A 94.32(9), N2A‒Fe1‒N1A 
85.68(9), O1SA‒Fe1‒N1 93.51(9), O1S‒Fe1‒N1 86.49(9), N2‒Fe1‒N1 
85.68(9), N2A‒Fe1‒N1 94.32(9), N1A‒Fe1‒N1 180.000(1)) (b) 
Intermolecular hydrogen bonding interactions in 17. 
 
Crystallized in a triclinic space group P-1, [Co(L2)2(H2O)2(ClO4)2] (18) shows 
a similar behaviour as 17 except by self-selecting the hydrate as coordinating 
solvate (Fig 5.9a). The mononuclear entities also self-assemble into an 
interconnecting 1-D supramolecular chain with the asssitance of 
intermolecular O−H⋅⋅⋅N hydrogen bonding interactions (∠OHN 176°, O⋅⋅⋅N 
2.78 Å, H⋅⋅⋅N 1.93 Å) (Fig 5.9b). The perchlorate anions also interact with 
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coordinated hydrates by hydrogen bonding interactions (∠OHO 164°, O⋅⋅⋅O 
2.88 Å, H⋅⋅⋅O 2.06 Å). 
 
 
Fig 5.9 (a) Molecular structure of 18 (Perchlorates are omitted for clarity). 
Co⋅⋅⋅Co, 10.60 Å. (Co1‒O1 2.101(3), Co1‒O1A 2.101(3), Co1‒N3 
2.105(3), Co1‒N3A 2.105(3), Co1‒N1 2.194(3), Co1‒N1A 2.194(3); 
O1‒Co1‒O1A 180.0, O1‒Co1‒N3 91.27(10), O1A‒Co1‒N3 88.73(10), 
O1‒Co1‒N3A 88.73(10), O1A‒Co1‒N3A 91.27(10), N3‒Co1‒N3A 
180.00(15), O1‒Co1‒N1 91.36(10), O1A‒Co1‒N1 88.64(10), N3‒Co1‒N1 
87.05(11), N3A‒Co1‒N1 92.95(11), O1‒Co1‒N1A 88.64(10), 
O1A‒Co1‒N1A 91.36(10), N3‒Co1‒N1A 92.95(11), N3A‒Co1‒N1A 
87.05(11), N1‒Co1‒N1A 180.0) (b) Intermolecular hydrogen bonding 
interactions in 18. 
 
[Ni(L2)2(NO3)2] (19) also crystallizes in a triclinic crystal system with space 
group of P-1. The asymmetric unit contains one complex cation (L2)2(NO3)Ni 
and one nitrate ion and two dichloromethane molecules. One of the 
dichloromethane molecule and substantial parts of the complex are disordered. 
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The disordered atoms were sorted into two parts. Free variable refinement 
gave occupancy ratio of 53:48. Usual restraints in bond geometry and thermal 
parameters were applied in final refinement. Due to the high degree of 
disorder and the overlapping of the disordered parts, the crystal refinement 
data were not exceptional, particularly the thermal parameters. Using the same 
metal precusor Ni(NO3)2 with 15 and under same reaction condition, the 
ligand change results in a totally different butterfly mononuclear structure (Fig 
5.10). Nonetheless, the chelating coordination mode of ligand L2 is unchanged 
compared with complex 16‒18. The Ni(II) center is also octahedral geometry 
which is coordinated by two triazolyl-pyridyl chelates and one nitrate anion, 
but without coordinated solvate. Two dichloromethane molecules which were 
used as recrystallized solvent are also cocrystallized in complex 19. 
 
Fig 5.10 Molecular structure of 19 (dichloromethane molecules are omitted 
for clarity). (Ni1‒N8 2.028(7), Ni1‒N3 2.033(6), Ni1‒N6 2.070(6), 
Ni1‒N1 2.082(6), Ni1‒O1 2.094(6), Ni1‒O2 2.110(6); N8‒Ni1‒N3 
95.2(3), N8‒Ni1‒N6 87.8(2), N3‒Ni1‒N6 93.0(2), N8‒Ni1‒N1 91.4(2), 
N3‒Ni1‒N1 88.3(2), N6‒Ni1‒N1 178.5(2), N8‒Ni1‒O1 165.5(3), 
N3‒Ni1‒O1 99.3(2), N6‒Ni1‒O1 91.3(2), N1‒Ni1‒O1 89.2(2), 
N8‒Ni1‒O2 103.8(3), N3‒Ni1‒O2 161.0(3), N6‒Ni1‒O2 89.5(2), 




The use of L2 demonstrates the difference of its structural proposition 
compared to that of its isomeric counterpart L4, it further suggests that it could 
support mononuclear formation and organise the coordination spheres into a 
diffferent form of 1-D supramolecules in which the intermetallic interactions 
switch from a spacer-centric model to a H-bonding-centric framework. This 
supports the proposition of the use of this series of hybrid ligands to support 
different forms of supramolecular networks with pre-defined structural 
characteristics. 
This and our earlier results conclusively pointed to the use of L4 as an open 
bridge spacer towards different metals, including Mn(II), Co(II), Ni(II), 
Cu(I) and Zn(II) complexes with a common 18-membered metallocycles. 
However, within this common structural motif, there are variations that 
reflect the geometric and steric characteristics of the metals. For example, 
preference of Cu(I) for a 1-D [Cu2I2] assembly and Zn(II) for a dinuclear 
framework and the current metals (Mn(II), Co(II) and Ni(II)) for a uniform 
1-D polymeric structural form. With the L2-Cu(I) coordination polymer as 
an exception, the thiopyridyl groups of ligands L4 and L2 are generally 
pendant, or not participative in any covalent or dative interaction with the 
metals (Mn(II), Fe(II), Co(II), Ni(II), Cu(I) and Zn(II)). They could 
stabilise the coordination sphere through intramolecular H-bonding, 
support the supramolecular formation or strengthen the lattice secondary H-
bonding interactions cohesion. We are currently seeking a more definitive 
mechanism to engineer such H-bonding to cooperate constuctively with the 
spacer coordination modes to direct to specific assembly outcome. Such 
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study requires the synthesis of spacers of specific and pre-defined 
functional units, not just for donor orientation but also H-bonding 
directional characters. Optimisation of the click synthesis would enable the 
synthesis of these new multi-functionalized hybridised triazole ligands. 
5.3 Conclusion 
Two multi-functionalized hybridised triazole ligands from ready click 
synthesis have been chosen to react with a series of first transition metals 
(Mn(II), Fe(II), Co(II) and Ni(II)). Based on the structure information of these 
and our previous complexes, ligand L4 demonstrate the open bridging 
coordination mode, while ligand L2 prefers chelating mode. Moreover, 
geometric and steric features of the metals, and multipurpose H-bonding 
interactions would also affect the assembly outcomes. The investigation of 
cooperation principle of all these factors (spacer coordination mode, metal 
characteristics and secondary interactions) could guide the assembly process 
for specific outcomes. 
 
5.4 Experimental Section 
Materials and General Methods 
The synthesis of precursors and ligands have been presented in chapter 1. 
Synthesis of [Mn(L4)2(H2O)2(ClO4)2]n (11). The methanol solution (5 
mL) of Mn(ClO4)2·4H2O (0.1 mmol, 32.6 mg) was added into the methanol 
solution (5 mL) of ligand L4 (0.2 mmol, 56.7 mg) under stirring. The 
reaction mixture was stirred at r.t. overnight. The solution was concentrated 
under vacuum, the residue was added by ether slowly and the suspension 
was stirred overnight. The suspension was filtrated under vacuum. The 
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solid obtained were collected and recrystallized by methanol and ether and 
dried under vacuum. Diffusion of ether to their methanol solution at r.t. 
afforded crystals after around one week. Yield: 49 mg, 57 %. Anal. Calcd. 
for C28H30Cl2MnN10O10S2 (856.57): C, 39.26; H, 3.53; N, 16.35; S, 7.49. 
Found: C, 38.98; H, 3.67; N, 16.19; S, 7.76 %. ESI-MS (m/z, %):  [H(L4)]+ 
(284.1, 40), [Na(L4)]+ (306.1, 4), [Mn(L4)2]
2+ (310.5, 48), 
[Mn(ClO4)(L4)]
+ (437.0, 33), [Mn(L4)3]
2+ (452.1, 80), [Na(L4)2]
+ (589.2, 
11), [Mn(L4)4]
2+ (593.6, 14), [Mn(ClO4)(L4)2]
+ (720.0, 100). IR/cm-1: 
3965w, 3437m, 3140w, 2997w, 2933w, 2472w, 2444w, 2408w, 2294m, 
2019m, 1936w, 1907w, 1623m, 1586m, 1555m, 1508m, 1458m, 1415m, 
1359m, 1336m, 1306m, 1283m, 1251w, 1227m, 1188w, 1159m, 994m, 
930w, 881m, 840m, 807m, 789m, 757m, 725m, 669m, 627m, 591m, 535w, 
483m and 442w. 
Synthesis of [Mn(L4)Cl2]n (12). The ethanol solution (5 mL) of 
MnCl2·4H2O (0.2 mmol, 39.6 mg) was added into the ethanol solution (5 
mL) of ligand L4 (0.2 mmol, 56.7 mg) under stirring. The reaction mixture 
was stirred at r.t. in the air overnight. The suspension was filtrated under 
vacuum, and washed by ethanol and ether. The solid obtained were 
collected and dried under vacuum. Diffusion of ether to its ethanol solution 
at r.t. afforded crystals after around one week. Yield: 65 mg, 79 %. Anal. 
Calcd. for C14H13N5MnCl2S (409.19): C, 41.09; H, 3.20; N, 17.11; S, 7.84. 
ESI-MS (m/z, %):  [H(L4)]+ (284.1, 15), [Na(L4)]+ (306.0, 5), [Mn(L4)2]
2+ 
(310.5, 34), [MnCl(L4)]+ (373.0, 20), [Mn(L4)3]
2+ (452.1, 36), [Na(L4)2]
+ 
(589.1, 14), [Mn(L4)4]
2+ (593.6, 13), [MnCl(L4)2]
+ (656.1, 100), 
[Mn2Cl3(L4)2]
+ (782.9, 7). IR/cm-1: 3455m, 3154w, 3124m, 3068w, 3036w, 
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2982m, 2932m, 2506w, 2408w, 2374w, 2303w, 2259w, 1964m, 1855m, 
1779w, 1617m, 1580m, 1556m, 1506m, 1455m, 1427m, 1371m, 1350m, 
1311m, 1286m, 1227m, 1151m, 1125m, 1089m, 1060m, 1045m, 1016m, 
987m, 956w, 884m, 864m, 849m, 810m, 782m, 763m, 723m, 669m, 620m, 
591m and 483m. 
Synthesis of [Fe(L4)2(H2O)2(ClO4)2]n (13). The ethanol solution (5 mL) of 
Fe(ClO4)2·6H2O (0.1 mmol, 36.3 mg) was added into the ethanol solution 
(5 mL) of ligand L4 (0.2 mmol, 56.7 mg) under stirring. The reaction 
mixture was stirred at room temperature under nitrogen overnight. The 
suspension was filtrated under vacuum, and washed by ethanol and ether. 
The solid obtained were collected and dried under vacuum. Diffusion of 
ether to its DMF solution at room temperature afforded crystals after 
around one week. The good quality crystal was not obtained for single X-
ray diffraction analysis. Yield: 62 mg, 72 %. Anal. Calcd. for 
C28H30Cl2FeN10O10S2 (857.48): C, 39.22; H, 3.53; N, 16.33; S, 7.48. 
Found: C, 39.46; H, 3.71; N, 18.41; S, 6.77 %. ESI-MS (m/z, %): [H(L4)]+ 
(284.0, 15), [Na(L4)]+ (306.0, 8), [Fe(L4)2]
2+ (311.0, 100), 
[Fe(ClO4)(L4)]
+ (438.0, 16), [Fe(L4)3]
2+ (452.6, 46), [Na(L4)2]
+ (589.2, 8), 
[Fe(L4)4]
2+ (594.0, 14), [Fe(ClO4)(L4)2]
+ (721.0, 97). IR/cm−1: 3443m, 
3140m, 3082w, 2932w, 2361w, 2018w, 1622m, 1587m, 1556m, 1508m, 
1458m, 1417m, 1358w, 1307w, 1283w, 1251w, 1227m, 1145w, 1087m, 
1044m, 1019m, 996m, 881w, 841w, 807m, 790m, 757m, 725m, 626m, 
592w, 485m. 
Synthesis of [Co(L4)2(H2O)2(ClO4)2]n (14) and [Co(L2)2(H2O)2(ClO4)2] 
(18). The methanol solution (5 mL) of Co(ClO4)2·6H2O (0.1 mmol, 36.6 
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mg) was added into the methanol solution (5 mL) of ligand L4 or L2 (0.2 
mmol, 56.7 mg) under stirring. The reaction mixture was stirred at room 
temperature in the air overnight. The solution was concentrated under 
vacuum, the residue was added by ether slowly and the suspension was 
stirred overnight. The suspension was filtrated under vacuum. The solid 
obtained were collected and recrystallized by methanol and ether and dried 
under vacuum. Diffusion of ether to their methanol solutions at room 
temperature afforded crystals after around one week. For complex 13: 
Yield: 67.8 mg, 76 %. Anal. Calcd. for C28H30Cl2CoN10O10S2 (860.57): C, 
39.08; H, 3.51; N, 16.28; S, 7.45. Found: C, 39.63; H, 3.17; N, 16.26; S, 
6.70 %. ESI-MS (m/z, %): [H(L4)]+ (284.0, 18), [Na(L4)]+ (306.1, 38), 
[Co(L4)2]
2+ (312.6, 75), [Co(CH3O)(L4)]
+ (373.0, 16), [Co(ClO4)(L4)]
+ 
(441.0, 25), [Co(L4)3]
2+ (454.1, 80), [Na(L4)2]
+ (589.2, 10), 
[Co(ClO4)(L4)2]
+ (724.0, 100), [Co2(ClO4)3(L4)2]
+ (982.8, 7). IR/cm-1: 
3451m, 3141w, 3085w, 2932w, 2300w, 2019w, 1830w, 1624m, 1588m, 
1556m, 1509m, 1458m, 1429m, 1359m, 1337m, 1307m, 1283m, 1251w, 
1229w, 1158m, 996m, 956w, 930w, 882m, 842m, 808m, 790m, 756m, 
725m, 711m, 624m, 593m, 555w, 488m, 445w and 419m. For complex 14: 
Yield: 49 mg, 57 %. Anal. Calcd. for C28H30Cl2CoN10O10S2 (860.57): C, 
39.08; H, 3.51; N, 16.28; S, 7.45. Found: C, 39.32; H, 3.39; N, 16.38; S, 
7.05 %. ESI-MS (m/z, %): [Co(L2)2]
2+ (312.5, 66), [Co(CH3O)(L2)]
+ 
(373.0, 4), [Co(ClO4)(L2)]
+ (440.9, 21), [Co(L2)3]
2+ (454.0, 22), 
[Na(L2)2]
+ (589.2, 7), [Co(L2)4]
2+ (595.5, 10), [Co2(ClO4)3(L2)]
+ (698.1, 
4), [Co(ClO4)(L2)2]
+ (724.0, 100), [Co2(ClO4)3(L2)2]
+ (982.7, 6). IR/cm-1: 
3424m, 3130w, 2851m, 2481w, 2330w, 2228w, 2190w, 2018w, 1984w, 
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1919w, 1871w, 1844w, 1800w, 1761w, 1674m, 1606w, 1575w, 1561w, 
1542m, 1483w, 1454w, 1424w, 1350m, 1321m, 1285m, 1258m, 1237m, 
1184w, 1163w, 950m, 930m, 875m, 844w, 827w, 783w, 760w, 718w, 
619m, 597m, 504w, 480m and 425m. 
Synthesis of [Ni(L4)2(H2O)2(NO3)2]n (15) and [Ni(L2)2(NO3)2] (19). The 
ethanol solution (5 mL) of Ni(NO3)2·6H2O (0.1 mmol, 29.1 mg) was added 
into the ethanol solution (5 mL) of ligand L4 or L2 (0.2 mmol, 56.7 mg) 
under stirring. The reaction mixture was stirred at room temperature in the 
air overnight. The suspension was filtrated under vacuum, and washed by 
ethanol and ether. The solid obtained were collected and dried under 
vacuum. Diffusion of ether or dichloromethane to its DMF solution at room 
temperature afforded crystals after around one week. For complex 11: 
Yield: 61.3 mg, 78 %. Anal. Calcd. for C28H30N12NiO8S2 (785.47): C, 
42.82; H, 3.85; N, 21.40; S, 8.16. Found: C, 42.41; H, 3.79; N, 20.97; S, 
8.20 %. ESI-MS (m/z, %): [H(L4)]+ (284.1, 100), [Na(L4)]+ (306.0, 4), 
[Ni(L4)2]
2+ (312.0, 14), [Ni(CH3CH2O)(L4)]
+ (386.0, 11), [Ni(NO3)(L4)]
+ 
(403.0, 24), [Ni(L4)3]
2+ (453.6, 13), [Na(L4)2]
+ (589.2, 7), [Ni(L4)4]
2+ 
(595.1, 19), [Ni(CH3CH2O)(L4)2]
+ (669.1, 8), [Ni(NO3)(L4)2]
+ (686.1, 41), 
[Ni2(NO3)2(CH3CH2O)(L4)2]
+ (851.0, 3), [Ni2(NO3)3(L4)2]
+ (869.9, 3). 
IR/cm-1: 3398m, 3153w, 3045w, 2965w, 2373w, 2037w, 1987w, 1950w, 
1903w, 1851w, 1763w, 1678m, 1621m, 1584m, 1549m, 1511m, 1458m, 
1431w, 1404w, 1225m, 1188m, 1158m, 1130m, 1073m, 1044m, 1020m, 
987m, 958m, 886m, 845m, 825m, 790m, 773m, 733m, 667m, 625w, 588m, 
489m, 454w and 420m. For complex 12: Yield: 61.5 mg, 82 %. Anal. 
Calcd. for C28H26N12NiO6S2 (749.41): C, 44.88; H, 3.50; N, 22.43; S, 8.56. 
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Found: C, 44.71; H, 3.85; N, 22.20; S, 8.59 %. ESI-MS (m/z, %): [H(L2)]+ 
(284.1, 42), [Na(L2)]+ (306.1, 12), [Ni(L2)2]
2+ (312.1, 35), 
[Ni(CH3CH2O)(L2)]
+ (386.0, 17), [Ni(NO3)(L2)]
+ (403.0, 39), [Ni(L2)3]
2+ 
(454.6, 35), [Na(L2)2]
+ (589.2, 23), [Ni(L2)4]
2+ (595.1, 17), 
[Ni(CH3CH2O)(L2)2]
+ (669.1, 69), [Ni(NO3)(L2)2]
+ (686.1, 100). IR/cm-1: 
3397m, 3130m, 3056m, 2995m, 2958w, 2936w, 2854w, 2763w, 2699w, 
2531w, 2471w, 2426w, 2362w, 2332w, 2235w, 2015w, 1748m, 1607m, 
1580m, 1558m, 1529m, 1481w, 1455m, 1415m, 1384m, 1348m, 1308m, 
1287m, 1245m, 1229m, 1183m, 1148m, 1123m, 1082m, 1060m, 1025m, 
987m, 962m, 890m, 874m, 840m, 803m, 770m, 721m, 698m, 645m, 620m, 
481m and 432m. 
Synthesis of [Mn2(L2)2(CH3OH)2Cl4] (16). The methanol solution (5 mL) 
of MnCl2·4H2O (0.2 mmol, 39.6 mg) was added into the methanol solution 
(5 mL) of ligand L2 (0.2 mmol, 56.7 mg) under stirring. The reaction 
mixture was stirred at r.t. overnight. The solution was concentrated under 
vacuum, the residue was added by ether slowly and the suspension was 
stirred overnight. The suspension was filtrated under vacuum. The solid 
obtained were collected and recrystallized by methanol and ether and dried 
under vacuum. Diffusion of ether to its methanol solution at r.t. afforded 
crystals after around one week. Yield: 66 mg, 75 %. Anal. Calcd. for 
C30H34Cl4Mn2N10O2S2 (882.47): C, 40.83; H, 3.88; N, 15.87; S, 7.27. ESI-
MS (m/z, %):  [Na(L2)]+ (306.0, 10), [Mn(L2)2]
2+ (310.5, 29), 
[MnCl(L2)]+ (373.0, 41), [Mn(L2)3]
2+ (452.1, 36), [Mn2Cl3(L2)]
+ (499.8, 
4), [Mn(L2)4]
2+ (593.6, 13), [MnCl(L2)2]
+ (656.1, 100), [Mn2Cl3(L2)2]
+ 
(782.9, 17), [Mn3Cl5(L2)2]
+ (907.7, 6), [MnCl(L2)3]




+ (1065.7, 6). IR/cm-1: 2924w, 2522w, 2305w, 2230w, 
2009w, 1933w, 1872w, 1851w, 1768w, 1711m, 1668m, 1461w, 1402w, 
1381w, 1324w, 1305w, 1261w, 1240w, 1186m, 1155m, 1124w, 1080m, 
1047w, 1037m, 1013m, 991m, 978w, 943m, 869w, 851w, 765w, 699w, 
637w, 607w, 482w, 464w and 414w. 
Synthesis of [Fe(L2)2(CH3OH)2(ClO4)2] (17). The methanol solution (5 
mL) of Fe(ClO4)2·6H2O (0.5 or 1 equiv. respectively) was added into the 
methanol solution (5 mL) of ligand L2 (0.2 mmol, 56.7 mg) under stirring. 
The reaction mixture was stirred at room temperature under nitrogen 
overnight. The solution was concentrated under vacuum, the residue was 
added by ether slowly and the suspension was stirred overnight. The 
suspension was filtrated under vacuum. The solid obtained were collected 
and recrystallized by methanol and ether and dried under vacuum. 
Diffusion of ether to their methanol solutions at room temperature afforded 
crystals after around one week. Yield: 66 mg, 75 %. Anal. Calcd. for 
C30H34Cl2FeN10O10S2 (885.53): C, 40.69; H, 3.87; N, 15.82; S, 7.24. 
Found: C, 40.53; H, 3.26; N, 16.95; S, 7.04 %. ESI-MS (m/z, %): [H(L2)]+ 
(283.9, 2), [Fe(L2)2]
2+ (311.0, 36), [Fe(ClO4)(L2)]
+ (438.0, 29), 
[Fe(L2)3]
2+ (452.5, 36), [Na(L2)2]
+ (589.2, 2), [Fe(L2)4]
2+ (594.1, 8), 
[Fe2(ClO4)2(CH3OH)2(L2)]
+ (657.1, 37), [Fe(ClO4)(L2)2]
+ (721.0, 100). 
IR/cm−1: 3406m, 3130m, 2979w, 2360m, 2017w, 1670w, 1604m, 1581m, 
1561m, 1541m, 1482m, 1456m, 1412m, 1350w, 1322m, 1286m, 1234m, 
1146m, 1122m, 1023m, 998m, 948w, 875m, 828w, 782m, 757m, 719w, 




X-ray Crystallographic Study 
CCDC reference numbers: 991496 (11), 991497 (12), 991493 (14), 991491 
(15), 991498 (16), 991495 (17), 991494 (18) and 991492 (19). 
Table 5.1 Crystallographic data and refinement parameters for complexes 
11‒12 and 14‒19. 
 










MW 872.58 409.19 892.61 785.47 
T / K 100(2) 100(2) 100(2) 100(2) 
Crystal size / 
mm3 
0.60 × 0.36 × 
0.16 
0.24 × 0.17 × 
0.14 
0.19 × 0.07 × 
0.05 
0.22 × 0.16 × 
0.14 
Crystal system Monoclinic Triclinic Monoclinic Triclinic 
Space group C2/c P-1 C2/c P-1 
a / Å 19.211(3) 8.5642(5) 19.4919(16) 8.3515(10) 
b / Å 21.382(3) 9.1677(5) 20.9980(16) 9.3103(12) 
c / Å 9.0644(13) 11.2131(6) 8.9634(7) 11.1232(13) 
α / ° 90 102.6160(10) 90 71.957(3) 
β / ° 92.706(3) 105.4880(10) 93.014(2) 83.166(3) 
γ / ° 90 98.5360(10) 90 85.366(3) 
V / Å3 3719.1(9) 807.67(8) 3663.6(5) 815.63(17) 
Z 4 2 4 1 
Dcalc / g·cm
−3 1.558 1.683 1.618 1.599 
µ / mm−1 0.681 1.281 0.801 0.793 
θ range / ° 1.43−27.50 1.96−27.50 1.94−27.50 1.94−27.50 
Reflections 
collected 




4278 [0.0276] 3698 [0.0277] 4215 [0.0684] 3718 [0.0266] 
Parameters 295 208 301 238 
GOF 1.139 1.049 1.068 1.124 
R1(I > 2σ(I)) 0.0459 0.0287 0.0570 0.0488 
wR2(I > 2σ(I)) 0.1412 0.0679 0.1143 0.1126 
 










MW 946.56 959.66 858.55 919.29 
T / K 100(2) 100(2) 100(2) 100(2) 
Crystal size / 
mm3 
0.50 × 0.40 × 
0.14 
0.34 × 0.10 × 
0.08 
0.23 × 0.12 × 
0.03 




Monoclinic Triclinic Triclinic Triclinic 
Space group P21/c P-1 P-1 P-1 
a / Å 14.0725(7) 8.463(2) 8.199(2) 10.520(2) 
b / Å 10.6463(5) 10.883(3) 9.748(2) 13.484(3) 
c / Å 14.4613(7) 12.314(3) 11.814(3) 14.052(3) 
α / ° 90 98.107(6) 83.786(5) 99.577(3) 
β / ° 108.1700(10) 93.655(6) 88.404(5) 101.065(3) 
γ / ° 90 112.028(6) 71.775(5) 97.532(3) 
V / Å3 2058.56(17) 1032.4(4) 891.5(4) 1901.5(7) 
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Z 2 1 1 2 
Dcalc / g·cm
−3 1.527 1.544 1.599 1.606 
µ / mm−1 1.024 0.667 0.818 0.961 
θ range / ° 1.52−27.50 1.68−27.50 1.73−27.50 1.51−25.00 
Reflections 
collected 




4715 [0.0324] 4730 [0.0509] 4094 [0.0708] 6682 [0.0728] 
Parameters 251 355 247 515 
GOF 1.038 1.067 1.009 1.135 
R1(I > 2σ(I)) 0.0341 0.0551 0.0572 0.1019 
















Chapter 6 Flexible hybridised triazole-based ligands 
supported Cu(II), Ni(II), Co(II), Fe(II) and Mn(II) 
complexes: structures and magnetic properties 
6.1 Introduction 
1,2,3-triazole and their derivatives prepared from modular CuAAC click 
reaction22-24,35,243 are excellent candidate for spacers of coordination 
complexes with specific properties, which have been widely used in various 
fields, such as photochemistry175,196,199,332-335, supramolecular 
chemistry147,190,206,245,246,253,312,336,337, catalytic reaction178,194,213,309,338-341 and 
magnetism221,236,310,326-329. Among their applications, the popular triazole 
ligands supporting magnetic complexes are still largely unexplored, especially 
magnetic dinuclear transition metal complexes. It has been known that 
magnetic dinuclear transition metal complexes play crucial roles in 
understanding of superexchange magnetic interactions, and comprehending of 
structures, functions and reactivities of bimetallic metalloprotein systems.342-
347 Due to their fundamental importance, they have attracted much attention in 
the past decades. Owing to the irreplacable role of ligand in the design and 
synthesis of functional complexes with tunable magnetic properties348-352, 
several kinds of heterocyclic ligands have been screened to form dinuclear 
magnetic complexes. Among them, pyrazole and 1,2,4-triazole bridged 
dinuclear Cu(II) complexes are the model examples, and most of them show 
strong intramolecular antiferromagnetic interactions.353-360 Based on the 
development of magnetic complexes and our exploration of a series of hybrid 
triazole ligands and corresponding transition metal complexes, herein, three 
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multifunctional flexible triazole ligands (1-(2-picolyl)-4-hexyl-1H-1,2,3-triazole 
(L15), 1-(2-picolyl)-4-(2-(methylthio)-pyridine)-1H-1,2,3-triazole (L2) and 1-
(2-picolyl)-4-(hydroxymethyl)-1H-1,2,3-triazole (L14)) have been chosen to 
support Cu(II) dinuclear  magnetic complexes. Meanwhile, 1-(2-picolyl)-4-
(hydroxymethyl)-1H-1,2,3-triazole (L14) supported other 3d transition metal 
complexes (Cu(II), Ni(II), Co(II), Fe(II) and Mn(II) complexes) have also 
been prepared. Among them, magnetic properties of five dinuclear complexes 
(Cu(II), Ni(II) and Co(II)) have been investigated systematically. 
 
6.2 Results and discussion 
6.2.1  Ligand synthesis and their coordination modes in complexes 
Three ligands have been synthesized conveniently by CuAAC click reaction 
using picolyl chloride, NaN3 and three different alkynes. A range of 
corresponding first transition metal complexes 20‒30 have also been prepared 
([Cu2Cl4(L15)2] (20), [Cu2Cl4(L2)] (21), [Cu2Cl4(L14)2] (22), 
[Ni2(L14)2(CH3OH)2(NO3)2](CH3OH)2(NO3)2 (23), 
[Ni2(L14)2(H2O)4](H2O)2Cl4 (24), [Co(L14)2(CH3OH)2](ClO4)2 (25), 
[Co2(L14)2(CH3OH)2(NO3)2](CH3OH)2(NO3)2 (26), 
[Co2(L14)2(CH3OH)2Cl2](H2O)(CoCl4) (27), 
[Fe2(L14)2(CH3OH)4](CH3OH)2(ClO4)4 (28), [Fe(L14)2(C3H7NO)2](ClO4)2 
(29) and [Mn(L14)2(CH3OH)2](ClO4)2 (30)) and the coordination modes of 
ligands in these complexes have been presented in Scheme 6.1. Comparison of 
the crystal structures of those transition metal complexes bearing ligand L14 
indicates that the different geometries of metal centers and anions both could 
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affect the coordination mode of ligand. The magnetic property of formed 












M = Ni(II), Co(II), Fe(II)















M = Co(II), Fe(II), Mn(II)
L14 in 25, 29, 30
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Scheme 6.1 The coordination modes of ligands in complexes 20‒30. 
 
6.2.2 Powder X-Ray Diffraction and TGA 
The powder XRD for complexes 20 have been shown in Fig 6.1. There is fair 
agreement between the experimental and calculated powder XRD patterns, 
which supporting reasonable phase purity. Meanwhile, using ground single 
crystals which were freshly prepared, the powder XRD for complex 21‒28 
have also been obtained and the curves are combined in Fig 6.2. Most of X-ray 
powder diffraction patterns agree with their simulated patterns indicating fair 
phase purity. Some disagreement between experimental and simulated data 
may be due to facile escape of cocrystallized solvates in the lattice as well as 
the crystal packing change.330 Powder XRD patterns of solvated complex 29 
and quite hydrophilic complex 30 could not be obtained. The 
thermogravimetric analysis (TGA) profiles of 20 are shown in Fig 6.3. It 
indicates a weight drop of ~3.4 % (calcd. 3.7 %) at ~170 °C under air and 
nitrogen flow, which may correspond to the liberation of a N2 from triazole 
groups based on the dinuclear structure. A steady decline follows towards 
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~680 °C (in air). The TGA analysis of other complexes were also conducted 
and combined in Fig 6.4. Suitable TGA curves of several perchlorate materials 
including complex 25 and 28‒30 could not be obtained because of their 
explosive property. Complexes 21 and 22 are stable up to about 160 °C and 
150 °C. TGA curve of complex 23 shows a two stepped weight loss of ~15.8 % 
(calcd 14.7 %) between 90‒190 °C, attributed to loss of free and coordinated 
methanol molecules in the lattice, respectively, and followed by steady 
decomposition. TGA curve of complex 24 indicates a weight loss of ~14.6 % 
(calcd 14.4 %) between 80‒150 °C, which may due to loss of coordinated 
hydrates. Differently, complex 26 shows a steady decomposition of the whole 
structure without stepped weight loss of coordinated solvent molecules. The 
weight loss of ~8.9 % (calcd 9.6 %) of 27 in 120‒180 °C could be assigned to 
loss of coordinated MeOH and free H2O in the lattice, followed by 
degradation of the complex structure. 
 
Fig 6.1 Powder XRD patterns of 20 (T = theoretical profile referenced to the 





Fig 6.2 Powder XRD patterns of 21‒28 (T/E see above). 
 
 





Fig 6.4 TGA profiles of complex 21‒24 and 26‒27. 
 
6.2.3 Single crystal structures 
Complex 20 crystallizes in a monoclinic space group C2/c. It shows a 
dinuclear structure in which the Cu(II) centers are bridged by triazolyl groups 
from two ligands. The Cu(II) center is five-coordinated in distorted square 
pyramidal geometry with the Addison parameter τ of 0.36.331 The square base 
is completed by two trans nitrogen atoms (N1 and N2A) of different L15 
ligands, and two trans orientated chlorides. The apical position is occupied by 
the triazole nitrogen atom (N3) with a long Cu−N bond length (2.58 Å), so the 
triazolyl N=N bridge presents an asymmetric basal-apical fashion between two 
Cu(II) centers. The torsion angle of Cu−N=N−Cu is 112.6°. The deviation of 
Cu(II) center from the mean plane of square base (N1, N2A, Cl1 and Cl2) is 
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0.21 Å. In the lattice, complex 20 consists of discrete neutral and chiral 
dinuclear Cu(II) units, with the Cu(II) centers in each unit being related by the 
crystallographic 2-fold axis (Fig 6.5a). Besides, there exist intermolecular H-
bonding interactions between the hydrogen from benzyl methylene of L15 
skeleton and the coordinated chlorides (C−H⋅⋅⋅Cl 3.62 Å), and form a 
homochiral two-dimensional supermolecular layer (Fig 6.5b). The nearest 
intra- and inter-molecular Cu⋅⋅⋅Cu distances are 4.44 and 7.81 Å, respectively. 
The neighbouring layers are symmetrically packed along c direction. 
Complex 21 crystallizes in a orthorhombic space group Fdd2. The asymmetric 
unit contains one molecule of C14H13N5SCu2Cl4 and one and a half 
dichloromethane molecules. It shows a bis-chelating ligand L2 bridged 
dinuclear Cu(II) structure (Fig 6.6a). There are two kinds of copper centers in 
complex 21 and both of them are four coordinated and show distorted square 
planar coordinating geometries. Cu1 center is completed by a triazolyl (N3)-
pyridyl chelate and two terminal chlorides. Meanwhile, Cu2 center is 
coordinated by a triazolyl (N4)-thiopyridyl chelate and two terminal chlorides. 
Moreover, weak intramolecular interactions between Cl3 and Cu1 (Cu1⋅⋅⋅Cl3, 
2.91 Å), Cl1 and Cu2 (Cu2⋅⋅⋅Cl1, 2.74 Å) are existed. There exist 
intermolecular π⋅⋅⋅π stacking interactions between two parallel 2-pyridyl 
groups (displacement angle290 1.5°, centroid-centroid distance290 3.57 Å and 
plane-plane distance 3.56 Å) of neighboring dinuclear moieties, which help to 
construct the dimer strucure (Fig 6.6b). Weak intermolecular interactions 






Fig 6.5 (a) Dinuclear structure of 20. Cu1⋅⋅⋅Cu1A, 4.44 Å. (Cu1‒N1 2.035(3), 
Cu1–Cl2 2.235(1), Cu1–Cl1 2.255(1), Cu1–N2A 2.013(3), Cu1–N3 2.582(3); 
N1–Cu1–Cl2 89.26(9), Cl2–Cu1–Cl1 153.03(6), N1‒Cu1–Cl1 89.83(9), 
N2A–Cu1–Cl1 91.8(1), N2A–Cu1–N1 174.5(1), N2A‒Cu1‒Cl2 91.6(1), N3–
Cu1–N1 89.5(1), N3–Cu1–Cl1 103.0(1), N3–Cu1–Cl2 104.0(1), N3–Cu1–
N2A 84.9(1), N2‒N3–Cu1 128.0(2), N3–N2–Cu1A 119.8(2)) (b) Homochiral 







Fig 6.6 (a) Dinuclear structure of 21. Cu1⋅⋅⋅Cu2, 3.45 Å; Cu1⋅⋅⋅Cu1A, 3.79 Å. 
(Dichloromethane molecules are omitted by clarity.) (Cu1‒N3 2.041(3), 
Cu1‒N1 2.054(3), Cu1‒Cl2 2.2639(9), Cu1‒Cl1 2.3085(10), Cu2‒N5 
2.025(3), Cu2‒N4 2.085(3), Cu2‒Cl4 2.2333(12), Cu2‒Cl3 2.2644(12); 
N3‒Cu1‒N1 85.03(13), N3‒Cu1‒Cl2 177.19(10), N1‒Cu1‒Cl2 95.03(9), 
N3‒Cu1‒Cl1 86.27(10), N1‒Cu1‒Cl1 170.37(10), Cl2‒Cu1‒Cl1 93.46(4), 
N5‒Cu2‒N4 88.90(12), N5‒Cu2‒Cl4 88.17(10), N4‒Cu2‒Cl4 171.49(9), 
N5‒Cu2‒Cl3 172.22(10), N4‒Cu2‒Cl3 87.50(10), Cl4‒Cu2‒Cl3 94.41(5)) (b) 
π⋅⋅⋅π stacking interactions in 21. 







Fig 6.7 (a) Dinuclear structure of 22. Cu1⋅⋅⋅Cu1A, 4.42 Å. (Cu1‒N1 1.996(3), 
Cu1‒N4A 2.020(3), Cu1‒Cl2 2.2605(9), Cu1‒Cl1 2.2872(9), Cu1‒N2A 2.544, 
Cu1‒O1 2.676; N1‒Cu1‒N4A 176.32(10), N1‒Cu1‒Cl2 90.78(8), 
N1‒Cu1‒N2A 85.30, N1‒Cu1‒O1 71.39, N1‒Cu1‒Cl1 92.56(8), 
N4A‒Cu1‒Cl2 89.94(7), N4A‒Cu1‒Cl1 88.11(7), N4A‒Cu1‒N2A 91.02, 
N4A‒Cu1‒O1 112.29, Cl2‒Cu1‒N2A 103.59, Cl2‒Cu1‒O1 82.06, 
Cl2‒Cu1‒Cl1 158.12(4), Cl1‒Cu1‒N2A 98.23, Cl1‒Cu1‒O1 78.56, 
N2A‒Cu1‒O1 156.19) (b) Intermolecular hydrogen bonding interactions in 22. 
 
Complex 22 crystallizes in the monoclinic space group C2/c. The asymmetric 
unit contains half a complex of C18H16N8O2Cu2Cl4. And OH group of ligand is 
disordered into two positions with occupancy ratio equalling 50:50. It shows a 
dinuclear structure in which two bis-chelating ligands L14 bridge two Cu(II) 
centers (Fig 6.7a). Different from the former complex 21, there is only one 
kind of copper center in 22, which is six coordinated and shows distorted 
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octahedral coordinating geometries. The square base consists of two trans 
nitrogen atoms (N4A from pyridyl group and N1 from trizolyl group) of 
different L14 ligands, and two trans orientated chlorides. The axial positions 
are occupied by the triazole nitrogen atom (N2A) with a long Cu−N bond 
length (2.54 Å) and hydroxyl oxygen atom (O1) with a long Cu‒O bond 
length (2.68 Å). The 1D supermolecular chain is constructed by intermolecular 
hydrogen bonding interactions between coordinated chlorides and neighboring 
OH groups (∠OHCl 154°, O⋅⋅⋅Cl 3.29 Å, H⋅⋅⋅Cl 2.52 Å) (Fig 6.7b). 
Complex 23 crystallizes in a monoclinic space group P21/n. The asymmetric 
unit contains half a cation C20H28N10O10Ni2, one nitrate anion and one 
methanol molecule. The methanol bonded to Ni(II) center is disordered into 
two positions with 75:25 occupancy ratio. It also shows a dinuclear structure 
in which two bis-chelating ligand L14 bridge two Ni(II) centers (Fig 6.8a). 
Both Ni(II) centers are in the same coordination environments and each one is 
six coordinated and show distorted octahedral coordinating geometries. The 
Ni(II) center is completed by one trizolyl-hydroxyl chelate and one pyridyl-
triazolyl chelate from two different ligands in the square plane, and one nitrate 
anion, one methanol molecule in the axial positions. In addition, every 
molecule is connected with neighbouring four units by three kinds of 
hydrogen bonding interactions (between coordinated and free methanol 
molecules in the lattice, ∠OHO 173°, O⋅⋅⋅O 2.57 Å, H⋅⋅⋅O 1.71 Å; between 
free methanol molecule and free nitrate anion in the lattice, ∠OHO 161°, 
O⋅⋅⋅O 2.79 Å, H⋅⋅⋅O 1.99 Å; between OH group of ligand and free nitrate anion 
in the lattice, ∠OHO 168°, O⋅⋅⋅O 2.63 Å, H⋅⋅⋅O 1.75 Å), which help to further 




Fig 6.8 (a) Molecular structure of 23 (free methanol molecules and nitrate 
anions are omitted for clarity). Ni⋅⋅⋅Ni, 4.04 Å. (Ni1‒O5 2.079(5), Ni1‒N1A 
2.051(2), Ni1‒O2 2.0584(19), Ni1‒N2 2.059(2), Ni1‒O1A 2.080(2), Ni1‒N4 
2.082(2); N1A‒Ni1‒O2 102.33(8), N1A‒Ni1‒N2 96.35(8), O2‒Ni1‒N2 
87.60(8), N1A‒Ni1‒O5 85.3(4), O2‒Ni1‒O5 172.0(3), N2‒Ni1‒O5 89.1(6), 
N1A‒Ni1‒O1A 79.00(8), O2‒Ni1‒O1A 93.24(8), N2‒Ni1‒O1A 175.35(7), 
O5‒Ni1‒O1A 90.6(6), N1A‒Ni1‒N4 168.09(8), O2‒Ni1‒N4 88.68(8), 
N2‒Ni1‒N4 88.56(8), O5‒Ni1‒N4 83.9(5), O1A‒Ni1‒N4 96.03(8)) (b) 
Intermolecular hydrogen bonding interactions in 23. (c) A segment of 2D 




Complex 24 crystallizes in a triclinic space group P-1. The asymmetric unit 
contains half a cation C18H20N8O2Ni2⋅(H2O)4, two chlorides and one free water. 
It shows a similar dinuclear structure to complex 23, the Ni(II) center is also 
completed by one trizolyl-hydroxyl chelate and one pyridyl-triazolyl chelate in 
the square plane (Fig. 6.9a). Differently, in the axial positions, there are two 
hydrates instead. In the lattice, six kinds of OH⋅⋅⋅Cl (between chloride and 
coordinated water molecule, ∠OHCl 173°, O⋅⋅⋅Cl 3.07 Å, H⋅⋅⋅Cl 2.24 Å, 
∠OHCl 173°, O⋅⋅⋅Cl 3.09 Å, H⋅⋅⋅Cl 2.23 Å, ∠OHCl 170°, O⋅⋅⋅Cl 3.09 Å, 
H⋅⋅⋅Cl 2.25 Å, ∠OHCl 168°, O⋅⋅⋅Cl 3.08 Å, H⋅⋅⋅Cl 2.26 Å; between chloride 
and free water molecule, ∠OHCl 163°, O⋅⋅⋅Cl 3.11 Å, H⋅⋅⋅Cl 2.30 Å, ∠OHCl 
146°, O⋅⋅⋅Cl 3.11 Å, H⋅⋅⋅Cl 2.39 Å) and one kind of OH⋅⋅⋅O (between OH 
group of ligand and free water molecule, ∠OHO 171°, O⋅⋅⋅O 2.57 Å, H⋅⋅⋅O 






Fig 6.9 (a) Molecular structure of 24 (water molecules and chlorides in the 
lattice are omitted for clarity). Ni⋅⋅⋅Ni, 4.06 Å. (Ni1‒O1W 2.0576(13), 
Ni1‒O2W 2.0620(13), Ni1‒N3 2.0664(15), Ni1‒N1 2.0692(15), Ni1‒N4A 
2.0721(15), Ni1‒O1A 2.0850(13); O1W‒Ni1‒O2W 176.86(5), O1W‒Ni1‒N3 
90.12(6), O2W‒Ni1‒N3 90.55(6), O1W‒Ni1‒N1 90.19(6), O2W‒Ni1‒N1 
86.74(6), N3‒Ni1‒N1 90.08(6), O1W‒Ni1‒N4A 95.34(6), O2W‒Ni1‒N4A 
87.66(6), N3‒Ni1‒N4A 95.32(6), N1‒Ni1‒N4A 172.25(6), O1W‒Ni1‒O1A 
88.42(5), O2W‒Ni1‒O1A 91.30(5), N3‒Ni1‒O1A 172.53(5), N1‒Ni1‒O1A 
97.24(5), N4A‒Ni1‒O1A 77.53(5)) (b) Intermolecular hydrogen bonding 




Complex 25 crystallizes in a triclinic space group P-1. The asymmetric unit 
contains half a cation of C20H28N8O4Co and one anion ClO4. The C atom of 
the methanol and three O atoms of the perchlorate anion were disordered into 
two positions with 71:29 and 61:39 occupancy ratios, respectively. H atoms of 
the methanol and CO group were located from different map and refined with 
restraints in bond lengths and thermal parameters. The Co(II) center in this 
mononuclear structure is octahedral geometry which is completed by two 
triazolyl-hydroxyl chelates and two methanol molecules (Fig 6.10a). There are 
intermolecular O−H⋅⋅⋅N hydrogen bonding interactions (∠OHN 171°, O⋅⋅⋅N 
2.64 Å, H⋅⋅⋅N 1.80 Å) in the lattice between hydroxyl groups and 
uncoordinated N1 of 2-pyridyl groups which help to construct the 1D network 
(Fig 6.10b). The perchlorate anions also interact with coordinated methanol by 











Fig 6.10 (a) Molecular structure of 25 (Perchlorates are omitted for clarity). 
Co⋅⋅⋅Co, 9.68 Å. (Co1‒O1 2.0576(17), Co1 ‒O1A 2.0576(17), Co1‒N4 
2.0829(19), Co1‒N4A 2.0829(19), Co1‒O2 2.1063(19), Co1‒O2A 2.1063(19); 
O1‒Co1‒O1A 180.0, O1‒Co1‒N4 77.43(7), O1A‒Co1‒N4 102.57(7), 
O1‒Co1‒N4A 102.57(7), O1A‒Co1‒N4A 77.43(7), N4‒Co1‒N4A 180.00(9), 
O1‒Co1‒O2 90.19(8), O1A‒Co1‒O2 89.81(8), N4‒Co1‒O2 89.74(8), 
N4A‒Co1‒O2 90.26(8), O1‒Co1‒O2A 89.81(8), O1A‒Co1‒O2A 90.19(8), 
N4‒Co1‒O2A 90.26(8), N4A‒Co1‒O2A 89.74(8), O2‒Co1‒O2A 180.00(10)) 
(b) Intermolecular hydrogen bonding interactions in 25. 
 
Complex 26 crystallizes in a monoclinic space group P21/n, which is 
isostructural with Ni(II) complex 23 (Fig 6.11a). Moreover, similar 2-D layers 
are also constructed with the help of three kinds of hydrogen bonding 
interactions (between coordinated and free methanol molecules in the lattice, 
∠OHO 174°, O⋅⋅⋅O 2.56 Å, H⋅⋅⋅O 1.75 Å; between free methanol molecule 
and free nitrate anion in the lattice, ∠OHO 162°, O⋅⋅⋅O 2.80 Å, H⋅⋅⋅O 2.11 Å; 
between OH group of ligand and free nitrate anion in the lattice, ∠OHO 165°, 





Fig 6.11 (a) Molecular structure of 26 (methanol molecules and nitrate anions 
are omitted for clarity). Co⋅⋅⋅Co, 4.07 Å. (Co1‒O2 2.0698(12), Co1‒O8 
2.0785(13), Co1‒N4A 2.1038(13), Co1‒O1A 2.1117(12), Co1‒N2 2.1158(14), 
Co1‒N1 2.1444(14); O2‒Co1‒O8 171.27(5), O2‒Co1‒N4A 102.43(5), 
O8‒Co1‒N4A 85.87(5), O2‒Co1‒O1A 94.01(5), O8‒Co1‒O1A 90.44(5), 
N4A‒Co1‒O1A 77.32(5), O2‒Co1‒N2 87.10(5), O8‒Co1‒N2 89.10(5), 
N4A‒Co1‒N2 97.84(5), O1A‒Co1‒N2 175.16(5), O2‒Co1‒N1 89.03(5), 
O8‒Co1‒N1 82.87(5), N4A‒Co1‒N1 167.99(5), O1A‒Co1‒N1 98.55(5), 
N2‒Co1‒N1 86.18(5)) (b) Intermolecular hydrogen bonding interactions in 26. 




Complex 27 crystallizes in a monoclinic space group P-1. The asymmetric 
unit contains two half of the complex C20H28N8O4Co2Cl2, one 
tetrachlorocobaltate anion and one water solvent. H atoms attached to O atoms 
of all methanol groups and water were located from different map. One Cl 
atom of the tetracholorocobaltate complex was disordered into two positions 
with 63:37 occupancy ratio. It's also a dinuclear structure and each Co(II) 
centre is distorted octahedral geometry which is coordinated by one triazolyl-
hydroxyl chelate, one triazolyl-pyridyl chelate, one coordinated methanol 
molecule and one chloride (Fig 6.12a). In every asymmetric unit, there exist 
two complex molecules, in which one is linked with two CoCl4 anions 
(∠OHCl 176°, O⋅⋅⋅Cl 3.09 Å, H⋅⋅⋅Cl  2.37 Å) and the other is linked with two 
water molecules (∠OHO 165°, O⋅⋅⋅O 2.71 Å, H⋅⋅⋅O 2.00 Å) by hydrogen 
bonding interactions (Fig 6.12b). There are two kinds of intermolecular 
O−H⋅⋅⋅Cl hydrogen bonding interactions (∠OHCl 158°, O⋅⋅⋅Cl 3.09 Å, H⋅⋅⋅Cl 
2.29 Å; ∠OHCl 176°, O⋅⋅⋅Cl 3.00 Å, H⋅⋅⋅Cl 2.17 Å) in the lattice between 
hydroxyl groups and coordinated chlorides which help to construct the 1D 




Fig 6.12 (a) Molecular structure of 27 (water molecules and CoCl4 anions are 
omitted for clarity). Co⋅⋅⋅Co, 4.08 Å and 4.04 Å. (Co1‒N2 2.0920(18), 
Co1‒N4A 2.1256(17), Co1‒N1 2.1266(18), Co1‒O1S 2.1301(17), Co1‒O1A 
2.1387(15), Co1‒Cl1 2.3839(7), Co2‒N8A 2.0837(17), Co2‒N6 2.0841(18), 
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Co2‒O2S 2.1082(18), Co2‒N5 2.1208(18), Co2‒O2A 2.1587(16), Co2‒Cl2 
2.4106(7), Co3‒Cl6 2.279(4), Co3‒Cl5 2.2798(6), Co3‒Cl3 2.2806(6), 
Co3‒Cl4 2.2944(6); N2‒Co1‒N4A 98.03(7), N2‒Co1‒N1 86.37(7), 
N4A‒Co1‒N1 166.11(7), N2‒Co1‒O1S 91.79(7), N4A‒Co1‒O1S 82.05(7), 
N1‒Co1‒O1S 84.66(7), N2‒Co1‒O1A 174.15(6), N4A‒Co1‒O1A 76.13(6), 
N1‒Co1‒O1A 99.20(6), O1S‒Co1‒O1A 86.97(6), N2‒Co1‒Cl1 91.43(5), 
N4A‒Co1‒Cl1 98.79(5), N1‒Co1‒Cl1 94.24(5), O1S‒Co1‒Cl1 176.52(5), 
O1A‒Co1‒Cl1 89.95(5), N8A‒Co2‒N6 97.66(7), N8A‒Co2‒O2S 84.89(7), 
N6‒Co2‒O2S 91.23(7), N8A‒Co2‒N5 170.09(7), N6‒Co2‒N5 87.19(7), 
O2S‒Co2‒N5 86.37(7), N8A‒Co2‒O2A 75.97(6), N6‒Co2‒O2A 173.15(6), 
O2S‒Co2‒O2A 85.72(7), N5‒Co2‒O2A 98.72(6), N8A‒Co2‒Cl2 96.49(5), 
N6‒Co2‒Cl2 92.55(5), O2S‒Co2‒Cl2 175.77(5), N5‒Co2‒Cl2 91.90(5), 
O2A‒Co2‒Cl2 90.73(5), Cl6‒Co3‒Cl5 114.0(2), Cl6‒Co3‒Cl3 110.06(19), 
Cl5‒Co3‒Cl3 110.52(2), Cl6‒Co3‒Cl4 108.2(4), Cl5‒Co3‒Cl4 105.65(2), 
Cl3‒Co3‒Cl4 108.17(2)) (b) Asymmetric unit of 27. (c) Intermolecular 
hydrogen bonding interactions in 27. 
 
Complex 28 crystallizes in a monoclinic space group P21/c. The asymmetric 
unit contains half a cation of [C9H10N4Fe(CH3OH)2]2, one methanol and two 
anions ClO4. One of the ClO4 was disordered with the four O atoms occupied 
two positions. The occupancy ratio is 60:40. The other ClO4 and C atom of 
one of the methanol molecules were disordered into two positions with 
occupancy ratio of 46:44. With the same ligand L14, it also shows the similar 
dinuclear structure to complex 23, in which distorted octahedral Fe(II) centers 
are also completed by one trizolyl-hydroxyl chelate and one pyridyl-triazolyl 
chelate in the square plane. Differently, in the axial positions, both are 
methanol molecules instead (Fig 6.13a). In addition, every molecule is also 
connected with neighbouring four units by three kinds of hydrogen bonding 
interactions (between hydroxyl group of ligand and free methanol molecule in 
the lattice, ∠OHO 167°, O⋅⋅⋅O 2.60 Å, H⋅⋅⋅O 1.77 Å; between free methanol 
molecule and free perchlorate anion in the lattice, ∠OHO 162°, O⋅⋅⋅O 2.99 Å, 
H⋅⋅⋅O 2.18 Å; between coordinated methanol molecule and free perchlorate 
anion in the lattice, ∠OHO 173°, O⋅⋅⋅O 2.65 Å, H⋅⋅⋅O 1.81 Å), which help to 
form 2D layers. (Fig 6.13b & c) The perchlorate anions also interact with 
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coordinated methanol by hydrogen bonding interactions (∠OHO 179°, O⋅⋅⋅O 
2.73 Å, H⋅⋅⋅O 1.87 Å). 
 
Fig 6.13 (a) Molecular structure of 28 (perchlorate anions are omitted for 
clarity). Fe⋅⋅⋅Fe, 4.16 Å. (Fe1‒O2 2.072(4), Fe1‒O3 2.090(4), Fe1‒O1A 
2.143(4), Fe1‒N3 2.146(4), Fe1‒N4A 2.160(4), Fe1‒N1 2.187(5); 
O2‒Fe1‒O3 177.23(18), O2‒Fe1‒O1A 87.69(17), O3‒Fe1‒O1A 90.94(17), 
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O2‒Fe1‒N3 89.52(16), O3‒Fe1‒N3 92.19(17), O1A‒Fe1‒N3 170.87(16), 
O2‒Fe1‒N4A 94.95(17), O3‒Fe1‒N4A 87.04(17), O1A‒Fe1‒N4A 75.30(16), 
N3‒Fe1‒N4A 96.30(16), O2‒Fe1‒N1 92.56(18), O3‒Fe1‒N1 85.37(18), 
O1A‒Fe1‒N1 102.24(17), N3‒Fe1‒N1 86.57(17), N4A‒Fe1‒N1 171.98(17)) 
(b) Intermolecular hydrogen bonding interactions in 28. (c) A segment of 2D 
crystal packing in 28. 
 
Complex 29 was afforded by dissolving the complex 28 in DMF. During this 
procedure, strong coordinated dimethylformamide solvent molecules would 
coordinate to Fe(II) center and destroy the former dinuclear structure to 
mononuclear structure. Complex 29 crystallizes in a triclinic space group P-1 
by diffusion ether to its DMF solution (Fig 6.14a). The asymmetric unit 
contains half a cation of C24H34N10O4Fe and one anion ClO4. H atom of O1 
was located from different map and refined with restraints in bond length. The 
Fe(II) center is slightly distorted octahedral geometry which is completed by 
two triazolyl-hydroxyl chelates and two dimethylformamide molecules. There 
are intermolecular O−H⋅⋅⋅N hydrogen bonding interactions (∠OHN 176°, 
O⋅⋅⋅N 2.63 Å, H⋅⋅⋅N 1.77 Å) in the lattice between hydroxyl groups and 
neighbouring uncoordinated N4 in 2-pyridyl groups which help to construct 
the 1-D chain. In addition, π⋅⋅⋅ π stacking interactions (displacement angle290 
1.5°, centroid-centroid distance290 3.74 Å and plane-plane distance 3.73 Å) 






Fig 6.14 (a) Molecular structure of 29 (perchlorate anions are omitted for 
clarity). Fe⋅⋅⋅Fe, 9.38 Å. (Fe1‒O2A 2.0845(11), Fe1‒O2 2.0845(11), 
Fe1‒O1A 2.1271(11), Fe1‒O1 2.1271(11), Fe1‒N1 2.1689(13), Fe1‒N1A 
2.1689(13); O2A‒Fe1‒O2 180.0, O2A‒Fe1‒O1A 90.52(4), O2‒Fe1‒O1A 
89.48(4), O2A‒Fe1‒O1 89.48(4), O2‒Fe1‒O1 90.52(4), O1A‒Fe1‒O1 180.0, 
O2A‒Fe1‒N1 86.51(5), O2‒Fe1‒N1 93.49(5), O1A‒Fe1‒N1 104.01(5), 
O1‒Fe1‒N1 75.99(5), O2A‒Fe1‒N1A 93.49(5), O2‒Fe1‒N1A 86.51(5), 
O1A‒Fe1‒N1A 75.99(5), O1‒Fe1‒N1A 104.01(5), N1‒Fe1‒N1A 180.00(5)) 
(b) Intermolecular hydrogen bonding and π⋅⋅⋅ π stacking interactions in 29. 
 
Complex 30 crystallizes in a triclinic space group P-1, which is isostructural 
with Co(II) complex 25. The asymmetric unit contains half a cation of 
(C9H10N4O)2Mn(CH3OH)2 and one anion ClO4. The O and C atoms of the 
methanol are disordered into two positions with 54:46 and 81:19 occupancy 
ratios, respectively. Restraints were applied to the disordered atoms. The 
Mn(II) center in this mononuclear structure is also octahedral geometry which 
is completed by two triazolyl-hydroxyl chelates and two methanol molecules. 
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(Fig 6.15a) There are intermolecular O−H⋅⋅⋅N hydrogen bonding interactions 
(∠OHN 170°, O⋅⋅⋅N 2.65 Å, H⋅⋅⋅N 1.82 Å) in the lattice between hydroxyl 
groups and uncoordinated N1 of 2-pyridyl groups which help to construct the 
1D network. Meanwhile, perchlorate anions interact with coordinated 
methanol by hydrogen bonding interactions (∠OHO 148°, O⋅⋅⋅O 2.78 Å, H⋅⋅⋅O 
2.05 Å). (Fig 6.15b) 
 
 
Fig 6.15 (a) Molecular structure of 30. Mn⋅⋅⋅Mn, 9.73 Å. (Mn1‒O1 2.1502(19), 
Mn1‒O1A 2.1502(19), Mn1‒N4 2.204(2), Mn1‒N4A 2.204(2), Mn1‒O2 
2.212(2), Mn1‒O2A 2.212(2); O1‒Mn1‒O1A 180.000(1), O1‒Mn1‒N4 
73.98(8), O1A‒Mn1‒N4 106.02(8), O1‒Mn1‒N4A 106.02(8), 
O1A‒Mn1‒N4A 73.98(8), N4‒Mn1‒N4A 180.000(1), O1‒Mn1‒O2 90.48(8), 
O1A‒Mn1‒O2 89.52(8), N4‒Mn1‒O2 89.83(9), N4A‒Mn1‒O2 90.17(9), 
O1‒Mn1‒O2A 89.52(8), O1A‒Mn1‒O2A 90.48(8), N4‒Mn1‒O2A 90.17(9), 
N4A‒Mn1‒O2A 89.83(9), O2‒Mn1‒O2A 180.0) (b) Intermolecular hydrogen 





6.2.4 Magnetic property of complexes 
For Cu(II) complex 20, solid X-band EPR spectrum at 298 K displays 
anisotropic EPR g-values (g1 = 2.24, g2 = 2.10 and g3 = 2.04) (Fig 6.16), 
which is consistent with the tetragonally distorted Cu(II).361,362,363  
 
Fig 6.16 EPR spectrum of complex 20 with frequency at 9.7773 GHz. 
 
Magnetic susceptibility of complex 20 was measured at 1 kOe applied field 
between 2−300 K (Fig. 6.17a). The temperature dependence of χM−1 obeys the 
Curie-Weiss law with a positive Weiss constant (θ = 0.95 K). The r.t. χMT 
value is ca. 0.43 emu K mol−1 per Cu(II) ion, slightly higher than the spin-only 
value (0.375 emu K mol−1) for an uncoupled S = 1/2 spin. Upon cooling, χMT 
remains constant to about 14 K, then increases smoothly to ca. 0.48 emu K 
mol−1 at 2 K. These may indicate a weak intradimer ferromagnetic interaction. 
The magnetic behavior of 20 was analyzed by the well-known Bleaney-
Bowers equation364 based on Hamiltonian Η = −JS1⋅S2: 
χM = (Nβ2g2/kT)[3 + exp(−J/kT)]−1  
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The least squares fit of the experimental data above 2 K to the above 
expression led to J = 0.91 cm−1 and g = 2.17. Field-dependent magnetization at 
2 K was also measured between 0−5 T (Fig. 6.17b). The magnetization at 5 T 
is 1.05 Nβ, it reached the theoretic value predicted by the Brillouin equation 
with S = 1/2 for non-interacting entities in a lattice.365 
 
 
Fig 6.17 (a) χM–1 and χMT versus T plot of 20. (The solid lines were plotted 
according to the fit parameters given in the text) (b) Field dependence of 
magnetization of 20. 
 
The magnetic properties of other four dinuclear Ni(II) and Co(II) complexes 
(23, 24, 26 and 27) have also been preliminarily investigated. Magnetic 
susceptibility of these complexes were measured at 2 kOe applied field 
between 4−300 K (Fig. 6.18a‒6.21a) Field-dependent magnetization at 4 K 
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was also measured between 0−7 T (Fig. 6.18b‒6.21b) The results indicate 
antiferromagnetic properties of these four dinuclear complexes, meanwhile, 
for two Co(II) complexes 26 and 27, the non-linear curve fitting of the 
experimental data above 4K lead to J = -3.14 cm−1 (R2 = 0.991) and J = -2.85 
cm−1 (R2 = 0.987), respectively. 
 
Fig 6.18 (a) χM–1 and χMT versus T plot of 23. (b) Field dependence of 
magnetization of 23. 
 
 
Fig 6.19 (a) χM–1 and χMT versus T plot of 24. (b) Field dependence of 





Fig 6.20 (a) χM–1 and χMT versus T plot of 26. (The red line was plotted 
according to the fit parameters given in the text) (b) Field dependence of 
magnetization of 26.  
 
 
Fig 6.21 (a) χM–1 and χMT versus T plot of 27. (The red line was plotted 
according to the fit parameters given in the text) (b) Field dependence of 
magnetization of 27. 
 
6.3 Conclusion 
In this chapter, a novel dinuclear Cu(II) complex with ligand 1-(2-picolyl)-4-
hexyl-1H-1,2,3-triazole (L15) shows a chelate-bridging mode. It represents a 
rare example of azole bridged dinuclear Cu(II) complexes with weak 
ferromagnetic coupling. Meanwhile, a series of first transition metal 
complexes with 1-(2-picolyl)-4-(hydroxymethyl)-1H-1,2,3-triazole (L14) 
indicates chelate/double chelate coordination modes, which influenced by 
geometry of metal centers and anions. Among them, magnetic property of 
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dinuclear Ni(II) and Co(II) complexes (23, 24, 26 and 27) have been 
investigated and they all illustrate antiferromagnetic couplings. The 
establishment of magneto-structural relationship and understanding of 
magnetic exchange mechanism through hybridised 1,2,3-triazoles still need 
further investigation, which is our next target. 
 
6.4 Experimental section 
The synthesis of precursors and ligands have been presented in chapter 1.  
Synthesis of Cu(II) complexes 
Complex 20 
The CH3OH solution (5 mL) of CuCl2·2H2O (34 mg, 0.2 mmol) was added 
into the CH3OH solution (5 mL) of L15 (49 mg, 0.2 mmol) under stirring. 
Slow evaporation the result solution afforded blue crystals of 20 after about 
one week. Yield: 45 mg, 60 %. Anal. Calcd. for C28H40Cl4Cu2N8 (757.56): C, 
44.39; H, 5.32; N, 14.79. Found: C, 44.31; H, 5.28; N, 14.83 %. Main IR 
(cm−1): 3125m, 3074m, 2927s, 2859m, 1607m, 1547m, 1449m, 1342m, 
1310m, 1230m, 1157m, 1064m, 1024m, 828m, 772s, 672m. ESI-MS (m/z, %):  
[CuCl(L1)]+ (342, 10), [CuCl(L1)2]
+ (586, 100). 
Complex 21 & 22 
The ethanol solution (5 mL) of CuCl2·2H2O (2 and 1 equiv. respectively) was 
added into the ethanol solution (5 mL) of ligand L2 or L14 (0.2 mmol) under 
stirring. The reaction mixtures were stirred at room temperature in the air 
overnight. The suspensions were filtrated under vacuum, and washed by 
ethanol and ether. The solid obtained were collected and dried under vacuum. 
Diffusion of ether or dichloromethane to their dimethylfomamide solutions at 
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room temperature afforded crystals after around one week. For complex 21, 
Yield: 88 mg, 80 %. Anal. Calcd. for C14H13Cl4Cu2N5S (552.26): C, 30.45; H, 
2.37; N, 12.68; S, 5.81. Found: C, 30.40; H, 2.46; N, 12.43; S, 5.98 %. IR/cm-1: 
3457m, 3116m, 3077w, 3032w, 2923m, 2362m, 2337m, 1609m, 1580m, 
1531m, 1482m, 1449s, 1428s, 1378w, 1306m, 1273m, 1228m, 1182m, 1160m, 
1090w, 1049m, 1025m, 889m, 827m, 773s, 725m, 679m, 641m, 507w, 478w, 
428m. ESI-MS (m/z, %): [CuCl(L2)]+ (380.9, 50), [CuCl(L2)2]
+ (663.9, 100), 
[Cu2Cl3(L2)]
+ (517.7, 14), [Cu2Cl3(L2)2]
+ (798.7, 25). For complex 22, Yield: 
46 mg, 70 %. Anal. Calcd. for C18H20Cl4Cu2N8O2 (649.31): C, 33.30; H, 3.10; 
N, 17.26. Found: C, 33.71; H, 3.08; N, 17.45 %. IR/cm-1: 3408m, 3207m, 
2925w, 2360m, 2339m, 1603s, 1570m, 1482m, 1436s, 1412s, 1307s, 1267m, 
1233m, 1147s, 1604s, 1031s, 974w, 933w, 887w, 834w, 793m, 765s, 661s, 
604w, 478w, 437m. ESI-MS (m/z, %):  [CuCl(L14)]+ (288.0, 34), 
[CuCl(L14)(DMF)]+ (362.0, 12), [Cu(L14)(L14‒H)-]+ (442.0,100), 
[Cu2Cl2(L14)(L14‒H)
-]+ (576.8, 21), [Cu2Cl3(L14)2]
+ (613.7, 6), 
[Cu2Cl2(L14)2(L14‒H)
-]+ (766.8, 25). 
Synthesis of Ni (II) complexes 
Complex 23 & 24 
The methanol solution (5 mL) of Ni(NO3)2·6H2O or NiCl2·6H2O (0.2 mmol, 
58.2 mg or 47.5 mg) was added into the methanol solution (5 mL) of ligand 
L14 (0.2 mmol, 38.0 mg) under stirring. The reaction mixture was stirred at 
room temperature in the air overnight. The solution was concentrated under 
vacuum, the residue was added by ether slowly and the suspension was stirred 
overnight. The suspension was filtrated under vacuum. The solid obtained 
were collected and recrystallized by methanol and ether and dried under 
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vacuum. Evaporation of their methanol solution at room temperature afforded 
crystals after around one week. For complex 23, Yield: 62.9 mg, 72 %. Anal. 
Calcd. for C20H28N12Ni2O16 (809.90): C, 29.66; H, 3.48; N, 20.75. Found: C, 
26.91; H, 3.39; N, 20.52 %. ESI-MS (m/z, %):  [H(L14)]+ (191.0, 9), 
[Na(L14)]+ (213.0, 9), [Ni(NO3)(L14)]
+ (310.0, 48), [Ni(L14‒H)(L14)]+ 
(437.1, 38), [Ni(NO3)(L14)2]
+ (500.1, 100), [Ni2(NO3)3(L14)2]
+ (682.0, 10), 
[Ni2(NO3)3(L14)2(CH3OH)4]
+ (811.0, 5). IR/cm-1: 3950w, 3499m, 2452w, 
2398w, 2359w, 2068w, 2019w, 1924w, 1871w, 1831w, 1766m, 1677m, 
1612w, 1560w, 1494w, 1198w, 1147m, 1109w, 1060m, 1003w, 953w, 912w, 
864w, 833w, 775w, 713w, 611w, 502w, 465w and 429w. For complex 24, 
Yield: 50.8 mg, 68 %. Anal. Calcd. for C18H32Cl4N8Ni2O8 (747.74): C, 28.91; 
H, 4.31; N, 14.99. Found: C, 28.63; H, 4.46; N, 14.70 %. ESI-MS (m/z, %):  
[H(L14)]+ (191.1, 12), [Na(L14)]+ (213.0, 13), [Ni(L14‒H)]+ (247.0, 7), 
[NiCl(L14)]+ (283.0, 48), [Ni2Cl3(L14)]
+ (412.8, 18), [Ni(L14‒H)(L14)]+ 
(437.1, 100), [NiCl(L14)2]
+ (473.0, 88), [Ni2Cl3(L14)2]
+ (602.9, 24), 
[NiCl(L14)3]
+ (665.1, 18), [Ni2Cl3(L14)3]
+ (792.9, 14). IR/cm-1: 3950w, 
3468m, 2850w, 2688w, 2622w, 2110w, 2026w, 1919w, 1882w, 1638w, 
1611w, 1574m, 1493m, 1454m, 1399w, 1367m, 1335m, 1299m, 1279m, 
1234w, 1203m, 1169w, 1144m, 1116m, 1097m, 1068m, 1022m, 936w, 905w, 
848m, 817m, 780w, 715w, 659w, 513w, 467w and 430m. 
Synthesis of Co (II) complexes 
Complex 25 & 26 & 27 
The methanol solution (5 mL) of Co(ClO4)2·6H2O (0.1 mmol, 36.6 mg) was 
added into the methanol solution (5 mL) of ligand L14 (0.2 mmol, 38.0 mg) 
under stirring. The reaction mixture was stirred at room temperature in the air 
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overnight. The solution was concentrated under vacuum, the residue was 
added by ether slowly and the suspension was stirred overnight. The 
suspension was filtrated under vacuum to get complex 25. The solid obtained 
were collected and recrystallized by methanol and ether and dried under 
vacuum. Diffusion of ether to their methanol solutions at room temperature 
afforded crystals after around one week. Yield: 36 mg, 51 %. Anal. Calcd. for 
C20H28Cl2CoN8O12 (702.33): C, 34.20; H, 4.02; N, 15.95. Found: C, 31.83; H, 
3.12; N, 16.36 %. ESI-MS (m/z, %): [H(L14)]+ (191.1, 7), [Co(L14‒H)]+ 
(247.9, 6), [Co(ClO4)(L14)]
+ (347.9, 14), [Co(ClO4)(H2O)(L14)]
+ (366.0, 6), 
[Co(ClO4)(CH3OH)(L14)]
+ (380.0, 8), [Na(L14)2]
+ (403.1, 10), 
[Co(L14)(L14‒H)]+ (438.1, 38), [Co(ClO4)(L14)2]
+ (538.1, 100), 
[Co(ClO4)(L14)3]
+ (728.1, 10), [Co2(ClO4)3(L14)2]
+ (794.8, 12). IR/cm-1: 
3499m, 2709w, 2362w, 2008m, 1869w, 1603m, 1575m, 1489m, 1443m, 
1366m, 1307m, 1282m, 1232m, 1165m, 1000m, 932w, 896w, 818m, 766m, 
713w, 659w, 627m, 503m, 460w and 422w. In the case of Co(NO3)2·6H2O 
(0.2 mmol, 58.2 mg) as metal precursor, complex 26 was obtained. Yield: 58 
mg, 66 %. Anal. Calcd. for C20H28Co2N12O16 (810.37): C, 29.64; H, 3.48; N, 
20.74. Found: C, 26.72; H, 3.19; N, 20.60 %. ESI-MS (m/z, %): 
[Co(NO3)(L14)]
+ (311.0, 50), [Co(L14)3]
2+ (314.5, 5), [Co(L14)(L14‒H)]+ 
(438.1, 42), [Co(NO3)(L14)2]
+ (501.1, 100), [Co2(NO3)3(L14)2]
+ (684.0, 4), 
[Co2(NO3)3(CH3OH)2(L14)2]
+ (748.1, 4), [Co2(NO3)2(L14‒H)(L14)2]
+ (811.0, 
13). IR/cm-1: 3969w, 3504m, 2396w, 2345w, 2067w, 2021w, 1986w, 1919w, 
1874w, 1763m, 1642m, 1614m, 1577m, 1497m, 1149w, 1112w, 1096w, 
1043w, 1010m, 952m, 902w, 862w, 826w, 771w, 712w, 617w, 462w and 
425m. When CoCl2·6H2O (0.2 mmol, 47.6 mg) was used as a starting 
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compound, complex 27 was obtained. Yield: 42 mg, 74 %. Anal. Calcd. for 
C20H28Cl6Co3N8O4 (834.01): C, 28.80; H, 3.38; N, 13.44. Found: C, 22.63; H, 
3.24; N, 11.65 %. ESI-MS (m/z, %): [H(L14)]+ (191.1, 12), [CoCl(L14)]+ 
(283.9, 8.7), [Co(L14)(L14‒H)]+ (438.1, 7.3), [CoCl(L14)2]
+ (474.0, 18.5), 
[Co2Cl3(L14)2]
+ (604.9, 4.6); [CoCl3]
- (166.1, 100), [(L14‒H)]- (189.1, 3), 
[Co2Cl5]
- (295.1, 9), [Co3Cl7]
- (424.2, 5). IR/cm-1: 3482m, 2997w, 2852w, 
2702w, 2365w, 2125w, 2011w, 1919w, 1636w, 1609m, 1565w, 1489m, 
1434m, 1366w, 1319m, 1271m, 1231w, 1189m, 1146m, 1101m, 1061m, 
1022m, 948m, 902w, 836m, 810m, 763m, 714m, 644w, 611w, 557w, 493w, 
458w and 425m. 
Synthesis of Fe(II) complexes 
Complex 28 & 29 
The methanol solution (5 mL) of Fe(ClO4)2·6H2O (0.5 or 1 equiv. 
respectively) was added into the methanol solution (5 mL) of ligand L14 (0.2 
mmol, 38.0 mg) under stirring. The reaction mixture was stirred at room 
temperature under nitrogen overnight. The solution was concentrated under 
vacuum, the residue was added by ether slowly and the suspension was stirred 
overnight. The suspension was filtrated under vacuum. The solid obtained 
were collected and recrystallized by methanol and ether and dried under 
vacuum. Diffusion of ether to their methanol solutions at room temperature 
afforded crystals of 28 after around one week. However, diffusion of ether to 
DMF solution of 28 afforded 29. For complex 28, Yield: 56 mg, 52 %. Anal. 
Calcd. for C24H44Cl4Fe2N8O24 (1082.17): C, 26.64; H, 4.10; N, 10.35. Found: 
C, 34.30; H, 3.71; N, 15.96 %. ESI-MS (m/z, %): [H(L14)]+ (191.0, 4), 
[Fe(ClO4)( L14)]
+ (345.0, 9), [Na(L14)2]
+ (403.0, 3), [Fe(L14)( L14‒H)]+ 
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(435.1, 13), [Fe(ClO4)( L14)2]
+ (535.0, 100), [Fe2(ClO4)2(L14)( L14‒H)]
+ 
(688.9, 3), [Fe2(ClO4)3(L14)2]
+ (788.8, 9). IR/cm−1: 3447w, 2632w, 2368w, 
2058w, 2015w, 1655m, 1628m, 1553m, 1476m, 1429m, 1403m, 1377m, 
1327m, 1298m, 1263m, 1242m, 1144m, 1068m, 1035w, 991w, 941m, 887m, 
836m, 793m, 773m, 700m, 665m, 624m, 467m. 
Synthesis of Mn(II) complexes 
Complex 30 
The methanol solution (5 mL) of Mn(ClO4)2·4H2O (0.1 mmol, 32.6 mg) was 
added into the methanol solution (5 mL) of ligand L14 (0.2 mmol, 38.0 mg) 
under stirring. The reaction mixture was stirred at r.t. overnight. The solution 
was concentrated under vacuum, the residue was added by ether slowly and 
the suspension was stirred overnight. The suspension was filtrated under 
vacuum. The solid obtained were collected and recrystallized by methanol and 
ether and dried under vacuum. Diffusion of ether to their methanol solution at 
r.t. afforded crystals of 30 after around one week. Yield: 34 mg, 49 %. Anal. 
Calcd. for C20H28Cl2MnN8O12 (698.33): C, 34.40; H, 4.04; N, 16.05. ESI-MS 
(m/z, %):  [H(L14)]+ (191.1, 8), [Na(L14)]+ (213.0, 10), [Mn(L14)3]
2+ (312.6, 
32), [Mn(L14)4]
2+ (407.6, 16), [Mn(L14‒H)( L14)]+ (434.1, 26), [Mn(ClO4)( 
L14)2]
+ (534.0, 100), [Mn(ClO4)( L14)3]




Table 6.1 Crystallographic data and refinement parameters for complexes 
20−30. 
 
Complex 20 21 22 
Formula C28H40Cl4Cu2N8 C15.5H16Cl7Cu2N5S C18H16Cl4Cu2N8O2 
MW 757.56 679.62 645.27 





0.30 × 0.20 × 
0.06 
0.60 × 0.56 × 0.32 0.28 × 0.22 × 0.10 
Crystal 
system 
monoclinic Orthorhombic Monoclinic 
Space group C 2/c Fdd2 C 2/c 
a / Å 14.653(1) 19.7702(12) 15.114(3) 
b / Å 9.0041(6) 22.6130(15) 8.4523(16) 
c / Å 26.567(2) 21.6022(14) 18.533(4) 
α / ° 90 90 90 
β / ° 102.276(2) 90 91.025(3) 
γ / ° 90 90 90 
V / Å3 3425.0(4) 9657.6(11) 2367.2(8) 
Z 4 16 4 
Dcalc / 
g·cm−3 
1.469 1.870 1.811 
µ / mm−1 1.585 2.638 2.283 
θ range / ° 1.57−25.00 1.66−27.50 2.20−27.49 
Reflections 
collected 




3022 [Rint = 
0.0281] 
4744 [Rint = 
0.0324] 
2715 [Rint = 
0.0314] 
Parameters 191 276 174 
GOF 1.177 1.096 1.063 
R1(I > 
2σ(I)) 
0.0500 0.0342 0.0404 
wR2(I > 
2σ(I)) 
0.1219 0.0851 0.1071 
 










MW 874.05 747.74 702.33 874.49 
T / K 100(2) 100(2) 100(2) 100(2) 
Crystal 
size / mm3 
0.30 × 0.26 × 
0.20 
0.32 × 0.12 × 
0.10 
0.60 × 0.60 × 
0.38 




Monoclinic Triclinic Triclinic Monoclinic 
Space 
group 
P21/n P-1 P-1 P21/n 
a / Å 12.957(4) 7.9732(8) 8.4338(8) 13.0287(13) 
b / Å 8.179(3) 9.3427(9) 9.0720(8) 8.2201(8) 
c / Å 16.163(6) 10.0250(10) 11.0784(10) 16.1462(16) 
α / ° 90 84.1450(10) 92.0240(10) 90 
β / ° 101.194(6) 77.4440(10) 108.2040(10) 100.3020(10) 
γ / ° 90 88.3330(10) 113.0120(10) 90 
V / Å3 1680.4(10) 725.09(12) 729.01(12) 1701.3(3) 





1.727 1.712 1.600 1.707 
µ / mm−1 1.218 1.723 0.845 1.072 
θ range / ° 1.85−27.50 2.09−27.50 1.97−27.50 2.21−27.50 
Reflections 
collected 





3857 [0.0576] 3328 [0.0253] 3303 [0.0207] 3907 [0.0281] 
Parameters 261 202 242 258 
GOF 0.993 1.056 1.068 1.058 
R1(I > 
2σ(I)) 
0.0414 0.0268 0.0325 0.0305 
wR2(I > 
2σ(I)) 
0.0897 0.0666 0.0858 0.0744 
 









MW 852.01 1082.17 781.36 698.34 
T / K 100(2) 100(2) 100(2) 100(2) 
Crystal size / 
mm3 
0.30 × 0.22 × 
0.10 
0.60 × 0.24 × 
0.10 
0.44 × 0.30 × 
0.16 
0.24 × 0.10 × 
0.08 
Crystal system Triclinic Monoclinic Triclinic Triclinic 
Space group P-1 P21/c P-1 P-1 
a / Å 10.5078(12) 12.8555(13) 9.3562(8) 8.4003(12) 
b / Å 12.1247(14) 14.4415(16) 9.3843(8) 9.0964(13) 
c / Å 13.4512(15) 11.9680(12) 11.1558(9) 11.2970(16) 
α / ° 68.917(2) 90 106.5800(10) 92.533(2) 
β / ° 89.790(2) 111.520(2) 91.6710(10) 108.542(2) 
γ / ° 82.267(2) 90 118.7620(10) 112.568(2) 
V / Å3 1582.6(3) 2067.0(4) 806.63(12) 742.00(18) 
Z 2 2 1 1 
Dcalc / g·cm
−3 1.788 1.739 1.609 1.563 
µ / mm−1 2.106 1.058 0.710 0.697 
θ range / ° 2.48−27.48 1.70−27.50 1.94−27.50 1.94−27.50 
Reflections 
collected 




7243 [0.0313] 4755 [0.0371] 3719 [0.0229] 3390 [0.0454] 
Parameters 413 386 229 245 
GOF 1.058 1.042 1.095 1.106 
R1(I > 2σ(I)) 0.0307 0.0929 0.0306 0.0475 




Chapter 7 Novel Pt(II) Complexes with Functionalized 
1,2,3-Triazole Pincer Type Ligands: Structures, 
Luminescence and Catalytic Activities 
7.1 Introduction 
The spectroscopic and photophysical behaviors of d8 Pt(II) complexes with 
coordinate-unsaturation and square-planar geometry have attracted great 
attention in the past few decades.366-371 Through systematic variation of the 
ligands and co-ligands, photoluminescent emissions of Pt(II) complexes can 
be adjusted and high quantum yield has been achieved, hence, they have 
shown great potentials as good candidates for OLED.372-375 A range of 
functionalized ligands have been screened and investigated for Pt(II) 
complexes, including polypyridyl system and NHC-carbene system.376-387 As 
analogues to popular terpyridyl ligand system, pincer triazole based ligands, 
which could be readily prepared and modified via CuAAC click reaction22,23, 
have the great potential as novel ligand system for photoluminescent Pt(II) 
complexes. Meanwhile, Pt(II) complexes also show great catalytic activities 
for different kinds of important catalytic reactions. For example, alkyne 
hydrosilylation is an important reaction as it enables the synthesis of 
vinylsilane388, which is a useful precursor for many organic syntheses.389 
However, hydrosilylation of terminal alkynes generally yields three 
regioisomers: the α, β(E) and β(Z) isomers390, while hydrosilylation of internal 
alkynes forms two isomers: E and Z391. High and reliable regioselectivity is 
crucial in this reaction, which is metal and ligand dependent. Herein, we have 
designed and synthesized a series of novel Pt(II) compounds bearing pincer 
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triazole based ligands, their photoluminescence and catalytic selectivity and 
activity have also been investigated. In this chapter, two conjugated pincer 
1,2,3-triazole based ligands 2,6-bis(1-ethyl-1H-1,2,3-triazol-4-yl)pyridine 
(L22) and 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine (L24) have been 
synthesized via click method. Novel Pt(II) complexes including three dimers 
have been synthesized accordingly, which are [(L22)PtCl]Cl (31), 
[(L24)PtCl]Cl (32), [(L22)Pt(CH3CN)][BF4]2 (33), [(L24)Pt(CH3CN)][BF4]2 
(34), [(L24)Pt(H2O)][BF4]2 (35), [(L22)Pt(Py)][BF4]2 (36), 
[(L24)Pt(Py)][BF4]2 (37), [(L22)2Pt2(4-Py)2][BF4]4 (38), [(L22)2Pt2(4-
PyCH2)2][BF4]4 (39) and [(L22)2Pt2(4-PyCH)2][BF4]4 (40). The 
photoluminescent property of these Pt(II) complexes will be described and the 
catalytic application of them as catalysts in hydrosilylation reaction of 
terminal and internal alkynes will also be presented and discussed.  
 
7.2 Results and Discussion 
7.2.1 Synthesis and characterization of Pt(II) complexes 
Pincer triazole ligands L22 and L24 were synthesized according to the 
literature179,223,253,256, and two R groups (ethyl and phenyl group) with different 
steric bulk have been introduced into the 1-substituted position of triazole, 
respectively. The key point of this study is whether these R groups with 
different steric and electronic effect could affect the photo luminescent and 
catalytic properties of corresponding Pt(II) complexes.  
The synthetic routes of Pt(II) complexes 31‒40 including dimers have been 
summarized in Scheme 7.1 and 7.2. According to the following reaction 




223,392 in mixed MeOH/DCM solvents at r.t., and they are bright 
yellow solids. 
 
Scheme 7.1 Synthetic routes of Pt(II) complexes 31‒37. 
 
Subsequently, AgBF4 was used to extract the chloride ions in 31 and 32, and 
let solvent molecules, CH3CN, coordinate to Pt(II) centres to give oily 
complex 33 and 34 with uncoordinated BF4
- anions. Complex 34 was found to 
be quite hydrophilic, its coordinated CH3CN molecule could be gradually 
replaced by H2O molecule in atmosphere to provide complex 35. Then, 
complex 33 and 34 reacted with pyridine, which is stronger coordinated ligand 
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than CH3CN, to provide pyridine coordinated complex 36 and 37 via ligand 
exchange. 
Single crystals of complex 34‒36 were obtained by slow diffusion of diethyl 
ether into their concentrated acetonitrile solutions, which are shown in Fig 
7.1‒7.3. The known crystal structures demonstrated that conjugated triazole 
based ligands are pincer ligands, and their three N atoms including N4 of 
pyridyl group and N1/N1A of two triazoles all coordinated to distorted square 
planar Pt(II) centres. In details, in 34, with respect to the Pt(II) metal centre, 
the compound has a distorted square planar geometry as the bond angle of 
N4‒Pt1‒N1 and N4‒Pt1‒N1A are only 80.28 o, which is slightly smaller than 
the ideal 90o in the perfect square planar. Besides, due to the conjugated 
property of L24, atoms of L24 are also coplanar with the coordination plane. 
The bond distance of Pt1‒N4 is 1.949(7) Å, which is shortest among all four 
Pt‒N bonds. Meanwhile, the distance between Pt(II) centre and coordinated 
CH3CN (Pt1‒N5 1.968(7)) is shorter than the distance between Pt(II) centre 
and triazolyl moieties (Pt1‒N1 2.004(6)). In 35, the Pt(II) centre show the 
similar distorted square planar geometry (N4‒Pt1‒N1 79.89(13), 
N4‒Pt1‒N1A 79.89(13)), and the Pt1‒N4 distance (1.951(6)) is also the 
shortest one. Differently, the distance between Pt(II) centre and coordinated O 
atom from water (Pt1‒O1) is 2.059(6) Å, longest among all four Pt‒N bonds, 
which is much longer than Pt1‒N5 distance in 34. In 36, the Pt(II) metal centre 
is strictly coplanar with the four donor atoms (three N atoms from L22 and 
another N atom from coordinated pyridine). The Pt(II) centre also show the 
similar distorted square planar geometry (N4‒Pt1‒N1A 80.17(7), N4‒Pt1‒N1 
80.17(7)), and the Pt1‒N4 distance is 1.972(4) Å, which is shorter than the 
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other Pt‒N bonds. However, compared with 34 and 35, its Pt1‒N4 distance is 
longer, which may be due to the effect of R group of ligands. And the 
coordinated pyridine is slightly tilted away from the square planar plane as 
seen in Fig 7.3. 
 
Scheme 7.2 Synthetic routes of Pt(II) dinuclear complexes 38‒40. 
 
For dinuclear Pt(II) complex 38‒40, they were synthesized by reacting 33 with 
three assistant bridging ligands bearing bis-pyridyl moieties in methanol, 
respectively. In these three complexes, pincer ligands have the same 
coordination modes and Pt(II) centres show the similar distorted square planar 
coordinating geometries. However, different from former complexes, they 
contain two symmetric Pt(II) centres and have more bulky structures. All these 
Pt(II) complexes were characterized by ESI and NMR spectra. From the ESI-
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MS spectra, the molecular cation peaks of the complexes were observed. 
Assignment of the peaks in the NMR spectra was also possible. 
Except 35, the photo luminescent and catalytic properties of all Pt(II) 
complexes have been investigated and discussed. The effect on the 
fluorescence of complexes, and catalytic activity and selectivity to 
hydrosilylation reaction of different R groups of ligands and different leaving 
groups (such as Cl, CH3CN, H2O, pyridine and bridged bipyridyl groups) on 
Pt(II) centres will also be checked.   
 
 
Fig 7.1 ORTEP diagram of cation moiety of 34. (Pt1‒N4 1.949(7), Pt1‒N5 
1.968(7), Pt1‒N1 2.004(6), Pt1‒N1A 2.004(6); N4‒Pt1‒N5 180.000(1), 
N4‒Pt1‒N1 80.28(13), N5‒Pt1‒N1 99.72(13), N4‒Pt1‒N1A 80.28(13), 





Fig 7.2 ORTEP diagram of cation moiety of 35. (Pt1‒N4 1.951(6), Pt1‒N1 
2.004(4), Pt1‒N1A 2.004(4), Pt1‒O1 2.059(6); N4‒Pt1‒N1 79.89(13), 
N4‒Pt1‒N1A 79.89(13), N1‒Pt1‒N1A 159.8(3), N4‒Pt1‒O1 180.0, 
N1‒Pt1‒O1 100.11(13), N1A‒Pt1‒O1 100.11(13)) 
 
  
Fig 7.3 ORTEP diagram of cation moiety of 36. (Pt1‒N4 1.972(4), Pt1‒N1A 
2.001(2), Pt1‒N1 2.001(2), Pt1‒N5 2.021(4); N4‒Pt1‒N1A 80.17(7), 
N4‒Pt1‒N1 80.17(7), N1A‒Pt1‒N1 160.34(14), N4‒Pt1‒N5 180.0, 
N1A‒Pt1‒N5 99.83(7), N1‒Pt1‒N5 99.83(7)) 
 
7.2.2 Catalytic activity investigation of Pt(II) complexes in hydrosilylation 
of terminal and internal alkynes 
Hydrosilylation of alkynes represents the most straightforward, atom 
economical access to vinylsilane388. However, it is hard to achieve high and 
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reliable regioselectivity. Hydrosilylation of terminal alkynes generally yields 
three major regioisomers: the α, β(E) and β(Z) isomers. Generally, the α 
isomer can be obtained using [Cp*Ru]-based catalyst388,393, while the 
thermodynamically more stable β(E) isomer along with α isomer can be 
obtained using platinum catalysts394-399 and β(Z) isomer can be obtained using 
rhodium and iridium catalysts389,400-402. The hydrosilylation of internal alkynes 
on the other hand, albeit forms lesser products than its terminal counterpart, 
will still result in the formation of two isomers: E and Z. 
Pt(II) complexes as one kind of common catalysts could provide high 
selectivity, as well as high tolerance toward various functional groups403. 
Traditionally, the Speier system (H2PtCl6/i-PrOH) and the Karstedt complex 
(Pt2(dvtms)3, dvtms = divinyltetramethyldisiloxane) are the most popular 
catalysts due to their outstanding activities and high β(E) selectivities, which 
could achieve 90-99 % for a variety of terminal alkynes.395 One disadvantage 
of these complexes is easy to generate colloidal platinum species, which is 
responsible for kinds of side reactions. Recently, Qiu and co-workers have 
synthesized polydentate pincer N-heterocyclic carbene supported Pt(II) 
complexes, which can catalyze the hydrosilylation reaction to yield β(E) 
product with up to 90 % selectivity.398 In these Pt(II) complexes, the use of 
pincer ligands could stabilize the Pt(II) centres and avoid the dissociation of 
Pt(II) from the ligands. The strong coordination of pincer ligands also prevent 
the decomposition of the complexes, while the donor atoms and their 
substituents allow the fine tuning of the steric and electronic properties of 
complexes. Therefore, on this basis, the catalytic activity and selectivity of our 
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synthesized Pt(II) complexes with pincer pyridyl triazole ligands have been 
investigated in the hydrosilylation reaction. 
For the hydrosilylation of terminal alkyne reaction, typical phenylacetylene 
(1.0 mmol) and triethylsilane (1.05 mmol) were chosen as starting 
materials, and toluene was chosen as solvent. Phenylacetylene was used as 
the limited reagent, then it was unable to act as a proton acceptor 
efficiently, which could further reduce the amount of dehydrogenative by-
product formed.404 This reaction produced two major products, α and β(E) 
isomers, together with β(Z) isomer and dehydrogenative silylation product 
as minor products. Some trace amounts of reductive side products of 
styrene and ethylbenzene were also detected by GC-MS, which were 
neglectful. Identification of the products was done using GC-MS and 1H 
NMR. Firstly, the molecular weights of the products were determined from 
the molecular ion peaks in the GC-MS analysis. This enables us to identify 
the starting materials, internal standard, hydrogenative products and the 
dehydrogenative product. Then, for α, β(E) and β(Z) isomers with same 
molecular weight, which can't be distinguished from GC-MS spectra 
because of the same m/z ratio, 1H NMR was hence used to identify them 
based on the olefinic coupling constants. From the integration value of the 
characteristic peaks of 1H NMR spectra, selectivity among these three 
isomers could be obtained. The reaction conversion based on 
phenylacetylene was determined from the calibration curve prepared using 
dodecane as the internal standard, which is shown in Fig 7.4 and the data 




Table 7.1 Calculated data for calibration curve of phenylacetylene 
Conc.





Area Ratio of 
PA/Dodecane  
Mass of 
Dodecane/ g  
Mass of 
PA/ g  
Mass ratio of 
PA/Dodecane  
0  1288263277  0  0  0.0861  0  0  
0.025  1193359776  189558966  0.1588  0.0855  0.0133  0.1556  
0.05  1210978924  422841603  0.3492  0.0856  0.0282  0.3294  
0.1  1228257877  826025979  0.6725  0.0866  0.0521  0.6016  
0.15  1255593081  1298220199  1.0339  0.0852  0.0784  0.9202  
0.2  1198855205  1650164106  1.3764  0.0851  0.1072  1.2597  
 
 
Fig 7.4 Calibration curve of phenylacetylene 
 
Optimisation of the reaction condition was done prior to the actual 
experiment using catalyst 31 (Table 7.2). Different temperatures (r.t., 60 oC 
and 100 oC) and catalyst loadings (0, 0.1 and 1 mol %) were screened, and 
the final reaction condition was then set at 100 °C with 1 mol % catalyst 
loading in toluene accordingly to achieve the best activity. It is noteworthy 
that the selectivity of catalyst could be significantly affected by the 
reaction temperature. At 100 oC, α isomer was dominant, while at r.t. or 60 
oC, β(E) isomer was main product. 
Under optimised reaction condition, samples were taken hourly for 31 































Area ratio of PA/Dodecane
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selectivity changes over time. The samples were analyzed by GC-MS and 
the results listed in Table 7.3 confirmed that the selectivity generally didn't 
change over time. 
 














b / % β(E)
b
 / % β(Z)
b / % 
b / % 
24 r.t. 1 4 20  80  0  0  
24 60 1 100 21  68  3  8  
4 100 1 100 65  31  0  4  
24 100 0.1 98 69 30 0 1 
48 100 0 8 70 30 0 0 
a Conversion determine by GC based on phenylacetylene using dodecane as 
internal standard. b Product selectivity was quantified with GC-MS and 1H 
NMR. 
 
Table 7.3 Comparison of different reaction time on hydrosilylation of 
phenylacetylene with triethylsilane using 31. 
 




    
α
b / % β(E)
b
 / % β(Z)
b / % 
b / % 
31 1 13 61 37 0 2 
31  2  41  60  37  1  2  
31  3  79  54  40  1  5  
31  4  100  55  38  0  7  
31  5  100  56  39  1  4  
31  6  100  58  40  1  1  
31  7  100  58  41  1  0  
31  8  100  59  40  1  0  
31  24  100  59  40  1  0  
a Conversion determine by GC based on phenylacetylene using dodecane as 
internal standard. b Product selectivity was quantified with GC-MS. 
 
Using the optimised reaction condition, hydrosilylation of phenylacetylene 
with triethylsilane have been catalyzed by catalyst 31‒34 and 36‒40. 
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(Scheme 7.3) Meanwhile, several simple Pt(II) metal salts, including PtCl2, 
PtBr2 and Pt(acac)2 have also been involved for comparison. Based on the 
results summarized in Table 7.4, it is observed that these simple Pt(II) 
metal salts as catalysts prefer to give the β(E) isomer as the major product. 
However, pincer triazole ligand based Pt(II) complexes with the exception 
of 34 mainly afford α isomer, with the selectivity up to 71 %. The catalytic 
results of PtCl2 to Pt(acac)2 to pincer triazole based Pt(II) complexes 
suggest that Pt(II) center with bulkier ligands tend to produce more α 
isomer. However, the catalytic selectivity of all nine Pt(II) complexes are 
almost same, implying that neither the leaving group nor the R group 
attached to the triazole ligands affect selectivity. It's noted that catalysts 31 
and 32, which contain Cl as leaving group, show the better catalytic 
activity than the others. It is suggested that the leaving group could affect 
the catalytic activity, which may be due to the detachment step of the 
leaving group from the Pt(II) centre before the rate determining cis-trans 
isomerisation step.405,406 
Catalyst 34 shows an unusual catalytic result, which not only gives the best 
catalytic activity (full conversion in 2 h), but also shows converse 
selectivity, mainly providing β(E) isomer with 55 % selectivity. This result 
may be due to the unstability of 34, its hydrophilic property result in rapid 
conversion to 35 in atmosphere. Subsequently, hydrogen atom of 
coordinated H2O in 35 could be acidic to form OH coordinated Pt(II) 
complex. Therefore, the unusual catalytic result caused by this complicated 
mixture and the details of mixed complexes and catalytic process still 




Scheme 7.3 Reaction scheme of Pt(II) complexes catalyzed hydrosilylation of 
phenylacetylene 
 
Table 7.4 Catalytic activity and selectivity of catalysts 31‒34 and 36‒40 in the 




























 1 100 18 77 1 4 69 
PtBr
2
 1 100 16 74 3 7 76 
Pt(acac)
2
 4 100 39 53 1 7 84 
31 4 100 65 31 0 4 82 
32 4 100 66 30 0 4 78 
33 24 100 68 31 0 1 75 
34 2 100 28 55 2 15 85 
36 24 92 70 29 0 1 75 
37 24 96 66 32 0 2 76 
38 50 95 71 29 0 0 81 
39 96 82 71 29 0 0 60 
40 96 80 69 31 0 0 77 
a Conversion determine by GC based on phenylacetylene using dodecane as 
internal standard.  b Product selectivity was quantified with GC-MS and 1H 
NMR. c Isolated yields of mixtures of isomers after column chromatography. 
 
Hydrosilylation of diphenylacetylene with triethysilane was also carried out 
with Pt(II) complexes to examine their catalytic activity for the hydrosilylation 
of internal alkynes. (Scheme 7.4) As compared to the hydrosilylation of 
terminal alkynes, longer reaction time was needed because of less activity of 
internal alkynes. As shown in Table 7.5, only the E isomer product was 
formed as determined from the GC-MS analysis and confirmed by 1H NMR 
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spectra. The peak δ at 6.79 ppm corresponds to the proton attached to the 
double bond for E isomer. It was also noticed that 40 exhibited much higher 
activity than the other catalysts which was not observed in the hydrosilylation 














Scheme 7.4 Reaction scheme of Pt(II) complexes catalyzed hydrosilylation of 
diphenylacetylene 
 
Table 7.5 Catalytic activity and selectivity of catalysts 31‒34 and 36‒40 in 
the hydrosilylation of diphenylacetylene 
 
Cat. Time / d Conv.
a
 / % Eb / % Zb / % 
31 2 84 100 0 
32 2 77 100 0 
33 7 56 100 0 
34 4 58 100 0 
36 3 70 100 0 
37 3 74 100 0 
38 7 37 100 0 
39 7 37 100 0 
40 1 100 100 0 
a Conversion determine by GC based on diphenylacetylene using dodecane as 
internal standard. b Product selectivity was quantified with GC-MS and 1H 
NMR. 
 
For the mechanism of Pt(II) catalyzed hydrosilylation of alkynes, despite the 
study have been started since 1974,407 it is still not well understood because 
catalytically active intermediates are difficult to isolate and characterize. 
Currently, the widely accepted mechanism is the Chalk-Harrod 
Mechanism408,409. However, this mechanism fails to account for the formation 
of dehydrogenative product.  
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Hence, based on our catalytic results, a plausible modified Chalk-Harrod 
Mechanism (Scheme 7.5) was proposed to give a better understanding of this 
catalytic reaction.  
 
Scheme 7.5 A plausible modified Chalk-Harrod Mechanism 
 
In the modified mechanism, alkynes inserts into the metal-silane bond instead 
of the metal-hydride bond. There are two possible ways of alkyne insertion: 1) 
the silane group would be on the same side of the R group, when this 
intermediate undergo reductive elimination, α isomer would be formed; 2) the 
silane group would be on the opposite side of the R group to give β(E) isomer. 
Meanwhile, the intermediate with the silane group on the opposite side of the 
R group could undergo isomerisation through a zwitterionic carbene-like 
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intermediate, which could be stabilized by the α silyl group, or a η2-vinyl 
complex. This helps to relief steric strain between the metal and the adjacent 
silane. Then this intermediate could undergo reductive elimination to provide 
β(Z) isomer. The same intermediate could also undergo β-hydride elimination 
to eventually form the dehydrogenative product.  
 
7.2.3 Preliminarily photoluminescent properties of Pt(II) complexes 
The pincer triazole ligands and corresponding Pt(II) complexes are all 
photoluminescence active at r.t.. For ligand L22 and L24, thanks to their 
conjugated structures, they show photoluminescent emissions between 
320‒470 nm (λem = 368 & 386 nm) under excitation wavelengths of 336 and 
352 nm in CH2Cl2 (0.01M), respectively. L24 shows much stronger emission 
than L22 because of its conjugated phenyl groups. For an array of 
corresponding Pt(II) complexes, due to the limited solubility of complex 31, 
32, 36 and 37, the fluorescence properties of them were analyzed in solid state 
and the normalized spectra are shown in Fig 7.6. These emission spectra have 
the maximum wavelength λmax at 477, 455, 426 and 418 nm with excitation 
wavelength λex = 310, 320, 350 & 300 nm, respectively. Meanwhile, 
photoluminescent spectra of 33 and 38‒40 in CH3CN are exhibited in Fig 7.7 
and these four complexes show similar emissions, with the λmax at ~400 nm 
(excitation wavelength λex = 345, 346, 343 & 332 nm, respectively), which are 
blue shift compared to the analogous terpyridyl Pt(II) complexes.378,410 The 





Fig 7.5 Photoluminescent spectra of ligand L22 and L24 in DCM (0.01M) at 
r.t. (Excitation wavelength λex = 336 & 352 nm; Emission wavelength λem = 
368 & 386 nm)  
 
 
Fig 7.6 Solid state emission spectra of 31, 32, 36 and 37 at r.t. (λex = 310, 320, 




Fig 7.7 Photoluminescent spectra of 33 and 38‒40 in CH3CN at r.t. (λex = 345, 
346, 343 & 332 nm; λem = 405, 396, 391 & 402 nm)  
 
Table 7.6 The photoluminescent data of Pt(II) complexes 31‒40. 
Complex λex / nm λem / nm status 
31 310 477 solid 
32 320 455 solid 
33 345 405 CH3CN solution 
36 350 426 solid 
37 300 418 solid 
38 346 396 CH3CN solution 
39 343 391 CH3CN solution 
40 332 402 CH3CN solution 
 
7.3 Conclusion 
Two conjugated 1,2,3-triazole 2,6-bis(1-ethyl-1H-1,2,3-triazol-4-yl)pyridine 
(L22) and 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine (L24) have been 
synthesized by CuAAC click reaction and used to support novel 
photoluminescent Pt(II) complexes bearing pincer ligands. These Pt(II) 
complexes show attractive solution photoluminescent properties, whose 
emissions are around 400 nm, blue shift compared to the similar terpyridyl 
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Pt(II) complexes. Their application as catalysts in hydrosilylation reaction of 
terminal and internal alkynes also gives promising results (for phenylacetylene, 
α-isomer selectivity up to 71%; for diphenylacetylene, only E isomer afforded), 
which have shown that they are potentially new catalysts. Further 
investigation of photoluminescence and more insight into the catalytic process 
is still under progress. 
7.4 Experimental Section  
Materials and physical measurements 
The synthesis of precursors and ligands have been presented in chapter 1.  
Synthesis of Pt(II) complexes 
Synthesis of [(L22)PtCl]Cl (31). Ligand L22 (0.2 mmol, 53.9 mg) and 
metal precursor Pt(DMSO)2Cl2 (0.2 mmol, 84.5 mg) were added in 20 mL 
CH3OH/CH2Cl2 (1:1) mixed solvent in a round-bottomed flask. The 
reaction mixture was stirred overnight at r.t. in atmosphere. The formed 
precipitate was collected by filtration under vacuum and washed by ether. 
The obtained bright yellow solid was dried under vacuum. Yield: 87.8 mg, 
82 %. Anal. Calcd. for C13H15Cl2N7Pt (535.30): C, 29.17; H, 2.82; N, 
18.32. Found: C, 29.23; H, 3.36; N, 18.18 %. ESI-MS (m/z, %) required for 
C13H15Cl2N7Pt (535.30): [(L22)PtCl]
+ (500, 100), [(L22)2Pt2Cl3]
+ (1035, 
14). 1H NMR (500 MHz, DMSO): δ (ppm) 9.37 (s, 2H, triazole-H), 8.53-
8.8.50 (t, 1H, Py-Hp), 8.24 and 8.22 (d, 2H, Py-Hm), 4.69-4.65 (m, 4H, 
CH2), 1.58-1.55 (t, 6H, CH3). 
13C NMR (125.77 MHz, DMSO): δ (ppm) 
150.29 (s, C(Py)), 149.94 (s, C(Py)), 143.17 (s, C(Triazole)), 127.80 (s, 
CH(Triazole)), 122.89 (s, C(Py)), 48.26 (s, CH2), 15.33 (s, CH3). 
Synthesis of [(L24)PtCl]Cl (32). Complex 32 was synthesized using a 
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similar procedure to 31 by replacing ligand L22 with ligand L24 (0.2 
mmol, 73.1 mg). Yield: 85.9 mg, 68 %. Anal. Calcd. for C21H15Cl2N7Pt 
(631.38): C, 39.95; H, 2.39; N, 15.53. Found: C, 37.53; H, 3.04; N, 14.46 
%. ESI-MS (m/z, %) required for C21H15Cl2N7Pt (631.38): [(L24)PtCl]
+ 
(596, 100), [(L24)2Pt2Cl3]
+ (1228, 3). 1H NMR (500 MHz, DMSO): δ 
(ppm) 9.39 (s, 2H, triazole-H), 8.09 (m, 3H, Py-Hp and Py-Hm), 8.03-8.02 
(m, 4H, Ph-H), 7.69-7.66 (m, 4H, Ph-H), 7.58-7.55 (t, 2H, Ph-H). 13C NMR 
(125.77 MHz, DMSO): δ (ppm) 149.43 (s, C(Py)), 148.14 (s, C(Py)), 
138.61 (s, C(Triazole)), 136.54 (s, C(Ph)), 129.98 (s, CH(Ph)), 129.04 (s, 
CH(Ph)), 121.89 (s, CH(Triazole)), 120.36 (s, CH(Py)), 118.82 (s, 
CH(Ph)). 
Synthesis of [(L22)Pt(CH3CN)][BF4]2 (33). Complex 31 (0.1 mmol, 53.5 
mg) reacted with excess AgBF4 (0.24 mmol, 46.7 mg) in CH3CN in a 
round-bottomed flask. The reaction mixture was stirred overnight in dark at 
r.t. The resulted suspension was exposed to the light and then filtered 
through celite under vacuum to get rid of silver chloride. The obtained 
yellow solution was dried under vacuum to give yellow oil. Yield: 51.6 mg, 
76 %. Anal. Calcd. for C15H18B2F8N8Pt (679.05): C, 26.53; H, 2.67; N, 
16.50%. ESI-MS (m/z, %) required for C15H18B2F8N8Pt (679.05): 
[(L22)Pt(CH3CN)]
2+ (253, 100), [(L22)Pt(CH3CN)(BF4)]
+ (592, 10). 1H 
NMR (500 MHz, CD3CN): δ (ppm) 8.72 (s, 2H, triazole-H), 8.38 (m, 1H, 
Py-Hp), 8.04 (d, 2H, Py-Hm), 4.58 (m, 4H, CH2), 1.95 (s, 3H, CNCH3), 1.60 
(m, 6H, CH3). 
Synthesis of [(L24)Pt(CH3CN)][BF4]2 (34). Complex 34 was synthesized 
using a similar procedure to 33 by replacing starting complex 31 with 32 
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(0.1 mmol, 63.1 mg). The single crystals of 34 were gotten by slow 
diffusion of diethyl ether into the concentrated solution of 34 in CH3CN 
after three days. Yield: 52.7 mg, 68 %. ESI-MS (m/z, %) required for 
C23H18B2F8N8Pt (775.14): [(L24)Pt(CH3CN)]
2+ (301, 100), 
[(L24)Pt(CH3CN)(BF4)]
+ (688, 63). Anal. Calcd. for C23H18B2F8N8Pt 
(775.14): C, 35.64; H, 2.34; N, 14.46 %. 1H NMR (500 MHz, CD3CN): δ 
(ppm) 9.26 (s, 2H, triazole-H), 8.51-8.48 (t, 1H, Py-Hp), 8.18 and 8.16 (d, 
2H, Py-Hm), 7.94-7.92 (m, 4H, Ph-H), 7.76-7.71 (m, 6H, Ph-H), 1.96 (s, 
3H, CNCH3). 
Complex 34 which is yellow oil would gradually change to deep blue 
complex [(L24)Pt(H2O)][BF4]2 (35) in atmosphere after several days by 
spontaneously replacing the coordinated CH3CN with H2O in air and the 
single crystals of 35 were also been obtained using the same crystallization 
method. Anal. Calcd. for C21H17B2F8N7OPt (752.10): C, 33.54; H, 2.28; N, 
13.04 %. 1H NMR (500 MHz, CD3CN): δ (ppm) 9.26 (s, 2H, triazole-H), 
8.51-8.48 (t, 1H, Py-Hp), 8.18 and 8.16 (d, 2H, Py-Hm), 7.94-7.92 (m, 4H, 
Ph-H), 7.76-7.71 (m, 6H, Ph-H), 2.51 (s, 2H, H2O). 
Synthesis of [(L22)Pt(Py)][BF4]2 (36). Complex 33 (0.1 mmol, 67.9 mg) 
was added into 5 mL pyridine in a 25 mL round-bottomed flask and stirred 
overnight at r.t in atmosphere. Then the reaction solution was dried under 
vacuum to remove extra pyridine. The formed precipitate was stirred in 
ether, collected by filtration under vacuum and washed by ether again. The 
obtained pale white solid was dried under vacuum. The single crystals of 
36 were gotten by slow diffusion of diethyl ether into the concentrated 
solution of 36 in CH3CN after three days. Yield: 54.5 mg, 76 %. Anal. 
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Calcd. for C18H20B2F8N8Pt (717.10): C, 30.15; H, 2.81; N, 15.63. Found: C, 
30.25; H, 2.72; N, 15.67 %. ESI-MS (m/z, %) required for C18H20B2F8N8Pt 
(717.10): [(L22)PtPy]2+ (272, 42), [(L22)PtPy(BF4)]
+ (630, 100). 1H NMR 
(500 MHz, CD3CN): δ (ppm) 9.02 (d, 2H, Py-Ho), 8.78 (s, 2H, triazole-H), 
8.43 (m, 1H, Py-Hp), 8.31 (m, 1H, Py-Hp), 8.11 (d, 2H, Py-Hm), 7.81 (m, 
2H, Py-Hm), 4.60 (m, 4H, CH2), 1.60 (m, 6H, CH3). 
13C NMR (125.77 
MHz, CD3CN): δ (ppm) 153.5 (s, Py), 150.5 (s, Py), 148.5 (s, Py), 145.1 (s, 
Py), 141.9 (s, triazole), 127.8 (s, Py), 127.4 (s, Py), 121.4 (s, triazole), 49.2 
(s, CH2), 13.9 (s,CH3).  
Synthesis of [(L24)Pt(Py)][BF4]2 (37). Complex 37 was synthesized using 
a similar procedure to 36 by replacing starting complex 33 with 34 (0.1 
mmol, 77.5 mg). Yield: 52.9 mg, 65 %. Anal. Calcd. for C26H20B2F8N8Pt 
(813.18): C, 38.40; H, 2.48; N, 13.78. Found: C, 38.30; H, 2.84; N, 10.73 
%. ESI-MS (m/z, %): [(L24)PtPy]2+ (320, 100), [(L24)PtPy(BF4)]
+ (726, 
21). 
Synthesis of [(L22)2Pt2(4-Py)2][BF4]4 (38). Complex 33 (0.1 mmol, 67.9 
mg) and 4,4'-bipyridine (0.05 mmol, 7.8 mg) were dissolved in MeOH 
respectively and mixed in a round-bottomed flask. The reaction mixture 
was stirred overnight at r.t. in atmosphere. The obtained suspension was 
filtered under vacuum and washed by MeOH and ether. The collected solid 
was dried under vacuum. Yield: 41.5 mg, 58 %. Anal. Calcd. for 
C36H38B4F16N16Pt2 (1432.18): C, 30.19; H, 2.67; N, 15.65. ESI-MS (m/z, 
%) required for C36H38B4F16N16Pt2 (1432.18): [(L22)Pt(4-Py)2]
2+ (311, 
100), [(L22)2Pt2(4-Py)2(BF4)]
3+ (391, 4), [(L22)2Pt2(4-Py)2(BF4)2]
2+ (629, 
3), [(L22)Pt(4-Py)2(BF4)]
+ (707, 62). 1H NMR (500 MHz, CD3CN): δ 
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(ppm) 9.25 (d, 4H, Py-Ho), 8.81 (s, 4H, triazole-H), 8.47 (m, 2H, Py-Hp), 
8.25 (d, 4H, Py-Hm), 8.12 (d, 4H, Py-Hm), 4.63 (m, 8H, CH2), 1.63 (m, 
12H, CH3). 
Synthesis of [(L22)2Pt2(4-PyCH2)2][BF4]4 (39). Complex 39 was 
synthesized using a similar procedure to 38 by replacing 4,4'-bipyridine 
with 1,2-di(pyridin-4-yl)ethane (0.05 mmol, 9.2 mg). Yield: 40.2 mg, 55 %. 
Anal. Calcd. for C38H42B4F16N16Pt2 (1460.24): C, 31.26; H, 2.90; N, 15.35. 
ESI-MS (m/z, %): [(L22)2Pt2(4-PyCH2)2]
4+ (278, 22), [(L22)Pt(4-
PyCH2)2]
2+ (324, 100), [(L22)2Pt2(4-PyCH2)2(BF4)]
3+ (400, 15), 
[(L22)2Pt2(4-PyCH2)2(BF4)2]
2+ (643, 10), [(L22)Pt(4-PyCH2)2(BF4)]
+ (735, 
50). 
Synthesis of [(L22)2Pt2(4-PyCH)2][BF4]4 (40). Complex 40 was 
synthesized using a similar procedure to 38 by replacing 4,4'-bipyridine 
with (E)-1,2-di(pyridin-4-yl)ethene (0.05 mmol, 9.1 mg). Yield: 40.1 mg, 
55 %. Anal. Calcd. for C38H40B4F16N16Pt2 (1458.22): C, 31.30; H, 2.76; N, 
15.37. ESI-MS (m/z, %) required for C38H40B4F16N16Pt2 (1458.22): 
[(L22)2Pt2(4-PyCH)2]
4+ (278, 16), [(L22)Pt(4-PyCH)2]
2+ (323, 100), 
[(L22)2Pt2(4-PyCH)2(BF4)]
3+ (399, 12), [(L22)2Pt2(4-PyCH)2(BF4)2]
2+ 
(642, 9), [(L22)Pt(4-PyCH)2(BF4)]
+ (733, 58). 1H NMR (500 MHz, 
CD3CN): δ (ppm) 9.06 (d, 4H, Py-Ho), 8.80 (s, 4H, triazole-H), 8.44 (m, 
2H, Py-Hp), 8.12 (d, 4H, Py-Hm), 8.00 (d, 4H, Py-Hm), 7.81 (s, 2H, CH), 
4.63 (m, 8H, CH2), 1.62 (m, 12H, CH3). 
 
General procedures for Hydrosilylation of Terminal and Internal 
Alkynes with Triethylsilane: Pt(II) catalyst (0.01 mmol) in toluene (5.0 
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mL) was added to a schlenk tube equipped with a magnetic stirrer and a 
nitrogen inlet. Dodecane (0.084 g, 0.5 mmol), phenylacetylene (0.10 g, 1 
mmol) or diphenylacetylene (0.18 g, 1 mmol) and triethylsilane (0.12 g, 
1.05 mmol), were added in quick successions via syringe to the reaction 
mixture. The reaction mixture was stirred under nitrogen at 100 °C. 
Samples were taken periodically in intervals for GC-MS analysis. After the 
reaction had gone to completion, the reaction was stopped and the crude 
mixture was filtered through a silica gel column with hexane, stripped of 
solvent, and analyzed by 1H NMR spectroscopy. The isolated yields of 
products were gotten and the selectivity of products were determined by 
GC-MS and confirmed by 1H NMR. 
 
Identification of Alkenylsilanes and Dehydrogenative Silylation 
Product. The molecular weights of the alkenylsilanes were determined 
from the molecular ion peaks in the GC-MS analysis. The regiochemistry 
and stereochemistry of the alkenylsilane isomers were determined from 1H 
NMR based on the olefinic coupling constants.405,411 For the β(Z) and β(E) 
isomers, the two CH=CH' vinyl resonances from 5 to 7.5 ppm show 
characteristic coupling. When these protons are mutually trans, 3J(H,H') 
coupling is in the typical range of 18‒20 Hz. When the protons are 
mutually cis, 3J(H,H') coupling is typically between 12 and 16 Hz. For the α 
isomer, the vinylic protons are geminal and the 2J(H,H') coupling found in 
this case is much smaller than 3J(H,H') coupling, which is about 0‒3 Hz.  
The hydrosilylation of phenylacetylene with triethylsilane yields three 
isomers which have been previously reported in the literature390: α-
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(triethylsilyl)styrene, cis-β-(triethylsilyl)styrene, and trans- β-
(triethylsilyl)styrene. These three products were unambiguously determined 
on the basis of the olefinic coupling constants in the 1H NMR spectra. 
Meanwhile, the product of dehydrogenative silylation reaction was 
identified based on their m/z data and characteristic MS fragmentation 
patters, determined by GC-MS.  
The hydrosilylation of diphenylacetylene with triethylsilane yields two 
isomers391: triethyl((E)-1,2-diphenylvinyl)silane and triethyl((Z)-1,2-
diphenylvinyl)silane. These two products were determined by the position 
of characteristic olefinic proton in the 1H NMR spectra. 
The detailed information for identification of these products have been 
summarized as follows. 
α-(Triethylsilyl)styrene, α. GC-MS: m/z = 218. 1H NMR (CD2Cl2) δ 5.85 (d, 
J = 2.5 Hz), 5.57 (d, J = 2.5 Hz). 
Trans-β-(triethylsilyl)styrene, β(E). GC-MS: m/z = 218. 1H NMR (CD2Cl2) δ 
6.90 (d, J = 19.5 Hz), 6.44 (d, J = 19.5 Hz). 
Cis-β-(triethylsilyl)styrene, β(Z). GC-MS: m/z = 218. 1H NMR (CD2Cl2) δ 
7.58 (d, J = 15.1 Hz), 5.89 (d, J = 15.1 Hz). 
Triethyl(phenylethynyl)silane. GC-MS: m/z = 216. MS fragmentation 
pattern: 216, 187, 159, 131, and 105. 
Triethyl((E)-1,2-diphenylvinyl)silane, E. GC-MS: m/z = 294. 1H NMR 







Table 7.7 Crystallographic data and refinement parameters for complexes 
34‒36. 
 
Complex 34 35 36 
Formula C23H18B2F8N8Pt C21H19B2F8N7O2Pt C18H20B2F8N8Pt 
MW 775.16 770.14 717.13 
T / K 100(2) 100(2) 100(2) 
Crystal size / 
mm3 
0.15×0.13×0.05 0.36×0.26×0.16 0.50×0.36×0.30 
Crystal system Monoclinic Monoclinic Orthorhombic 
Space group C2/c C2/c Pbcn 
a / Å 12.387(7) 12.211(2) 7.7753(8) 
b / Å 18.415(11) 18.003(2) 13.7213(15) 
c / Å 11.121(6) 10.9444(16) 21.774(2) 
α / ° 90 90 90 
β / ° 93.872(13) 93.203(7) 90 
γ / ° 90 90 90 
V / Å3 2531(3) 2402.2(7) 2323.0(4) 
Z 4 4 4 
Dcalc / g·cm
−3 2.034 2.129 2.050 
µ / mm−1 5.635 5.941 6.130 
θ range / ° 1.98‒27.48 2.263‒27.497 1.87‒27.50 
Reflections 
collected 
8717 46360 15356 
Independent 
reflections [Rint] 
2890 [0.0517] 2764 [0.0364] 2667 [0.0332] 
Parameters 194 222 171 
GOF 0.999 1.041 1.080 
R1(I > 2σ(I)) 0.0357 0.0280 0.0220 
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